UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period ended March 31, 2020
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From ________ to ________.
 
Commission File Number 001-35750 
First Internet Bancorp
(Exact Name of Registrant as Specified in Its Charter)
Indiana
 
20-3489991
(State or Other Jurisdiction of
Incorporation or Organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
11201 USA Parkway
Fishers, IN
 
46037
(Address of Principal Executive Offices)
 
(Zip Code)
 
(317) 532-7900
 
 
(Registrant’s Telephone Number, Including Area Code)
 

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbols
 
Name of each exchange on which registered
Common Stock, without par value
 
INBK
 
The Nasdaq Stock Market LLC
6.0% Fixed to Floating Subordinated Notes due 2026
 
INBKL
 
The Nasdaq Stock Market LLC
6.0% Fixed to Floating Subordinated Notes due 2029
 
INBKZ
 
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ No ¨
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer ¨
Accelerated Filer þ
Non-accelerated Filer ¨ 
Smaller Reporting Company þ
Emerging growth company ¨
 





If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ
 
As of May 1, 2020, the registrant had 9,801,825 shares of common stock issued and outstanding.




Cautionary Note Regarding Forward-Looking Statements
  
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the federal securities laws. These statements are not historical facts, but rather statements based on the current expectations of First Internet Bancorp and its consolidated subsidiaries (“we,” “our,” “us” or the “Company”) regarding its business strategies, intended results and future performance. Forward-looking statements are generally preceded by terms such as “anticipate,” “attempt,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “pending,” “plan,” “position,” “preliminary,” “remain,” “should,” “will,” “would” and other similar expressions. Forward-looking statements are not a guarantee of future performance or results, are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the information in the forward-looking statements. The COVID-19 pandemic crisis is adversely affecting us, our customers, counterparties, employees, and third-party service providers, and the ultimate extent of the impacts on our business, financial position, results of operations, liquidity, and prospects remains uncertain. Continued deterioration in general business and economic conditions, including further increases in unemployment rates, or turbulence in domestic or global financial markets could adversely affect our revenues and the values of our assets and liabilities, reduce the availability of funding, lead to a tightening of credit, and further increase stock price volatility. In addition, changes to statutes, regulations, or regulatory policies or practices as a result of, or in response to COVID-19, could affect us in substantial and unpredictable ways. Other factors that may cause such differences include: general economic conditions, whether national or regional, and conditions in the lending markets in which we participate that may have an adverse effect on the demand for our loans and other products; our credit quality and related levels of nonperforming assets and loan losses, and the value and salability of the real estate that we own or that is the collateral for our loans; failures or breaches of or interruptions in the communication and information systems on which we rely to conduct our business that could reduce our revenues, increase our costs or lead to disruptions in our business; our plans to grow our commercial real estate, commercial and industrial, public finance, U.S. Small Business Administration and healthcare finance loan portfolios, which may carry greater risks of non-payment or other unfavorable consequences; our dependence on capital distributions from First Internet Bank of Indiana (the “Bank”); results of examinations of us by our regulators, including the possibility that our regulators may, among other things, require us to increase our allowance for loan losses or to write-down assets; changing bank regulatory conditions, policies or programs, whether arising as new legislation or regulatory initiatives, that could lead to restrictions on activities of banks generally, or the Bank in particular; more restrictive regulatory capital requirements; increased costs, including deposit insurance premiums; regulation or prohibition of certain income producing activities or changes in the secondary market for loans and other products; changes in market rates and prices that may adversely impact the value of securities, loans, deposits and other financial instruments and the interest rate sensitivity of our balance sheet; our liquidity requirements being adversely affected by changes in our assets and liabilities; the effect of legislative or regulatory developments, including changes in laws concerning taxes, banking, securities, insurance and other aspects of the financial services industry; competitive factors among financial services organizations, including product and pricing pressures and our ability to attract, develop and retain qualified banking professionals; execution of future acquisition, reorganization or disposition transactions, including without limitation, the related time and costs of implementing such transactions, integrating operations as part of these transactions and possible failures to achieve expected gains, revenue growth and/or expense savings and other anticipated benefits from such transactions; changes in applicable tax laws; the growth and profitability of noninterest or fee income being less than expected; the loss of any key members of senior management; the effect of changes in accounting policies and practices, as may be adopted by the Financial Accounting Standards Board, the Securities and Exchange Commission (the “SEC”), the Public Company Accounting Oversight Board and other regulatory agencies; and the effect of fiscal and governmental policies of the United States federal government. Additional factors that may affect our results include those discussed in this Quarterly Report on Form 10-Q, our most recent Annual Report on Form 10-K under the heading “Risk Factors” and in other reports filed with the SEC. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The factors listed above could affect our financial performance and could cause our actual results for future periods to differ materially from any opinions or statements expressed with respect to future periods in any current statements.
Except as required by law, we do not undertake, and specifically disclaim any obligation, to publicly release the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.


i



PART I

ITEM 1.
FINANCIAL STATEMENTS 

First Internet Bancorp
Condensed Consolidated Balance Sheets
(Amounts in thousands except share data)
 
 
March 31, 2020
 
December 31, 2019
 
 
(Unaudited)
 
 
Assets
 
 

 
 

Cash and due from banks
 
$
5,726

 
$
5,061

Interest-bearing deposits
 
345,542

 
322,300

Total cash and cash equivalents
 
351,268

 
327,361

Securities available-for-sale, at fair value (amortized cost of $608,567 and $546,640 in 2020 and 2019, respectively)
 
608,682

 
540,852

Securities held-to-maturity, at amortized cost (fair value of $69,468 and $62,560 in 2020 and 2019, respectively)
 
66,331

 
61,878

Loans held-for-sale (includes $52,394 and $56,097 at fair value in 2020 and 2019, respectively)
 
52,394

 
56,097

Loans
 
2,892,093

 
2,963,547

Allowance for loan losses
 
(22,857
)
 
(21,840
)
Net loans
 
2,869,236

 
2,941,707

Accrued interest receivable
 
16,960

 
18,607

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

Cash surrender value of bank-owned life insurance
 
37,238

 
37,002

Premises and equipment, net
 
18,883

 
14,630

Goodwill
 
4,687

 
4,687

Servicing asset, at fair value
 
2,415

 
2,481

Other real estate owned
 
2,065

 
2,065

Accrued income and other assets
 
112,337

 
67,066

Total assets
 
$
4,168,146

 
$
4,100,083

Liabilities and Shareholders’ Equity
 
 

 
 

Liabilities
 
 

 
 

Noninterest-bearing deposits
 
$
70,562

 
$
57,115

Interest-bearing deposits
 
3,107,944

 
3,096,848

Total deposits
 
3,178,506

 
3,153,963

Advances from Federal Home Loan Bank
 
514,911

 
514,910

Subordinated debt, net of unamortized debt issuance costs of $2,395 and $2,472 in 2020 and 2019, respectively
 
69,605

 
69,528

Accrued interest payable
 
3,293

 
3,767

Accrued expenses and other liabilities
 
96,704

 
53,002

Total liabilities
 
3,863,019

 
3,795,170

Commitments and Contingencies
 


 


Shareholders’ Equity
 
 

 
 

Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none
 

 

Voting common stock, no par value; 45,000,000 shares authorized; 9,801,825 and 9,741,800 shares issued and outstanding in 2020 and 2019, respectively
 
219,893

 
219,423

Nonvoting common stock, no par value; 86,221 shares authorized; issued and outstanding - none
 

 

Retained earnings
 
105,100

 
99,681

Accumulated other comprehensive loss
 
(19,866
)
 
(14,191
)
Total shareholders’ equity
 
305,127

 
304,913

Total liabilities and shareholders’ equity
 
$
4,168,146

 
$
4,100,083


See Notes to Condensed Consolidated Financial Statements

1



First Internet Bancorp
Condensed Consolidated Statements of Income – Unaudited
(Amounts in thousands except share and per share data)
 
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Interest Income
 
 

 
 

Loans
 
$
30,408

 
$
29,218

Securities – taxable
 
3,619

 
3,324

Securities – non-taxable
 
572

 
684

Other earning assets
 
1,645

 
1,773

Total interest income
 
36,244

 
34,999

Interest Expense
 
 

 
 

Deposits
 
17,208

 
15,386

Other borrowed funds
 
4,018

 
3,369

Total interest expense
 
21,226

 
18,755

Net Interest Income
 
15,018

 
16,244

Provision for Loan Losses
 
1,461

 
1,285

Net Interest Income After Provision for Loan Losses
 
13,557

 
14,959

Noninterest Income
 
 

 
 

Service charges and fees
 
212

 
236

Loan servicing revenue
 
251

 

Loan servicing asset revaluation
 
(179
)
 

Mortgage banking activities
 
3,668

 
1,617

Gain (loss) on sale of loans
 
1,801

 
(104
)
Gain on sale of securities
 
41

 

Other
 
417

 
623

Total noninterest income
 
6,211

 
2,372

Noninterest Expense
 
 

 
 

Salaries and employee benefits
 
7,774

 
6,321

Marketing, advertising and promotion
 
375

 
469

Consulting and professional services
 
1,177

 
814

Data processing
 
375

 
317

Loan expenses
 
599

 
314

Premises and equipment
 
1,625

 
1,500

Deposit insurance premium
 
485

 
555

Other
 
1,076

 
819

Total noninterest expense
 
13,486

 
11,109

Income Before Income Taxes
 
6,282

 
6,222

Income Tax Provision
 
263

 
526

Net Income
 
$
6,019

 
$
5,696

Income Per Share of Common Stock
 
 

 
 

Basic
 
$
0.62

 
$
0.56

Diluted
 
$
0.62

 
$
0.56

Weighted-Average Number of Common Shares Outstanding
 
 

 
 

Basic
 
9,721,485

 
10,217,637

Diluted
 
9,750,528

 
10,230,531

Dividends Declared Per Share
 
$
0.06

 
$
0.06


See Notes to Condensed Consolidated Financial Statements

2



First Internet Bancorp
Condensed Consolidated Statements of Comprehensive Income – Unaudited
(Amounts in thousands)
 
 
Three Months Ended March 31,
 
 
2020
 
2019
Net income
 
$
6,019

 
$
5,696

Other comprehensive loss (income)
 
 
 
 
Net unrealized holding gains on securities available-for-sale recorded within other comprehensive (loss) income before income tax
 
6,299

 
6,910

Reclassification adjustment for gains realized
 
(41
)
 

Net unrealized holding losses on cash flow hedging derivatives recorded within other comprehensive (loss) income before tax
 
(13,458
)
 
(3,572
)
Other comprehensive (loss) income before income tax
 
(7,200
)
 
3,338

Income tax (benefit) provision
 
(1,525
)
 
965

Other comprehensive (loss) income
 
(5,675
)
 
2,373

Comprehensive income
 
$
344

 
$
8,069

 
 See Notes to Condensed Consolidated Financial Statements

3




First Internet Bancorp
Condensed Consolidated Statements of Changes in Shareholders’ Equity - Unaudited
Three Months Ended March 31, 2020 and 2019
(Amounts in thousands except per share data)
 
 
Voting and
Nonvoting
Common
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Loss
 
Total
Shareholders’
Equity
Balance, January 1, 2020
 
$
219,423

 
$
99,681

 
$
(14,191
)
 
$
304,913

Net income
 

 
6,019

 

 
6,019

Other comprehensive loss
 

 

 
(5,675
)
 
(5,675
)
Dividends declared ($0.06 per share)
 

 
(600
)
 

 
(600
)
Recognition of the fair value of share-based compensation
 
555

 

 

 
555

Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units
 
8

 

 

 
8

Common stock redeemed for the net settlement of share-based awards
 
(93
)
 

 

 
(93
)
Balance, March 31, 2020
 
$
219,893

 
$
105,100

 
$
(19,866
)
 
$
305,127

 
 
 
 
 
 
 
 
 
Balance, January 1, 2019
 
$
227,587

 
$
77,689

 
$
(16,541
)
 
$
288,735

Impact of adoption of new accounting standards (1)
 

 
(821
)
 

 
(821
)
Net income
 

 
5,696

 

 
5,696

Other comprehensive income
 

 

 
2,373

 
2,373

Dividends declared ($0.06 per share)
 

 
(618
)
 

 
(618
)
Recognition of the fair value of share-based compensation
 
478

 

 

 
478

Repurchase of common stock
 
(1,746
)
 
 
 
 
 
(1,746
)
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units
 
10

 

 

 
10

Common stock redeemed for the net settlement of share-based awards
 
(94
)
 

 

 
(94
)
Balance, March 31, 2019
 
$
226,235

 
$
81,946

 
$
(14,168
)
 
$
294,013


(1) Represents the impact of adopting Accounting Standards Update (“ASU”) 2017-08.

See Notes to Condensed Consolidated Financial Statements











4



First Internet Bancorp
Condensed Consolidated Statements of Cash Flows – Unaudited
(Amounts in thousands)
 
 
Three Months Ended March 31,
 
 
2020
 
2019
Operating Activities
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Adjustments to reconcile net income to net cash used in operating activities:
 
 

 
 

Depreciation and amortization
 
1,644

 
2,271

Increase in cash surrender value of bank-owned life insurance
 
(236
)
 
(234
)
Provision for loan losses
 
1,461

 
1,285

Share-based compensation expense
 
555

 
478

Gain on sale of available-for-sale securities
 
(41
)
 

Loans originated for sale
 
(215,385
)
 
(75,239
)
Proceeds from sale of loans
 
225,547

 
81,048

Gain on loans sold
 
(6,144
)
 
(1,369
)
(Increase) decrease in fair value of loans held-for-sale
 
(316
)
 
182

Loss (gain) on derivatives
 
1,163

 
(314
)
Net change in servicing asset
 
66

 

Amortization of operating lease right-of-use assets
 
152

 
176

Net change in accrued income and other assets
 
(40,631
)
 
(20,833
)
Net change in accrued expenses and other liabilities
 
311

 
1,570

Net cash used in operating activities
 
(25,835
)
 
(5,283
)
Investing Activities
 
 
 
 
Net loan activity, excluding purchases
 
(1,305
)
 
(73,783
)
Maturities and calls of securities available-for-sale
 
30,851

 
13,840

Proceeds from sale of securities available-for-sale
 
795

 

Purchase of securities available-for-sale
 
(95,835
)
 
(46,562
)
Purchase of securities held-to-maturity
 

 
(8,500
)
Purchase of premises and equipment
 
(4,856
)
 
(1,564
)
Loans purchased
 
(97,306
)
 
(79,343
)
Net proceeds from sale of portfolio loans
 
193,533

 
35,673

Net cash provided by (used in) investing activities
 
25,877

 
(160,239
)
Financing Activities
 
 
 
 
Net increase in deposits
 
24,543

 
139,757

Cash dividends paid
 
(585
)
 
(613
)
Repurchase of common stock
 

 
(1,746
)
Proceeds from advances from Federal Home Loan Bank
 
110,000

 
165,000

Repayment of advances from Federal Home Loan Bank
 
(110,000
)
 
(195,000
)
Other, net
 
(93
)
 
(94
)
Net cash provided by financing activities
 
23,865

 
107,304

Net Increase (Decrease) in Cash and Cash Equivalents
 
23,907

 
(58,218
)
Cash and Cash Equivalents, Beginning of Period
 
327,361

 
188,712

Cash and Cash Equivalents, End of Period
 
$
351,268

 
$
130,494

Supplemental Disclosures
 
 
 
 
Initial recognition of right-of-use asset
 
$

 
$
2,096

Initial recognition of operating lease liabilities
 

 
2,096

Cash paid during the period for interest
 
21,699

 
18,314

Loans transferred to held-for-sale from portfolio
 
192,768

 
35,599

Cash dividends declared, paid in subsequent period
 
585

 
606

Transfer of available-for-sale municipal securities to held-to-maturity municipal securities
 
4,479

 

See Notes to Condensed Consolidated Financial Statements

5



First Internet Bancorp
Notes to Condensed Consolidated Financial Statements – Unaudited
(Table amounts in thousands except share and per share data)
  
Note 1:        Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results expected for the year ending December 31, 2020 or any other period. The March 31, 2020 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2019.
 
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for loan losses, valuations and impairments of investment securities, and the accounting for income tax expense are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements.

The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.
 
The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company.
 
Certain reclassifications have been made to the 2019 financial statements to conform to the presentation of the 2020 financial statements. These reclassifications had no effect on net income.



    




6



Note 2:        Earnings Per Share
 
Earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.
 
The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three months ended March 31, 2020 and 2019
(dollars in thousands, except per share data)
 
Three Months Ended March 31,
 
 
2020
 
2019
Basic earnings per share
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Weighted-average common shares
 
9,721,485

 
10,217,637

Basic earnings per common share
 
$
0.62

 
$
0.56

Diluted earnings per share
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Weighted-average common shares
 
9,721,485

 
10,217,637

Dilutive effect of equity compensation
 
29,043

 
12,894

     Weighted-average common and incremental shares
 
9,750,528

 
10,230,531

Diluted earnings per common share (1)
 
$
0.62

 
$
0.56

(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 8,575 and 45,565 for the three months ended March 31, 2020 and 2019, respectively.
  
Note 3:         Securities
 
The following tables summarize securities available-for-sale and securities held-to-maturity as of March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
71,387

 
$
438

 
$
(1,821
)
 
$
70,004

Municipal securities
 
94,981

 
4,049

 
(4,211
)
 
94,819

Agency mortgage-backed securities
 
279,458

 
6,901

 
(3,727
)
 
282,632

Private label mortgage-backed securities
 
114,363

 
813

 
(152
)
 
115,024

Asset-backed securities
 
5,000

 

 
(287
)
 
4,713

Corporate securities
 
43,378

 
322

 
(2,210
)
 
41,490

Total available-for-sale
 
$
608,567

 
$
12,523

 
$
(12,408
)
 
$
608,682

 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
14,617

 
$
1,061

 
$

 
$
15,678

Corporate securities
 
51,714

 
2,262

 
(186
)
 
53,790

Total held-to-maturity
 
$
66,331

 
$
3,323

 
$
(186
)
 
$
69,468


7



 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
77,715

 
$
99

 
$
(1,942
)
 
$
75,872

Municipal securities
 
97,447

 
1,706

 
(1,501
)
 
97,652

Agency mortgage-backed securities
 
264,142

 
1,304

 
(4,006
)
 
261,440

Private label mortgage-backed securities
 
63,704

 
97

 
(188
)
 
63,613

Asset-backed securities
 
5,000

 

 
(45
)
 
4,955

Corporate securities
 
38,632

 
220

 
(1,532
)
 
37,320

Total available-for-sale
 
$
546,640

 
$
3,426

 
$
(9,214
)
 
$
540,852

 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
10,142

 
$
226

 
$

 
$
10,368

Corporate securities
 
51,736

 
588

 
(132
)
 
52,192

Total held-to-maturity
 
$
61,878

 
$
814

 
$
(132
)
 
$
62,560


The Company elected to transfer ten available-for-sale (“AFS”) securities with an aggregate fair value of $4.5 million to a classification of held-to-maturity (“HTM”) on March 1, 2020. The net unrealized holding gain of $0.1 million, net of tax, as the date of the transfer was retained in accumulated other comprehensive loss, with the associated pretax amount retained in the carrying value of the HTM securities. Such amounts will be amortized to interest income over the remaining life of the securities. The fair value of the transferred AFS securities became the book value of the HTM securities as of March 1, 2020, with no unrealized gain or loss at that date.

The carrying value of securities at March 31, 2020 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
 
 
Available-for-Sale
(in thousands)
 
Amortized
Cost
 
Fair
Value
Within one year
 
$
15

 
$
15

One to five years
 
19,032

 
15,068

Five to ten years
 
81,662

 
80,465

After ten years
 
109,037

 
110,765

 
 
209,746

 
206,313

Agency mortgage-backed securities
 
279,458

 
282,632

Private label mortgage-backed securities
 
114,363

 
115,024

Asset-backed securities
 
5,000

 
4,713

Total
 
$
608,567

 
$
608,682

 
 
Held-to-Maturity
(in thousands)
 
Amortized
Cost
 
Fair
Value
One to five years
 
$
1,505

 
$
1,584

Five to ten years
 
52,301

 
54,610

After ten years
 
12,525

 
13,274

Total
 
$
66,331

 
$
69,468



8



There were less than $0.1 million gross gains resulting from sales of available securities during the three months ended March 31, 2020 and no gross gains or losses resulting from sales of available-for-sale securities during the three months ended March 31, 2019.

Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at March 31, 2020 and December 31, 2019 was $205.1 million and $317.5 million, which was approximately 30% and 53%, respectively, of the Company’s available-for-sale and held-to-maturity securities portfolios. These declines resulted primarily from fluctuations in market interest rates after purchase. Management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced, with the resulting loss recognized in net income in the period the other-than-temporary impairment (“OTTI”) is identified.

U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities

The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2020.
 
Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities
 
The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost bases over the term of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2020.

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities available-for-sale
 
 

 
 

 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
3,274

 
$
(96
)
 
$
57,775

 
$
(1,725
)
 
$
61,049

 
$
(1,821
)
Municipal securities
 
61,974

 
(4,211
)
 

 

 
61,974

 
(4,211
)
Agency mortgage-backed securities
 
18,798

 
(317
)
 
13,516

 
(3,410
)
 
32,314

 
(3,727
)
Private label mortgage-backed securities
 
10,201

 
(122
)
 
2,639

 
(30
)
 
12,840

 
(152
)
Asset-backed securities
 

 

 
4,713

 
(287
)
 
4,713

 
(287
)
Corporate securities
 
9,274

 
(286
)
 
20,076

 
(1,924
)
 
29,350

 
(2,210
)
Total
 
$
103,521

 
$
(5,032
)
 
$
98,719

 
$
(7,376
)
 
$
202,240

 
$
(12,408
)
 
 
March 31, 2020
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities held-to-maturity
 
 

 
 

 
 

 
 

 
 

 
 

Corporate securities
 
$
2,814

 
$
(186
)
 
$

 
$

 
$
2,814

 
$
(186
)
Total
 
$
2,814

 
$
(186
)
 
$

 
$

 
$
2,814

 
$
(186
)

 

9



 
 
December 31, 2019
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities available-for-sale
 
 

 
 

 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
4,820

 
$
(61
)
 
$
62,182

 
$
(1,881
)
 
$
67,002

 
$
(1,942
)
Municipal securities
 
1,279

 
(1,501
)
 

 

 
1,279

 
(1,501
)
Agency mortgage-backed securities
 
91,159

 
(829
)
 
83,212

 
(3,177
)
 
174,371

 
(4,006
)
Private label mortgage-backed securities
 
30,077

 
(180
)
 
2,884

 
(8
)
 
32,961

 
(188
)
Asset-backed securities
 

 

 
4,955

 
(45
)
 
4,955

 
(45
)
Corporate securities
 

 

 
22,985

 
(1,532
)
 
22,985

 
(1,532
)
Total
 
$
127,335

 
$
(2,571
)
 
$
176,218

 
$
(6,643
)
 
$
303,553

 
$
(9,214
)
 
 
December 31, 2019
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities held-to-maturity
 
 

 
 

 
 

 
 

 
 

 
 

Corporate securities
 
13,977

 
(132
)
 

 

 
13,977

 
(132
)
Total
 
$
13,977

 
$
(132
)
 
$

 
$

 
$
13,977

 
$
(132
)

There were no amounts reclassified from accumulated other comprehensive loss to the condensed consolidated statements of income during the three months ended March 31, 2019. Amounts reclassified from accumulated other comprehensive loss and the affected line items in the condensed consolidated statements of income during the three months ended March 31, 2020 were as follows:

(in thousands)



Details About Accumulated Other Comprehensive Loss Components
 
 
 
Affected Line Item in the
Statements of Income
 
Three Months Ended March 31, 2020
 
Realized gains on securities available-for-sale
 
 

 
 
Gain realized in earnings
 
$
41

 
Gain on sale of securities
Total reclassified amount before tax
 
41

 
Income Before Income Taxes
Tax expense
 
11

 
Income Tax Provision
Total reclassifications out of accumulated other comprehensive loss
 
$
30

 
Net Income


10



Note 4:        Loans
 
Loan balances as of March 31, 2020 and December 31, 2019 are summarized in the table below.
 
Categories of loans include:
(in thousands)
 
March 31, 2020
 
December 31, 2019
Commercial loans
 
 

 
 

Commercial and industrial
 
$
95,227

 
$
96,420

Owner-occupied commercial real estate
 
74,737

 
73,392

Investor commercial real estate
 
13,421

 
12,567

Construction
 
64,581

 
60,274

Single tenant lease financing
 
972,275

 
995,879

Public finance
 
627,678

 
687,094

Healthcare finance
 
372,266

 
300,612

Small business lending
 
67,275

 
60,279

Total commercial loans
 
2,287,460

 
2,286,517

Consumer loans
 
 
 
 
Residential mortgage
 
218,730

 
313,849

Home equity
 
23,855

 
24,306

Other consumer
 
296,605

 
295,309

Total consumer loans
 
539,190

 
633,464

Total commercial and consumer loans
 
2,826,650

 
2,919,981

Net deferred loan origination costs and premiums and discounts on purchased loans and other(1)
 
65,443

 
43,566

Total loans
 
2,892,093

 
2,963,547

Allowance for loan losses
 
(22,857
)
 
(21,840
)
Net loans
 
$
2,869,236

 
$
2,941,707


(1) Includes carrying value adjustments of $44.6 million and $21.4 million as of March 31, 2020 and December 31, 2019, respectively, related to interest rate swaps associated with public finance loans. 

The risk characteristics of each loan portfolio segment are as follows:

Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in Central Indiana and adjacent markets and the greater Phoenix, Arizona market.

Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in Central Indiana and adjacent markets and the greater Phoenix, Arizona market and its loans are often secured by manufacturing and service facilities, as well as office buildings.


11



Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the state of Indiana or markets immediately adjacent to Indiana. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects or properties outside of its designated market areas unless other underwriting factors are present to mitigate these additional risks.

Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, multi-family) properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in Central Indiana.
Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses.  The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant.  Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria.

Public Finance: These loans are made to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment. Public finance loans have been completed primarily in the Midwest, with plans to continue expanding nationwide.

Healthcare Finance: These loans are made to healthcare providers, primarily dentists, for practice acquisition refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities if the real estate is held in a separate entity and secondarily on the underlying collateral provided by the borrower. This portfolio segment was initially concentrated in the Western United States but has been growing rapidly throughout the rest of the country with the addition of a growing sales force located in Eastern and Midwestern markets.

Small Business Lending: These loans are to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration ("SBA"). We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. This portfolio segment has an emerging geography, with a nationwide focus.

Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also

12



be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Company offers these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market.
Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
Allowance for Loan Losses Methodology
 
Company policy is designed to maintain an adequate allowance for loan losses (“ALLL”). The portfolio is segmented by loan type, and the required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on average historical losses, adjusted for current economic factors and portfolio trends. Management adds qualitative factors for observable trends, changes in internal practices, changes in delinquencies and impairments, and external factors. Observable factors include changes in the composition and size of portfolios, as well as loan terms or concentration levels. The Company evaluates the impact of internal changes such as management and staff experience levels or modification to loan underwriting processes. Delinquency trends are scrutinized for both volume and severity of past due, nonaccrual, or classified loans, as well as any changes in the value of underlying collateral. Finally, the Company considers the effect of other external factors such as national, regional, and local economic and business conditions, as well as competitive, legal, and regulatory requirements. Loans that are considered to be impaired are evaluated to determine the need for a specific allowance by applying at least one of three methodologies: present value of future cash flows; fair value of collateral less costs to sell; or the loan’s observable market price. All troubled debt restructurings (“TDR”) are considered impaired loans. Loans evaluated for impairment are removed from other pools to prevent double-counting. Accounting Standards Codification (“ASC”) Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral less costs to sell and allows existing methods for recognizing interest income.
 
Provision for Loan Losses
 
A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations.
 
Policy for Charging Off Loans
 
The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest.


13



The following tables present changes in the balance of the ALLL during the three months ended March 31, 2020 and 2019

(in thousands)
Three Months Ended March 31, 2020
Allowance for loan losses:
Balance, Beginning of Period
 
Provision (Credit) Charged to Expense
 
Losses
Charged Off
 
Recoveries
 
Balance,
End of Period
Commercial and industrial
$
1,521

 
$
346

 
$
(197
)
 
$

 
$
1,670

Owner-occupied commercial real estate
561

 
84

 

 

 
645

Investor commercial real estate
109

 
19

 

 

 
128

Construction
380

 
80

 

 

 
460

Single tenant lease financing
11,175

 
(420
)
 

 

 
10,755

Public finance
1,580

 
(97
)
 

 

 
1,483

Healthcare finance
3,247

 
1,071

 

 

 
4,318

Small business lending
54

 
203

 

 
8

 
265

Residential mortgage
657

 
(143
)
 
(15
)
 
1

 
500

Home equity
46

 
5

 

 
2

 
53

Other consumer
2,510

 
313

 
(286
)
 
43

 
2,580

Total
$
21,840

 
$
1,461

 
$
(498
)
 
$
54

 
$
22,857


(in thousands)
Three Months Ended March 31, 2019
Allowance for loan losses:
Balance, Beginning of Period
 
Provision (Credit) Charged to Expense
 
Losses
Charged Off
 
Recoveries
 
Balance,
End of Period
Commercial and industrial
$
1,384

 
$
79

 
$
(112
)
 
$

 
$
1,351

Owner-occupied commercial real estate
783

 
(38
)
 

 

 
745

Investor commercial real estate
61

 
42

 

 

 
103

Construction
251

 
16

 

 

 
267

Single tenant lease financing
8,827

 
541

 

 

 
9,368

Public finance
1,670

 
(20
)
 

 

 
1,650

Healthcare finance
1,264

 
467

 

 

 
1,731

Small business lending
203

 
(8
)
 

 

 
195

Residential mortgage
1,079

 
(36
)
 

 
1

 
1,044

Home equity
53

 
(6
)
 

 
2

 
49

Other consumer
2,321

 
248

 
(317
)
 
86

 
2,338

Total
$
17,896

 
$
1,285

 
$
(429
)
 
$
89

 
$
18,841









14



The following tables present the recorded investment in loans based on portfolio segment and impairment method as of March 31, 2020 and December 31, 2019
(in thousands)
Loans
 
Allowance for Loan Losses
March 31, 2020
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
 
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
Commercial and industrial
$
94,329

 
$
898

 
$
95,227

 
$
1,561

 
$
109

 
$
1,670

Owner-occupied commercial real estate
74,142

 
595

 
74,737

 
645

 

 
645

Investor commercial real estate
13,421

 

 
13,421

 
128

 

 
128

Construction
64,581

 

 
64,581

 
460

 

 
460

Single tenant lease financing
967,595

 
4,680

 
972,275

 
9,095

 
1,660

 
10,755

Public finance
627,678

 

 
627,678

 
1,483

 

 
1,483

Healthcare finance
372,266

 

 
372,266

 
4,318

 

 
4,318

Small business lending
63,948

 
3,327

 
67,275

 
265

 
 
 
265

Residential mortgage
217,370

 
1,360

 
218,730

 
500

 

 
500

Home equity
23,855

 

 
23,855

 
53

 

 
53

Other consumer
296,557

 
48

 
296,605

 
2,580

 

 
2,580

Total
$
2,815,742

 
$
10,908

 
$
2,826,650

 
$
21,088

 
$
1,769

 
$
22,857

(in thousands)
Loans
 
Allowance for Loan Losses
December 31, 2019
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
 
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
Commercial and industrial
$
93,520

 
$
2,900

 
$
96,420

 
$
1,412

 
$
109

 
$
1,521

Owner-occupied commercial real estate
71,067

 
2,325

 
73,392

 
561

 

 
561

Investor commercial real estate
12,567

 

 
12,567

 
109

 

 
109

Construction
60,274

 

 
60,274

 
380

 

 
380

Single tenant lease financing
991,199

 
4,680

 
995,879

 
9,515

 
1,660

 
11,175

Public finance
687,094

 

 
687,094

 
1,580

 

 
1,580

Healthcare finance
300,612

 

 
300,612

 
3,247

 

 
3,247

Small business lending
56,941

 
3,338

 
60,279

 
54

 
 
 
54

Residential mortgage
312,714

 
1,135

 
313,849

 
657

 

 
657

Home equity
24,306

 

 
24,306

 
46

 

 
46

Other consumer
295,266

 
43

 
295,309

 
2,510

 

 
2,510

Total
$
2,905,560

 
$
14,421

 
$
2,919,981

 
$
20,071

 
$
1,769

 
$
21,840



15



The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows:
 
“Pass” - Higher quality loans that do not fit any of the other categories described below.

“Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention.

“Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any.

“Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable.

“Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted.

Nonaccrual Loans
 
Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest.

16




The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of March 31, 2020 and December 31, 2019
 
March 31, 2020
(in thousands)
Pass
 
Special Mention
 
Substandard
 
Total
Commercial and industrial
$
91,028

 
$
3,301

 
$
898

 
$
95,227

Owner-occupied commercial real estate
74,142

 

 
595

 
74,737

Investor commercial real estate
13,421

 

 

 
13,421

Construction
64,581

 

 

 
64,581

Single tenant lease financing
959,161

 
8,434

 
4,680

 
972,275

Public finance
627,678

 

 

 
627,678

Healthcare finance
371,203

 
1,063

 

 
372,266

Small business lending
62,226

 
1,722

 
3,327

 
67,275

Total commercial loans
$
2,263,440

 
$
14,520

 
$
9,500

 
$
2,287,460

 
March 31, 2020
(in thousands)
Performing
 
Nonaccrual
 
Total
Residential mortgage
$
217,739

 
$
991

 
$
218,730

Home equity
23,855

 

 
23,855

Other consumer
296,566

 
39

 
296,605

Total consumer loans
$
538,160

 
$
1,030

 
$
539,190

 
December 31, 2019
(in thousands)
Pass
 
Special Mention
 
Substandard
 
Total
Commercial and industrial
$
89,818

 
$
3,973

 
$
2,629

 
$
96,420

Owner-occupied commercial real estate
71,068

 
1,727

 
597

 
73,392

Investor commercial real estate
12,567

 

 

 
12,567

Construction
60,274

 

 

 
60,274

Single tenant lease financing
983,448

 
7,751

 
4,680

 
995,879

Public finance
687,094

 

 

 
687,094

Healthcare finance
300,612

 

 

 
300,612

Small business lending
55,206

 
1,735

 
3,338

 
60,279

Total commercial loans
$
2,260,087

 
$
15,186

 
$
11,244

 
$
2,286,517

 
December 31, 2019
(in thousands)
Performing
 
Nonaccrual
 
Total
Residential mortgage
$
313,088

 
$
761

 
$
313,849

Home equity
24,306

 

 
24,306

Other consumer
295,276

 
33

 
295,309

Total consumer loans
$
632,670

 
$
794

 
$
633,464

  

17



The following tables present the Company’s loan portfolio delinquency analysis as of March 31, 2020 and December 31, 2019

 
 
March 31, 2020
(in thousands)
 
30-59
Days
Past Due
 
60-89
Days
Past Due
 
90 Days 
or More
Past Due
 
Total 
Past Due
 
Current
 
Total
Loans
 
Non-
accrual
Loans
 
Total Loans
90 Days or
More Past
Due and
Accruing
Commercial and industrial
 
$

 
$

 
$
285

 
$
285

 
$
94,942

 
$
95,227

 
$
218

 
$
73

Owner-occupied commercial real estate
 

 

 
464

 
464

 
74,273

 
74,737

 
464

 

Investor commercial real estate
 

 

 

 

 
13,421

 
13,421

 

 

Construction
 

 

 

 

 
64,581

 
64,581

 

 

Single tenant lease financing
 

 

 
4,680

 
4,680

 
967,595

 
972,275

 
4,680

 

Public finance
 

 

 

 

 
627,678

 
627,678

 

 

Healthcare finance
 

 

 

 

 
372,266

 
372,266

 

 

Small business lending
 
676

 
43

 
926

 
1,645

 
65,630

 
67,275

 
926

 

Residential mortgage
 
870

 

 
1,042

 
1,912

 
216,818

 
218,730

 
991

 
51

Home equity
 

 

 

 

 
23,855

 
23,855

 

 

Other consumer
 
95

 
149

 
1

 
245

 
296,360

 
296,605

 
39

 
1

Total
 
$
1,641

 
$
192

 
$
7,398

 
$
9,231

 
$
2,817,419

 
$
2,826,650

 
$
7,318

 
$
125

 
 
December 31, 2019
(in thousands)
 
30-59
Days
Past Due
 
60-89
Days
Past Due
 
90 Days 
or More
Past Due
 
Total 
Past Due
 
Current
 
Total
Loans
 
Non-
accrual
Loans
 
Total Loans
90 Days or
More Past
Due and
Accruing
Commercial and industrial
 
$
15

 
$
96

 
$
122

 
$
233

 
$
96,187

 
$
96,420

 
$
226

 
$

Owner-occupied commercial real estate
 

 

 
464

 
464

 
72,928

 
73,392

 
464

 

Investor commercial real estate
 

 

 

 

 
12,567

 
12,567

 

 

Construction
 

 

 

 

 
60,274

 
60,274

 

 

Single tenant lease financing
 

 
4,680

 

 
4,680

 
991,199

 
995,879

 
4,680

 

Public finance
 

 

 

 

 
687,094

 
687,094

 

 

Healthcare finance
 

 

 

 

 
300,612

 
300,612

 

 

Small business lending
 
54

 
 
 

 
54

 
60,225

 
60,279

 

 

Residential mortgage
 

 

 
1,177

 
1,177

 
312,672

 
313,849

 
761

 
416

Home equity
 

 

 

 

 
24,306

 
24,306

 

 

Other consumer
 
240

 
107

 

 
347

 
294,962

 
295,309

 
33

 

Total
 
$
309

 
$
4,883

 
$
1,763

 
$
6,955

 
$
2,913,026

 
$
2,919,981

 
$
6,164

 
$
416


Impaired Loans
 
A loan is designated as impaired, in accordance with the impairment accounting guidance, when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well-secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due.
 

18



Impaired loans include nonperforming loans as well as loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection.
 
ASC Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income.
 
The following table presents the Company’s impaired loans as of March 31, 2020 and December 31, 2019
 
 
March 31, 2020
 
December 31, 2019
(in thousands)
 
Recorded
Balance
 
Unpaid
Principal
Balance
 
Specific
Allowance
 
Recorded
Balance
 
Unpaid
Principal
Balance
 
Specific
Allowance
Loans without a specific valuation allowance
 
 

 
 

 
 

 
 

 
 

 
 

Commercial and industrial
 
$
695

 
$
697

 
$

 
$
2,693

 
$
2,694

 
$

Owner-occupied commercial real estate
 
595

 
598

 

 
2,325

 
2,327

 

Small business lending
 
3,327

 
3,327

 

 
3,338

 
3,338

 

Residential mortgage
 
1,360

 
1,450

 

 
1,135

 
1,209

 

Other consumer
 
48

 
116

 

 
43

 
107

 

Total
 
6,025

 
6,188

 

 
9,534

 
9,675

 

Loans with a specific valuation allowance
 
 

 
 

 
 

 
 

 
 

 
 

Commercial and industrial
 
203

 
240

 
109

 
207

 
244

 
109

Single tenant lease financing
 
4,680

 
4,680

 
1,660

 
4,680

 
4,680

 
1,660

Total
 
4,883

 
4,920

 
1,769

 
4,887

 
4,924

 
1,769

Total impaired loans
 
$
10,908

 
$
11,108

 
$
1,769

 
$
14,421

 
$
14,599

 
$
1,769

 
The table below presents average balances and interest income recognized for impaired loans during the three months ended March 31, 2020 and 2019.
 
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
(in thousands)
 
Average
Balance
 
Interest
Income
 
Average
Balance
 
Interest
Income
Loans without a specific valuation allowance
 
 

 
 

 
 

 
 

Commercial and industrial
 
$
2,066

 
$
18

 
$
4,699

 
$
81

Owner-occupied commercial real estate
 
1,890

 
2

 
1,253

 
13

Small business lending
 
3,332

 

 
952

 
14

Residential mortgage
 
1,274

 

 
2,054

 

Home equity
 

 

 
41

 

Other consumer
 
45

 

 
76

 

Total
 
8,607

 
20

 
9,075

 
108

Loans with a specific valuation allowance
 
 

 
 

 
 

 
 

Commercial and industrial
 
204

 

 

 

Single tenant lease financing
 
4,680

 

 

 

Total
 
4,884

 

 

 

Total impaired loans
 
$
13,491

 
$
20

 
$
9,075

 
$
108


The Company had no residential mortgage other real estate owned as of March 31, 2020 and December 31, 2019. There were no loans in the process of foreclosure at March 31, 2020 and December 31, 2019.

Troubled Debt Restructurings
 
The loan portfolio includes TDRs, which are loans that have been modified to grant economic concessions to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs

19



are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months.
 
When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or using the current fair value of the collateral, less selling costs, for collateral dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific allowance or charge-off to the allowance. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the allowance.
 
In the course of working with troubled borrowers, the Company may choose to restructure the contractual terms of certain loans in an effort to work out an alternative payment schedule with the borrower in order to optimize the collectability of the loan. Any loan modification is reviewed by the Company to identify whether a TDR has occurred when the Company grants a concession to the borrower that it would not otherwise consider based on economic or legal reasons related to a borrower’s financial difficulties. Terms may be modified to fit the ability of the borrower to repay in line with its current financial status or the loan may be restructured to secure additional collateral and/or guarantees to support the debt, or a combination of the two.

There were no commercial and industrial loans classified as new TDRs during the three months ended March 31, 2020 and 2019. There were no performing TDRs that had payment defaults within the twelve months following modification during the three months ended March 31, 2020 and 2019.

Non-TDR Loan Modifications due to COVID-19

The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

Additionally, Section 4013 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

In accordance with this guidance, the Company offered modifications to borrowers who were both impacted by COVID-19 and current on all principal and interest payments. The modifications completed in the three months ended March 31, 2020 consisted of only loans in the healthcare finance portfolio with total balances of $233.5 million.


Note 5:        Premises and Equipment
 
The following table summarizes premises and equipment at March 31, 2020 and December 31, 2019.
(in thousands)
 
March 31,
2020
 
December 31,
2019
Land
 
$
2,500

 
$
2,500

Right of use leased asset
 
1,450

 
1,602

Building and improvements
 
14,291

 
10,004

Furniture and equipment
 
10,258

 
9,689

Less: accumulated depreciation
 
(9,616
)
 
(9,165
)
Total
 
$
18,883

 
$
14,630

  

During 2018, the Bank's subsidiary, SPF15, Inc., (“SPF15”) acquired several parcels of land consisting of approximately 3.3 acres located in Fishers, Indiana for approximately $10.2 million, inclusive of acquisition costs.  Pursuant to a Land Acquisition Agreement with the City of Fishers, Indiana (the “City”), and its Redevelopment Commission, among others, the City agreed to reimburse SPF15 for the purchase price and other specified land acquisition costs. The Land Acquisition

20



Agreement was replaced by a Project Agreement in December 2018, which extended the reimbursement deadline to October 31, 2019 and made additional financial incentives available to the Company for constructing an office building and associated parking garage on the property. As contemplated under the Project Agreement, the City transferred to SPF15 two additional parcels of land consisting of approximately 0.75 acres and SPF15 transferred to the Fishers Town Hall Building Corporation and third parties a certain parcel of land consisting of approximately 1.65 acres in connection with the development of the property. On October 25, 2019, the City satisfied its reimbursement obligation, resulting in the payment of SPF15 of an aggregate of $11.1 million for purchase prices and other specified land acquisition costs.

Site demolition has been completed and construction of a multi-use development, to include the Company's future headquarters, began on October 7, 2019. Development of the site is estimated to be substantially completed by September 30, 2021.

Note 6:
Leases

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU 2016-02 - Leases (Topic 842) and elected the optional transition method, which allows the Company to not separate non-lease components from the associated lease component if certain conditions are met. In addition, the Company elected not to adjust prior comparative periods.

The Company has two operating leases that are used for general office operations with remaining lease terms of two to four years. With the adoption of ASU 2016-02, operating lease agreements are required to be recognized on the condensed consolidated balance sheets as a right-of-use asset and a corresponding lease liability.

The following table shows the components of lease expense.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Operating lease cost
 
$
215

 
$
187


The following table shows supplemental cash flow information related to leases.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
 
 
     Operating cash flows from operating leases
 
$
231

 
$
200


The following table shows the operating leases’ impact on the condensed consolidated balance sheets. The Company elected not to include short-term leases (leases with original terms of 12 months or less) or equipment leases, as those amounts are insignificant. The Company’s leases do not provide an implicit rate. The discount rate utilized to determine the present value of lease payments is the Company’s incremental borrowing rate based on the information available at the lease inception date. The incremental borrowing rate is the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.

21



(dollars in thousands)
 
 
 
 
March 31, 2020
 
December 31, 2019
Operating lease right-of-use assets
 
$
(1,485
)
 
$
1,602

Operating lease liabilities
 
(1,485
)
 
1,602

 
 
 
 
 
Weighted-average remaining lease term (years)
 
 
 
 
     Operating leases
 
2.2

 
2.4

 
 
 
 
 
Weighted-average discount rate
 
 
 
 
     Operating leases
 
2.0
%
 
2.0
%

The following table shows the future minimum payments of operating leases with initial or remaining terms of one year or more as of March 31, 2020.

(in thousands)
 
 
Twelve months ended March 31,
 
 
2021
 
$
824

2022
 
315

2023
 
230

2024
 
58

2025
 

Thereafter
 

Total lease payments
 
1,427

     Less: imputed interest
 
(39
)
Total
 
$
1,388



Note 7:        Goodwill        
 
As of March 31, 2020 and December 31, 2019, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three months ended March 31, 2020.  Goodwill is tested for impairment on an annual basis as of August 31, or whenever events or changes in circumstances indicate the carrying amount of goodwill exceeds its implied fair value. The annual test indicated no impairment existed as of August 31, 2019.

Due to the impact of COVID-19 on the economy and the financial markets, the Company evaluated goodwill and determined no triggering event has occurred since the last goodwill impairment test was conducted.
Note 8:
Servicing Asset

Activity for the servicing asset and the related changes in fair value for the three months ended March 31, 2020 and 2019 are shown in the table below.


22



(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Beginning balance
 
$
2,481

 
$

Additions
 
113

 

Changes in fair value
 
(179
)
 

     Ending balance
 
$
2,415

 
$


Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of March 31, 2020 and December 31, 2019 are shown in the table below.

(in thousands)
 
 
 
 
March 31, 2020
 
December 31, 2019
Loan portfolios serviced for:
 
 
 
 
   SBA guaranteed loans
 
$
103,878

 
$
103,981

     Total
 
$
103,878

 
$
103,981


Loan servicing revenue totaled $0.3 million for the three months ended March 31, 2020. There was no loan servicing revenue for the three months ended March 31, 2019. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $0.2 million downward valuation for the three months ended March 31, 2020.

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 12 - Fair Value of Financial Instruments for further details.

Note 9:        Subordinated Debt
 
In October 2015, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2025 (the “2025 Note”). The 2025 Note bears a fixed interest rate of 6.4375% per year, payable quarterly, and is scheduled to mature on October 1, 2025. The 2025 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after October 15, 2020. The 2025 Note is intended to qualify as Tier 2 capital under regulatory guidelines.

In September 2016, the Company issued $25.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2026 Notes”) in a public offering. The 2026 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding September 30, 2021, and thereafter a floating rate equal to the then-current three-month LIBOR rate plus 485 basis points. All interest on the 2026 Notes is payable quarterly. The 2026 Notes are scheduled to mature on September 30, 2026. The 2026 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 30, 2021. The 2026 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate) plus 411 basis points. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.


23



The following table presents the principal balance and unamortized debt issuance costs for the 2025 Note, the 2026 Notes and the 2029 Notes as of March 31, 2020 and December 31, 2019.
 
March 31, 2020
 
December 31, 2019
(in thousands)
Principal
 
Unamortized Debt Issuance Costs
 
Principal
 
Unamortized Debt Issuance Costs
2025 Note
10,000

 
(132
)
 
10,000

 
(138
)
2026 Notes
25,000

 
(808
)
 
25,000

 
(839
)
2029 Notes
37,000

 
(1,455
)
 
37,000

 
(1,495
)
Total
$
72,000

 
$
(2,395
)
 
$
72,000

 
$
(2,472
)

Note 10:        Benefit Plans
 
Employment Agreement
 
The Company is party to an employment agreement with its Chief Executive Officer that provides for an annual base salary and an annual bonus, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonus is to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee for the Chief Executive Officer and other senior officers. The agreement also provides that the Chief Executive Officer may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine.

The agreement provides for the continuation of salary and certain other benefits for a specified period of time upon termination of his employment under certain circumstances, including his resignation for “good reason” or termination by the Company without “cause” at any time or any termination of his employment for any reason within twelve months following a “change in control,” along with other specific conditions.
 
2013 Equity Incentive Plan
 
The 2013 Equity Incentive Plan (the “2013 Plan”) authorizes the issuance of 750,000 shares of the Company’s common stock in the form of equity-based awards to employees, directors, and other eligible persons.  Under the terms of the 2013 Plan, the pool of shares available for issuance may be used for available types of equity awards under the 2013 Plan, which includes stock options, stock appreciation rights, restricted stock awards, stock unit awards, and other share-based awards.  All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2013 Plan.

The Company recorded $0.6 million of share-based compensation expense for the three months ended March 31, 2020, related to awards made under the 2013 Plan. The company recorded $0.5 million of share-based compensation expense for the three months ended March 31, 2019, related to awards made under the 2013 plan.

The following table summarizes the status of the 2013 Plan awards as of March 31, 2020, and activity for the three months ended March 31, 2020.
 
Restricted Stock Units
 
Weighted-Average Grant Date Fair Value Per Share
 
Restricted Stock Awards
 
Weighted-Average Grant Date Fair Value Per Share
 
Deferred Stock Units
 
Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2019
107,244

 
$
29.03

 

 
$

 

 
$

   Granted
66,756

 
27.56

 
13,164

 
27.56

 
3

 
23.48

   Vested
(48,499
)
 
30.34

 
(3,336
)
 
27.56

 
(3
)
 
23.48

   Forfeited

 

 
(1,638
)
 
27.56

 

 

Nonvested at March 31, 2020
125,501

 
$
27.74

 
8,190

 
$
27.56

 

 
$


At March 31, 2020, the total unrecognized compensation cost related to nonvested awards was $3.6 million with a weighted-average expense recognition period of 2.1 years.


24



Directors Deferred Stock Plan
 
Until January 1, 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The Directors Deferred Stock Plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right.
 
The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the three months ended March 31, 2020.
 
 
Deferred Stock Rights
Outstanding, beginning of period
 
84,505

Granted
 
214

Exercised
 

Outstanding, end of period
 
84,719


All deferred stock rights granted during the 2020 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.

Note 11:        Commitments and Credit Risk
 
 
In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying consolidated financial statements. At March 31, 2020 and December 31, 2019, the Company had outstanding loan commitments totaling approximately $295.9 million and $254.4 million, respectively.

In addition, the Company is a limited partner in a Small Business Investment Company fund (the “SBIC Fund”). As of March 31, 2020, the Company has committed to contribute up to $1.7 million of capital to the SBIC Fund.

Capital Commitments

Capital expenditures contracted to at the balance sheet date but not yet recognized in the financial statements are associated with the construction of premises intended to house our future corporate headquarters. The Company has entered into construction-related contracts in the amount of $65.1 million. As of March 31, 2020, $58.9 million of such contract commitments had not yet been incurred. These commitments are due within two years.

Note 12:        Fair Value of Financial Instruments
 
ASC Topic 820, Fair Value Measurement, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1
Quoted prices in active markets for identical assets or liabilities

Level 2
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities

Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy.

25




Available-for-Sale Securities
 
Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.
 
Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage and asset-backed securities and certain corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.
 
In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of March 31, 2020 or December 31, 2019.

Loans Held-for-Sale (mandatory pricing agreements)

The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2).
 
Servicing Asset

Fair value is based on a loan-by-loan basis taking into consideration the original maturity of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing assets begins with generating estimated future cash flows for each servicing asset, based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3).

Interest Rate Swap Agreements

The fair value of interest rate swap agreements is estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data and, therefore, are classified within Level 2 of the valuation hierarchy.

Forward Contracts

The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1).
 
Interest Rate Lock Commitments
 
The fair values of interest rate lock commitments (“IRLCs”) are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3).


26



The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2020 and December 31, 2019.
 
 
 
 
March 31, 2020 Fair Value Measurements Using
(in thousands)
 
Fair
Value
 
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
U.S. Government-sponsored agencies
 
$
70,004

 
$

 
$
70,004

 
$

Municipal securities
 
94,819

 

 
94,819

 

Agency mortgage-backed securities
 
282,632

 

 
282,632

 

Private label mortgage-backed securities
 
115,024

 
 
 
115,024

 

Asset-backed securities
 
4,713

 

 
4,713

 

Corporate securities
 
41,490

 

 
41,490

 

Total available-for-sale securities
 
608,682

 

 
608,682

 

Servicing asset
 
2,415

 

 

 
2,415

Interest rate swap liabilities
 
(78,552
)
 

 
(78,552
)
 

Loans held-for-sale (mandatory pricing agreements)
 
52,394

 

 
52,394

 

Forward contracts
 
(2,298
)
 
(2,298
)
 

 

IRLCs
 
2,064

 

 

 
2,064

 
 
 
 
December 31, 2019
Fair Value Measurements Using
(in thousands)
 
Fair
Value
 
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
U.S. Government-sponsored agencies
 
$
75,872

 
$

 
$
75,872

 
$

Municipal securities
 
97,652

 

 
97,652

 

Agency mortgage-backed securities
 
261,440

 

 
261,440

 

Private label mortgage-backed securities
 
63,613

 

 
63,613

 

Asset-backed securities
 
4,955

 

 
4,955

 

Corporate securities
 
37,320

 

 
37,320

 

Total available-for-sale securities
 
540,852

 

 
540,852

 

Servicing asset
 
2,481

 

 

 
2,481

Interest rate swap liabilities
 
(37,786
)
 

 
(37,786
)
 

Loans held-for-sale (mandatory pricing agreements)
 
56,097

 

 
56,097

 

Forward contracts
 
(153
)
 
(153
)
 

 

IRLCs
 
910

 

 

 
910


The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three months ended March 31, 2020 and 2019.


27



 
 
Three Months Ended
(in thousands)
 
Servicing Asset
 
Interest Rate Lock
Commitments
Balance, January 1, 2020
 
$
2,481

 
$
910

Total realized (losses) gains
 


 
 
Additions
 
113

 

Change in fair value
 
(179
)
 
1,154

Balance, March 31, 2020
 
2,415

 
2,064

 
 
 
 
 
Balance as of January 1, 2019
 
$

 
$
389

Total realized gains
 
 
 
 
Change in fair value
 

 
392

Balance, March 31, 2019
 
$

 
$
781



The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy.

Impaired Loans (Collateral Dependent)

Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price.

If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment.

Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets.

The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at March 31, 2020 and December 31, 2019.


 
 
 
 
December 31, 2019
(in thousands)
 
 
 
Fair Value Measurements Using
 
 
Fair
Value
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Impaired loans
 
$
3,019

 
$

 
$

 
$
3,019



28



 Significant Unobservable (Level 3) Inputs
 
The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)
 
Fair Value at
March 31, 2020
 
Valuation
Technique
 
Significant Unobservable
Inputs
 
Range
 
Weighted-Average Range
IRLCs
 
$
2,064

 
Discounted cash flow
 
Loan closing rates
 
36% - 100%
 
56%
Servicing asset
 
2,415

 
Discounted cash flow
 
Prepayment speeds
 
0% - 25%
 
14.4%
 
 
 
 
 
 
Expected weighted-average loan life
 
3.3 - 5.3 years
 
4.7 years

(dollars in thousands)
 
Fair Value at
December 31, 2019
 
Valuation
Technique
 
Significant Unobservable
Inputs
 
Range
 
Weighted-Average Range
Impaired loans
 
$
3,019

 
Fair value of collateral
 
Discount for type of property and current market conditions
 
10%
 
10%
IRLCs
 
910

 
Discounted cash flow
 
Loan closing rates
 
50% - 100%
 
84%
Servicing asset
 
2,481

 
Discounted cash flow
 
Prepayment speeds
 
0% - 25%
 
13.5%
 
 
 
 
 
 
Expected weighted-average loan life
 
3.2 - 5.7 years
 
5.0 years

The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.
 
Cash and Cash Equivalents
 
For these instruments, the carrying amount is a reasonable estimate of fair value.
 
Securities Held-to-Maturity
 
Fair values are determined by using models that are based on security-specific details, as well as relevant industry and economic factors. The most significant of these inputs are quoted market prices and interest rate spreads on relevant benchmark securities.
 
Loans Held-for-Sale (best efforts pricing agreements)
 
The fair value of these loans approximates carrying value.

Loans
 
The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.
 
Accrued Interest Receivable
 
The fair value of these financial instruments approximates carrying value.
 
Federal Home Loan Bank of Indianapolis Stock
 
The fair value approximates carrying value.
 

29



Deposits 
The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities.

Advances from Federal Home Loan Bank
 
The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value.
 
Subordinated Debt
 
The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments.

 Accrued Interest Payable
 
The fair value of these financial instruments approximates carrying value.

Commitments
 
The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of March 31, 2020 and December 31, 2019.
  
The following tables present the carrying value and estimated fair value of all financial assets and liabilities at March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
Fair Value Measurements Using
(in thousands)
 
Carrying
Amount
 
Fair Value
 
Quoted Prices
In Active
Market for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Cash and cash equivalents
 
$
351,268

 
$
351,268

 
$
351,268

 
$

 
$

Securities held-to-maturity
 
66,331

 
69,468

 

 
69,468

 

Net loans
 
2,869,236

 
2,842,894

 

 

 
2,842,894

Accrued interest receivable
 
16,960

 
16,960

 
16,960

 

 

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

 

 
25,650

 

Deposits
 
3,178,506

 
3,245,748

 
1,156,978

 

 
2,088,770

Advances from Federal Home Loan Bank
 
514,911

 
546,378

 

 
546,378

 

Subordinated debt
 
69,605

 
61,092

 
50,890

 
10,202

 

Accrued interest payable
 
3,293

 
3,293

 
3,293

 

 


30



 
 
December 31, 2019
Fair Value Measurements Using
(in thousands)
 
Carrying
Amount
 
Fair Value
 
Quoted Prices
In Active
Market for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Cash and cash equivalents
 
$
327,361

 
$
327,361

 
$
327,361

 
$

 
$

Securities held-to-maturity
 
61,878

 
62,560

 

 
62,560

 

Net loans
 
2,941,707

 
2,876,688

 

 

 
2,876,688

Accrued interest receivable
 
18,607

 
18,607

 
18,607

 

 

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

 

 
25,650

 

Deposits
 
3,153,963

 
3,232,065

 
1,002,141

 

 
2,229,924

Advances from Federal Home Loan Bank
 
514,910

 
520,950

 

 
520,950

 

Subordinated debt
 
69,528

 
75,206

 
64,996

 
10,210

 

Accrued interest payable
 
3,767

 
3,767

 
3,767

 

 

 
Note 13:        Mortgage Banking Activities

The Company’s residential real estate lending business originates mortgage loans for customers and typically sells a majority of the originated loans into the secondary market. For most of the mortgages it sells in the secondary market, the Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income.  Refer to Note 14 for further information on derivative financial instruments. 

During the three months ended March 31, 2020 and 2019, the Company originated mortgage loans held-for-sale of $215.4 million and $75.2 million, respectively, and sold $225.5 million and $81.0 million of mortgage loans, respectively, into the secondary market. Additionally, the Company sold $90.8 million of portfolio residential mortgage loans during the three months ended March 31, 2020 and sold $5.2 million of portfolio residential mortgage loans during the three months ended March 31, 2019.

The following table presents the components of income from mortgage banking activities for the three months ended March 31, 2020 and 2019.
 
Three Months Ended March 31,
(in thousands)
2020
 
2019
Gain on loans sold
$
4,343

 
$
1,473

Gain (loss) resulting from the change in fair value of loans held-for-sale
316

 
(182
)
(Loss) gain resulting from the change in fair value of derivatives
(991
)
 
326

Net revenue from mortgage banking activities
$
3,668

 
$
1,617


Fluctuations in interest rates and changes in IRLC and loan volume within the mortgage banking pipeline may cause volatility in the fair value of loans held-for-sale and the fair value of derivatives used to hedge the mortgage banking pipeline.

Note 14:        Derivative Financial Instruments
 
The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans.

31



 
The Company entered into various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of March 31, 2020 and December 31, 2019.  

(in thousands)
 
Carrying amount of the hedged asset
 
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included
 
March 31, 2020
 
December 31, 2019
 
March 31, 2020
 
December 31, 2019
Loans
 
$
494,019

 
$
474,957

 
$
44,586

 
$
21,440

Securities available-for-sale (1)
 
152,551

 
151,538

 
6,790

 
2,802

(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item
is the last layer expected to be remaining at the end of the hedging relationship. At both March 31, 2020 and December 31, 2019, the amounts of the designated hedged items were $88.2 million.

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at March 31, 2020 and December 31, 2019, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands)

 
March 31, 2020
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Instruments Associated With
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Loans
 
$
424,834

 
5.3
 
$
(44,872
)
 
3-month LIBOR
 
2.86
%
Securities available-for-sale
 
88,200

 
3.9
 
(6,793
)
 
3-month LIBOR
 
2.54
%
Total at March 31, 2020
 
$
513,034

 
5.0
 
$
(51,665
)
 
3-month LIBOR
 
2.80
%

(dollars in thousands)


December 31, 2019
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Instruments Associated With
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Loans
 
$
427,446

 
5.5
 
$
(21,551
)
 
3-month LIBOR
 
2.86
%
Securities available-for-sale
 
88,200

 
4.1
 
(2,806
)
 
3-month LIBOR
 
2.54
%
Total at December 31, 2019
 
$
515,646

 
5.3
 
$
(24,357
)
 
3-month LIBOR
 
2.80
%


32



The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at March 31, 2020 and December 31, 2019.

(dollars in thousands)

 
March 31, 2020
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Cash Flow Hedges
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Interest rate swaps
 
$
110,000

 
6.8
 
$
(17,509
)
 
3-month LIBOR
 
2.88
%
Interest rate swaps
 
100,000

 
3.7
 
(9,378
)
 
1-month LIBOR
 
2.88
%

(dollars in thousands)


December 31, 2019
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Cash Flow Hedges
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Interest rate swaps
 
$
110,000

 
7.1
 
$
(8,390
)
 
3-month LIBOR
 
2.88
%
Interest rate swaps
 
100,000

 
4.0
 
(5,040
)
 
1-month LIBOR
 
2.88
%

These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. The Company pledged $81.3 million and $42.3 million of cash collateral to counterparties as security for its obligations related to these interest rate swap transactions at March 31, 2020 and December 31, 2019, respectively. Collateral posted and received is dependent on the market valuation of the underlying hedges.

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at March 31, 2020 and December 31, 2019.

 
 
March 31, 2020
 
December 31, 2019
(in thousands)
 
Notional
Amount
 
Fair
Value
 
Notional
Amount
 
Fair
Value
Asset Derivatives
 
 

 
 

 
 

 
 

Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Interest rate swaps associated with loans
 
$

 
$

 
$

 
$

Interest rate swaps associated with securities available-for-sale
 

 

 

 

Derivatives not designated as hedging instruments
 
 

 
 

 
 

 
 

IRLCs
 
139,907

 
2,064

 
56,256

 
910

Total contracts
 
$
139,907

 
$
2,064

 
$
56,256

 
$
910

Liability Derivatives
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Interest rate swaps associated with loans
 
$
424,834

 
$
(44,872
)
 
$
427,446

 
$
(21,551
)
Interest rate swaps associated with securities available-for-sale
 
88,200

 
(6,793
)
 
88,200

 
(2,806
)
Interest rate swaps associated with liabilities
 
210,000

 
(26,887
)
 
210,000

 
(13,429
)
Derivatives not designated as hedging instruments
 
 
 
 
 
 
 
 
Forward contracts
 
106,750

 
(2,298
)
 
115,000

 
(153
)
Total contracts
 
$
829,784

 
$
(80,850
)
 
$
840,646

 
$
(37,939
)

The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three months ended March 31, 2020 and 2019.

33




 
 
Amount of Loss Recognized in Other Comprehensive (Loss) Income in The Three Months Ended
(in thousands)
 
March 31, 2020
 
March 31, 2019
Interest rate swap agreements
 
$
(13,458
)
 
$
(3,572
)

The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three months ended March 31, 2020 and 2019.

 
 
Amount of Gain / (Loss) Recognized in the Three Months Ended
(in thousands)
 
March 31, 2020
 
March 31, 2019
Asset Derivatives
 
 

 
 

Derivatives not designated as hedging instruments
 
 

 
 

IRLCs
 
$
1,154

 
$
392

 
 
 
 
 
Liability Derivatives
 
 

 
 

Derivatives not designated as hedging instruments
 
 
 
 
Forward contracts
 
$
(2,145
)
 
$
(67
)
  
The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three months ended March 31, 2020 and 2019.

(in thousands)

Line item in the condensed consolidated statements of income
 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
Interest income
 
 
 
 
Loans
 
$
(1,224
)
 
$
21

Securities - taxable
 
(91
)
 
(7
)
Securities - non-taxable
 
(67
)
 
45

Total interest income
 
(1,382
)
 
59

Interest expense
 
 

 
 

Deposits
 
307

 
90

Other borrowed funds
 
322

 
34

Total interest expense
 
629

 
124

Net interest income
 
$
(2,011
)
 
$
(65
)



34



Note 15:     Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below.
(in thousands)
 
Available-For-Sale Securities
 
Cash Flow Hedges
 
Total
Balance, January 1, 2020
 
$
(4,388
)
 
$
(9,803
)
 
$
(14,191
)
Net change in unrealized gain (loss)
 
6,299

 
(13,458
)
 
(7,159
)
Reclassification of gain realized and included in earnings
 
(41
)
 

 
(41
)
Accumulated other comprehensive income (loss) before income tax
 
1,870

 
(23,261
)
 
(21,391
)
Income tax provision (benefit)
 
2,109

 
(3,634
)
 
(1,525
)
Balance, March 31, 2020
 
$
(239
)
 
$
(19,627
)
 
$
(19,866
)
 
 
 
 
 
 
 
Balance, January 1, 2019
 
$
(13,360
)
 
$
(3,181
)
 
$
(16,541
)
Net change in unrealized gain (loss)
 
6,910

 
(3,572
)
 
3,338

Accumulated other comprehensive loss before income tax
 
(6,450
)
 
(6,753
)
 
(13,203
)
Income tax provision (benefit)
 
1,930

 
(965
)
 
965

Balance, March 31, 2019
 
$
(8,380
)
 
$
(5,788
)
 
$
(14,168
)


Note 16:     Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy

35



that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In October 2019, the FASB voted to delay the effective date for smaller reporting companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update.

The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s condensed consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies.

ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018)

The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU are effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance and it did not have a material impact on the condensed consolidated financial statements.


36



ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019)

The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the condensed consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company elected the temporary relief in the CARES Act not to apply the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this report. This discussion and analysis includes certain forward-looking statements that involve risks, uncertainties, and assumptions. You should review the “Risk Factors” sections of this report and our Annual Report on Form 10-K for the year ended December 31, 2019 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by such forward-looking statements. See also “Cautionary Note Regarding Forward-Looking Statements” at the beginning of this report.
 
Overview
 
First Internet Bancorp (“we,” “our,” “us,” or the “Company”) is a bank holding company that conducts its primary business activities through its wholly owned subsidiary, First Internet Bank of Indiana, an Indiana chartered bank (the “Bank”). The Bank was the first state-chartered, Federal Deposit Insurance Corporation (“FDIC”) insured Internet bank and commenced banking operations in 1999. The Company was incorporated under the laws of the State of Indiana on September 15, 2005. On March 21, 2006, we consummated a plan of exchange by which we acquired all of the outstanding shares of the Bank.

The Bank has three wholly owned subsidiaries. First Internet Public Finance Corp. provides a range of public and municipal finance lending and leasing products to governmental entities throughout the United States and acquires securities issued by state and local governments and other municipalities. JKH Realty Services, LLC, manages other real estate owned (“OREO”) properties as needed. SPF15, Inc. is a real estate holding company.

We offer a wide range of commercial, small business, consumer and municipal banking products and services. We conduct our consumer and small business deposit operations primarily through online channels on a nationwide basis and have no traditional branch offices. Our residential mortgage products are offered nationwide primarily through an online direct-to-consumer platform and are supplemented with Central Indiana-based mortgage and construction lending. Our consumer lending products are primarily originated on a nationwide basis over the Internet, as well as through relationships with dealerships and financing partners.

Our commercial banking products and services are delivered through a relationship banking model and include commercial real estate (“CRE”) banking, commercial and industrial (“C&I”) banking, public finance, healthcare finance, small business lending

37



and commercial deposits and treasury management. Through our CRE team, we offer single tenant lease financing on a nationwide basis in addition to traditional investor CRE and construction loans primarily within Central Indiana and adjacent markets. To meet the needs of commercial borrowers and depositors located primarily in Central Indiana, Phoenix, Arizona and adjacent markets, our C&I banking team provides credit solutions such as lines of credit, term loans, owner-occupied CRE loans and corporate credit cards. Our public finance team provides a range of public and municipal lending and leasing products to government entities on a nationwide basis. Our healthcare finance team was established in conjunction with our strategic partnership with Lendeavor, Inc., a San Francisco-based technology-enabled lender to healthcare practices, and provides lending for healthcare practice finance or acquisition, acquisition or refinancing owner-occupied CRE and equipment purchases. This portfolio segment is generally concentrated in the Western and Southwestern regions of the United States with plans to continue expanding nationwide. Our commercial deposits and treasury management team works with the other commercial teams to provide deposit products and treasury management services to our commercial and municipal lending customers as well as pursues commercial deposit opportunities in business segments where we have no credit relationships.

In 2018, we identified small business as an area for potential growth in loans, revenue and deposits. We believe that we can differentiate ourselves from larger financial institutions through providing a full suite of services to emerging small businesses and entrepreneurs. We have begun adding experienced personnel to build out our capabilities in small business lending and U.S. government guaranteed lending programs, including loans originated under the Small Business Administration (“SBA”) guidelines. To accelerate our efforts in this area, on November 1, 2019 we acquired a loan portfolio, a servicing portfolio and a team of experienced SBA professionals from First Colorado National Bank. As of March 31, 2020, the principal balance of loans acquired was approximately $31.3 million and was comprised primarily of SBA 7(a) loans while the principal balance of the servicing portfolio acquired was approximately $89.2 million and consisted of guaranteed SBA 7(a) loans sold in the secondary market. We expect to continue adding personnel to build out a nationwide small business platform.

COVID-19 Pandemic

The coronavirus pandemic (“COVID-19”) has caused health and economic concerns across the world and continues to have negative effects on global, national and local economies. In response, federal, state and local governments have recently passed laws intended to provide relief to affected businesses and individuals and to stimulate national and local economies. While the ongoing spread of COVID-19 did not have a material impact on our operating results as of March 31, 2020, a sustained outbreak could have an adverse affect on our financial condition and results of operations in future periods. The ultimate impact of COVID-19 on our business is highly uncertain as the extent of the pandemic is unknown, and we cannot predict with confidence when restrictions on businesses and individuals will be lifted and the economies in which we operate return to conditions existing prior to COVID-19. As a result of actions taken to either contain or reduce the impact of COVID-19, we may experience issues that negatively impact our business, such as a decline in the liquidity of our borrowers or volatility in interest rates affecting our rate-sensitive assets and liabilities.

To date, our response to COVID-19 has centered around supporting our employees, caring for our communities and serving our clients. We fully implemented our Company-wide business continuity plan in order to continue conducting business while focusing on the health and safety of our employees, clients and community. The majority of our workforce is working remotely and for those that continue to come into the office we have implemented social distancing policies and increased cleaning protocols and frequency at all Company locations. With regard to our community, among other things, we have announced a $250,000 grant in April 2020 to provide financial stimulus to small businesses and not-for-profits in Marion and Hamilton counties in Indiana.

As a digitally-focused institution without branch locations, we believe we have been able to continue serving clients while minimizing operational disruptions caused by COVID-19. For clients affected by COVID-19, we have offered loan payment deferral programs and, as a preferred SBA lender, we have assisted clients in participating in the Paycheck Protection Program (“PPP”). Despite the challenging environment, we have continued to prudently extend credit to both commercial and consumer clients.

U.S. Small Business Administration Paycheck Protection Program

Section 1102 of the CARES Act created the PPP, which is administered by the SBA. Loans originated under the PPP have a two-year term, bear an interest rate of 1.00% and are designed to provide a direct incentive to small businesses to retain employees on their payroll during COVID-19. These loans will be forgiven if the funds were used for payroll costs and other qualifying business expenses as long as 75% of the forgiven amount was used to maintain payroll costs. The federal government approved an initial appropriation of $349.0 billion for PPP loans and when that was depleted approved an additional $310.0 billion. As a preferred SBA lender, we assisted our clients in participating in both rounds of the PPP. Through May 1, 2020, we provided

38



437 PPP loans totaling $59.6 million, with an average loan size of $136,000, to help small businesses maintain their workforces in an uncertain and challenging environment.


39



Results of Operations

The following table presents a summary of the Company’s financial performance for the last five completed fiscal quarters.
(dollars in thousands except for per share data)
Three Months Ended
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Income Statement Summary:
 
 
 
 
 
 
 
 
 
Net interest income
$
15,018

 
$
15,374

 
$
15,244

 
$
16,105

 
$
16,244

Provision for loan losses
1,461

 
468

 
2,824

 
1,389

 
1,285

Noninterest income
6,211

 
5,405

 
5,558

 
3,454

 
2,372

Noninterest expense
13,486

 
12,613

 
11,203

 
11,709

 
11,109

Income tax provision
263

 
602

 
449

 
340

 
526

Net income
$
6,019

 
$
7,096

 
$
6,326

 
$
6,121

 
$
5,696

Per Share Data:
 
 
 
 
 
 
 
 
 
Earnings per share - basic
$
0.62

 
$
0.72

 
$
0.63

 
$
0.60

 
$
0.56

Earnings per share - diluted
$
0.62

 
$
0.72

 
$
0.63

 
$
0.60

 
$
0.56

Dividends declared per share
$
0.06

 
$
0.06

 
$
0.06

 
$
0.06

 
$
0.06

Book value per common share
$
31.13

 
$
31.30

 
$
30.30

 
$
29.56

 
$
29.03

Tangible book value per common share 1
$
30.65

 
$
30.82

 
$
29.82

 
$
29.10

 
$
28.57

Common shares outstanding
9,801,825

 
9,741,800

 
9,741,800

 
10,016,458

 
10,128,587

Average common shares outstanding:
 
 
 
 
 
 
 
 
 
Basic
9,721,485

 
9,825,784

 
9,979,603

 
10,148,285

 
10,217,637

Diluted
9,750,528

 
9,843,829

 
9,980,612

 
10,148,285

 
10,230,531

Dividend payout ratio 2
9.68
%
 
8.33
%
 
9.52
%
 
10.00
%
 
10.71
%
Performance Ratios:
 
 
 
 
 
 
 
 
 
Return on average assets
0.59
%
 
0.69
%
 
0.63
%
 
0.65
%
 
0.64
%
Return on average shareholders’ equity
7.78
%
 
9.46
%
 
8.40
%
 
8.26
%
 
7.91
%
Return on average tangible common equity 1
7.90
%
 
9.61
%
 
8.53
%
 
8.39
%
 
8.04
%
Net interest margin
1.50
%
 
1.51
%
 
1.54
%
 
1.73
%
 
1.86
%
Net interest margin - FTE 1,3
1.65
%
 
1.67
%
 
1.70
%
 
1.91
%
 
2.04
%
Noninterest expense to average assets
1.32
%
 
1.22
%
 
1.11
%
 
1.23
%
 
1.24
%
Capital Ratios:
 
 
 
 
 
 
 
 
 
Total shareholders’ equity to assets
7.32
%
 
7.44
%
 
7.21
%
 
7.48
%
 
8.01
%
Tangible common equity to tangible assets ratio 1
7.22
%
 
7.33
%
 
7.10
%
 
7.37
%
 
7.89
%
Tier 1 leverage ratio
7.82
%
 
7.64
%
 
7.66
%
 
8.06
%
 
8.34
%
Common equity tier 1 capital ratio
10.76
%
 
10.84
%
 
10.93
%
 
11.08
%
 
11.66
%
Tier 1 capital ratio
10.76
%
 
10.84
%
 
10.93
%
 
11.08
%
 
11.66
%
Total risk-based capital ratio
13.87
%
 
13.99
%
 
14.17
%
 
14.31
%
 
13.68
%

1 This information represents a non-GAAP financial measure. See the “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of these measures to their most directly comparable GAAP measures.
2 Dividends per share divided by diluted earnings per share.
3 On a fully-taxable equivalent (“FTE”) basis assuming a 21% tax rate. Net interest income is adjusted to reflect income from assets such as municipal loans and securities that are exempt from Federal income taxes.   This is to recognize the income tax savings that facilitates a comparison between taxable and tax-exempt assets.  The Company believes that it is a standard practice in the banking industry to present net interest margin and net interest income on a fully-taxable equivalent basis, as these measures provide useful information to make peer comparisons.

During the first quarter 2020, net income was $6.0 million, or $0.62 per diluted share, compared to the first quarter 2019 net income of $5.7 million, or $0.56 per diluted share, representing an increase in net income of $0.3 million, or 5.7%.

The $0.3 million increase in net income in the first quarter 2020 compared to the first quarter 2019 was due primarily to an increase of $3.8 million, or 161.8%, in noninterest income and a decrease of $0.3 million, or 50.0%, in income tax expense, partially offset by a $0.2 million, or 13.7%, increase in provision for loan losses, a $2.4 million, or 21.4%, increase in noninterest expense and a decrease of $1.2 million, or 7.5%, in net interest income.


40



During the first quarter 2020, return on average assets (“ROAA”) and return on average shareholders’ equity (“ROAE”) were 0.59% and 7.78%, respectively, compared to 0.64% and 7.91%, respectively, for the first quarter 2019. The decrease in ROAA for the three months ended March 31, 2020 compared to the three months ended March 31, 2019 was due primarily to the Company’s growth in average assets. The decrease in ROAE during the three months ended March 31, 2020 compared to the three months ended March 31, 2019 resulted primarily from the Company’s growth in average shareholders’ equity. The increase in average shareholder’s equity was due mainly to an increase in retained earnings.


41



Consolidated Average Balance Sheets and Net Interest Income Analyses
 
For the periods presented, the following tables provide the average balances of interest-earning assets and interest-bearing liabilities and the related yields and cost of funds. The tables do not reflect any effect of income taxes except for net interest margin - FTE, as discussed below. Balances are based on the average of daily balances. Nonaccrual loans are included in average loan balances.
(dollars in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
December 31, 2019
 
March 31, 2019
 
 
Average Balance
 
Interest /Dividends
 
Yield /Cost
 
Average Balance
 
Interest /Dividends
 
Yield /Cost
 
Average Balance
 
Interest /Dividends
 
Yield /Cost
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest-earning assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loans, including
loans held-for-sale
 
$
2,977,994

 
$
30,408

 
4.11
%
 
$
2,981,333

 
$
31,574

 
4.20
%
 
$
2,774,852

 
$
29,218

 
4.27
%
Securities - taxable
 
531,046

 
3,619

 
2.74
%
 
497,739

 
3,475

 
2.77
%
 
429,020

 
3,324

 
3.14
%
Securities - non-taxable
 
99,833

 
572

 
2.30
%
 
99,310

 
604

 
2.41
%
 
94,245

 
684

 
2.94
%
Other earning assets
 
415,927

 
1,645

 
1.59
%
 
452,945

 
2,224

 
1.95
%
 
246,732

 
1,773

 
2.91
%
Total interest-earning assets
 
4,024,800

 
36,244

 
3.62
%
 
4,031,327

 
37,877

 
3.73
%
 
3,544,849

 
34,999

 
4.00
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allowance for loan losses
 
(22,059
)
 
 
 
 
 
(21,967
)
 
 
 
 
 
(18,229
)
 
 
 
 
Noninterest-earning assets
 
97,191

 
 
 
 
 
98,856

 
 
 
 
 
100,888

 
 
 
 
Total assets
 
$
4,099,932

 
 
 
 
 
$
4,108,216

 
 
 
 
 
$
3,627,508

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest-bearing liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest-bearing demand deposits
 
$
122,925

 
$
219

 
0.72
%
 
$
122,031

 
$
223

 
0.73
%
 
$
109,453

 
$
212

 
0.79
%
Regular savings accounts
 
30,345

 
78

 
1.03
%
 
34,298

 
94

 
1.09
%
 
38,853

 
108

 
1.13
%
Money market accounts
 
866,605

 
3,743

 
1.74
%
 
752,941

 
3,653

 
1.92
%
 
563,106

 
2,752

 
1.98
%
Certificates and brokered deposits
 
2,069,170

 
13,168

 
2.56
%
 
2,201,231

 
14,447

 
2.60
%
 
2,017,262

 
12,314

 
2.48
%
Total interest-bearing deposits
 
3,089,045

 
17,208

 
2.24
%
 
3,110,501

 
18,417

 
2.35
%
 
2,728,674

 
15,386

 
2.29
%
Other borrowed funds
 
584,465

 
4,018

 
2.76
%
 
584,386

 
4,086

 
2.77
%
 
540,705

 
3,369

 
2.53
%
Total interest-bearing liabilities
 
3,673,510

 
21,226

 
2.32
%
 
3,694,887

 
22,503

 
2.42
%
 
3,269,379

 
18,755

 
2.33
%
Noninterest-bearing deposits
 
60,456

 
 
 
 
 
49,570

 
 
 
 
 
42,551

 
 
 
 
Other noninterest-bearing liabilities
 
54,961

 
 
 
 
 
66,136

 
 
 
 
 
23,695

 
 
 
 
Total liabilities
 
3,788,927

 
 
 
 
 
3,810,593

 
 
 
 
 
3,335,625

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shareholders’ equity
 
311,005

 
 
 
 
 
297,623

 
 
 
 
 
291,883

 
 
 
 
Total liabilities and shareholders’ equity
 
$
4,099,932

 
 
 
 
 
$
4,108,216

 
 
 
 
 
$
3,627,508

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
 
 
 
$
15,018

 
 
 
 
 
$
15,374

 
 
 
 
 
$
16,244

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate spread 1
 
 
 
 
 
1.30%
 
 
 
 
 
1.31%
 
 
 
 
 
1.67
%
Net interest margin 2
 
 
 
 
 
1.50%
 
 
 
 
 
1.51%
 
 
 
 
 
1.86
%
Net interest margin - FTE 3
 
 
 
 
 
1.65%
 
 
 
 
 
1.67%
 
 
 
 
 
2.04
%
1 Yield on total interest-earning assets minus cost of total interest-bearing liabilities.
2 Net interest income divided by total average interest-earning assets (annualized).
3 On an FTE basis assuming a 21% tax rate. Net interest income is adjusted to reflect income from assets such as municipal loans and securities that are exempt from Federal income taxes.   This is to recognize the income tax savings that facilitates a comparison between taxable and tax-exempt assets.  The Company believes that it is a standard practice in the banking industry to present net interest margin and net interest income on a fully-taxable equivalent basis, as these measures provide useful information to make peer comparisons. Net interest margin - FTE represents a non-GAAP financial measure. See the “Reconciliation of Non-GAAP Financial Measures” for a reconciliation of these measures to their most directly comparable GAAP measures.







42



Rate/Volume Analysis 

The following table illustrates the impact of changes in the volume of interest-earning assets and interest-bearing liabilities and interest rates on net interest income for the periods indicated. The change in interest not due solely to volume or rate has been allocated in proportion to the absolute dollar amounts of the change in each. 
(dollars in thousands)
 
Three Months Ended March 31, 2020 vs. December 31, 2019 Due to Changes in
 
Three Months Ended March 31, 2020 vs. March 31, 2019 Due to Changes in
 
 
Volume
 
Rate
 
Net
 
Volume
 
Rate
 
Net
Interest income
 
 

 
 

 
 

 
 
 
 
 
 
Loans, including loans held-for-sale
 
$
(58
)
 
$
(1,108
)
 
$
(1,166
)
 
$
6,661

 
$
(5,471
)
 
$
1,190

Securities – taxable
 
381

 
(237
)
 
144

 
2,427

 
(2,132
)
 
295

Securities – non-taxable
 
20

 
(52
)
 
(32
)
 
234

 
(346
)
 
(112
)
Other earning assets
 
(178
)
 
(401
)
 
(579
)
 
3,844

 
(3,972
)
 
(128
)
Total
 
165

 
(1,798
)
 
(1,633
)
 
13,166

 
(11,921
)
 
1,245

 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 

 
 

 
 

 
 

 
 

 
 

Interest-bearing deposits
 
(155
)
 
(1,054
)
 
(1,209
)
 
3,905

 
(2,083
)
 
1,822

Other borrowed funds
 
2

 
(70
)
 
(68
)
 
306

 
343

 
649

Total
 
(153
)
 
(1,124
)
 
(1,277
)
 
4,211

 
(1,740
)
 
2,471

 
 
 
 
 
 
 
 
 
 
 
 
 
Increase (decrease) in net interest income
 
$
318

 
$
(674
)
 
$
(356
)
 
$
8,955

 
$
(10,181
)
 
$
(1,226
)
 

Net interest income for the first quarter 2020 was $15.0 million, a decrease of $1.2 million, or 7.5%, compared to $16.2 million for the first quarter 2019. The decrease in net interest income was primarily the result of a $2.5 million, or 13.2%, increase in total interest expense to $21.2 million for the first quarter 2020 from $18.8 million for the first quarter 2019. The increase in total interest expense was partially offset by a $1.2 million, or 3.6%, increase in total interest income to $36.2 million for the first quarter 2020 from $35.0 million for the first quarter 2019.

The increase in total interest income for the first quarter 2020 compared to the first quarter 2019 was due primarily to an increase in interest earned on loans resulting from an increase of $203.1 million, or 7.3%, in the average balance of loans, including loans held-for-sale, partially offset by a decline of 16 basis point (“bp”) in the yield earned on these balances. Interest income earned on securities increased as well, due to an increase in the average balance of securities of $107.6 million, or 20.6%, offset by a decline of 44 bps in the yield earned on these assets for the first quarter 2020 compared to the first quarter 2019. The overall yield on interest-earning assets for the first quarter of 2020 declined to 3.62% from 4.00% in the prior year quarter due primarily to the continued decline in market interest rates from the year-ago period. The decline in interest rates negatively impacted the yields earned on variable rate loans, including fixed rate loans that have been effectively converted to variable rate loans through the use of interest rate swap agreements, and new loan originations as well as variable rate securities and cash balances, which remained elevated throughout the first quarter 2020.

    
The increase in total interest expense for the first quarter 2020 compared to the first quarter 2019 was driven primarily by an increase of $360.4 million, or 13.2%, in the average balance of interest-bearing deposits, partially offset by a 5 bp decline in the cost of funds related to these deposits. The increase in interest expense associated with interest-bearing deposits was due primarily to a $303.5 million, or 53.9%, increase in average money market balances as well as a $51.9 million, or 2.6%, increase in average certificates and brokered deposits balances. The decrease in the cost of funds primarily reflects a decline in the rate paid on money market accounts as well as a shift in the deposit mix due to the growth in money market balances. Compared to the first quarter 2019, the cost of money market deposits decreased 24 bps and the average balance of money market accounts comprised 28.1% of total interest-bearing deposits in the first quarter 2020 versus 20.6% in the first quarter 2019.

Interest expense related to other borrowed funds also contributed to the increase in total interest expense due to a $43.8 million, or 8.1%, increase in the average balance of other borrowed funds as well as a 23 bp increase in the cost of these funds for the first quarter 2020 compared to the first quarter 2019. The increase in both the average balance and cost of other borrowed funds was due to the Company issuing $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes in June 2019.


43



Net interest margin (“NIM”) was 1.50% for the first quarter 2020 compared to 1.86% for the first quarter 2019. The decrease in NIM for the first quarter 2020 compared to the first quarter 2019 was driven primarily by the decline in the yield earned on interest-earning assets as discussed above. On a fully-taxable equivalent basis, NIM was 1.65% for the first quarter 2020 compared to 2.04% for the first quarter 2019. As a result of COVID-19, economic uncertainties, including potential volatility in interest rates affecting our rate-sensitive assets and liabilities, may put downward pressure on net interest margin.

Noninterest Income

The following table presents noninterest income for the last five completed fiscal quarters.
(in thousands)
Three Months Ended
 
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Service charges and fees
$
212

 
$
213

 
$
211

 
$
225

 
$
236

Loan servicing revenue
251

 
166

 

 

 

Loan servicing asset revaluation
(179
)
 

 

 

 

Mortgage banking activities
3,668

 
2,953

 
4,307

 
2,664

 
1,617

Gain (loss) on sale of loans
1,801

 
1,721

 
523

 
(66
)
 
(104
)
Gain (loss) on sale of securities
41

 

 

 
(458
)
 

Other
417

 
352

 
517

 
1,089

 
623

Total noninterest income
$
6,211

 
$
5,405

 
$
5,558

 
$
3,454

 
$
2,372


During the first quarter 2020, noninterest income was $6.2 million, representing an increase of $3.8 million, or 161.8%, compared to $2.4 million for the first quarter 2019. The increase was due primarily to increases in revenue from mortgage banking activities and gain on sale of loans. The increase in mortgage banking revenue was due mainly to an increase in mandatory pipeline volumes as the year-over-year decline in market interest rates drove increased interest rate lock commitment and origination activity. The increase in gain on sale of loans was due to the Company selling single tenant lease financing, public finance, portfolio residential mortgages and SBA 7(a) loans with book values totaling $190.7 million during the first quarter 2020, recognizing a net gain of $1.8 million, as compared to a $0.1 million loss on sale of loans in the first quarter 2019, when the Company sold $31.5 million of seasoned lower-yielding public finance and portfolio residential mortgage loans. Compared to the first quarter 2019, the Company also recognized loan servicing revenue, net of the loan servicing asset revaluation, in connection with the SBA 7(a) servicing portfolio acquired in the fourth quarter 2019.


Noninterest Expense

The following table presents noninterest expense for the last five completed fiscal quarters.
(in thousands)
Three Months Ended
 
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Salaries and employee benefits
$
7,774

 
$
7,168

 
$
6,883

 
$
6,642

 
$
6,321

Marketing, advertising and promotion
375

 
409

 
456

 
466

 
469

Consulting and professional services
1,177

 
1,242

 
778

 
835

 
814

Data processing
375

 
312

 
381

 
328

 
317

Loan expenses
599

 
289

 
247

 
292

 
314

Premises and equipment
1,625

 
1,556

 
1,506

 
1,497

 
1,500

Deposit insurance premium
485

 
601

 

 
747

 
555

Other
1,076

 
1,036

 
952

 
902

 
819

Total noninterest expense
$
13,486

 
$
12,613

 
$
11,203

 
$
11,709

 
$
11,109



44



Noninterest expense for the first quarter 2020 was $13.5 million, compared to $11.1 million for the first quarter 2019. The increase of $2.4 million, or 21.4%, compared to the first quarter 2019 was due primarily to increases of $1.5 million in salaries and employee benefits, $0.4 million in consulting and professional services, $0.3 million in loan expenses, $0.3 million in other and $0.1 million in premises and equipment. The increase in salaries and employee benefits was due mainly to an increase in headcount which includes the impact of personnel growth associated with the Company’s small business lending platform as well as increased mortgage incentive compensation. The increase in consulting and professional services was due primarily to an increase in recruiting fees and director compensation. The increase in loan expenses was driven primarily by costs associated with nonperforming loans. The increase in other expenses was due to various items, none of which were deemed significant individually. The increase in premises and equipment was due primarily to higher software expense.
Income tax provision was $0.3 million for the first quarter 2020, resulting in an effective tax rate of 4.2%, compared to $0.5 million and an effective tax rate of 8.5% for the first quarter 2019. The decrease in both income tax provision and the effective tax rate was due primarily to the impact of the CARES Act, which was signed into law on March 27, 2020.  The CARES Act provided the opportunity to carryback certain federal net operating losses based on the difference between the current statutory rate and the statutory rate in effect during the period to which the net operating loss will be carried back.

Financial Condition

The following table presents summary balance sheet data for the last five completed fiscal quarters.
(in thousands)
 
 
 
 
 
 
 
 
 
 
Balance Sheet Data:
 
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Total assets
 
$
4,168,146

 
$
4,100,083

 
$
4,095,491

 
$
3,958,829

 
$
3,670,176

Loans
 
2,892,093

 
2,963,547

 
2,881,272

 
2,861,156

 
2,839,928

Total securities
 
675,013

 
602,730

 
591,549

 
558,160

 
551,604

Loans held-for-sale
 
52,394

 
56,097

 
41,119

 
30,642

 
13,706

Noninterest-bearing deposits
 
70,562

 
57,115

 
50,560

 
44,040

 
45,878

Interest-bearing deposits
 
3,107,944

 
3,096,848

 
3,097,682

 
2,962,223

 
2,765,230

Total deposits
 
3,178,506

 
3,153,963

 
3,148,242

 
3,006,263

 
2,811,108

Advances from Federal Home Loan Bank
 
514,911

 
514,910

 
514,908

 
514,906

 
495,146

Total shareholders’ equity
 
305,127

 
304,913

 
295,140

 
296,120

 
294,013


Total assets increased $68.1 million, or 1.7%, to $4.2 billion at March 31, 2020 compared to $4.1 billion at December 31, 2019. Deposit growth of $24.5 million, or 0.8%, and the decline in the total loan balances of $71.5 million, or 2.4%, driven by loan sales during the first quarter 2020, led to an increase in liquid assets as securities balances increased $72.3 million, or 12.0%, and cash balances increased $23.9 million, or 7.3%. The increase in balance sheet liquidity was reflected in the percentage of loans to deposits, which declined to 91.0% as of March 31, 2020, compared to 94.0% as of December 31, 2019.
    


45



Loan Portfolio Analysis

The following table presents a summary of the Company’s loan portfolio for the last five completed fiscal quarters.
(dollars in thousands)
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Commercial loans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
$
95,227

 
3.3
%
 
$
96,420

 
3.3
%
 
$
88,874

 
3.1
%
 
$
106,517

 
3.7
%
 
$
110,560

 
3.8
%
Owner-occupied commercial real estate
74,737

 
2.6
%
 
73,392

 
2.5
%
 
74,384

 
2.6
%
 
71,908

 
2.5
%
 
75,317

 
2.7
%
Investor commercial real estate
13,421

 
0.5
%
 
12,567

 
0.4
%
 
11,852

 
0.4
%
 
21,179

 
0.7
%
 
11,188

 
0.4
%
Construction
64,581

 
2.2
%
 
60,274

 
2.0
%
 
54,131

 
1.9
%
 
47,849

 
1.7
%
 
42,319

 
1.5
%
Single tenant lease financing
972,275

 
33.6
%
 
995,879

 
33.6
%
 
1,008,247

 
35.0
%
 
1,001,196

 
35.1
%
 
975,841

 
34.3
%
Public finance
627,678

 
21.7
%
 
687,094

 
23.2
%
 
686,622

 
23.8
%
 
706,161

 
24.7
%
 
708,816

 
25.0
%
Healthcare finance
372,266

 
12.9
%
 
300,612

 
10.1
%
 
251,530

 
8.6
%
 
212,351

 
7.4
%
 
158,796

 
5.6
%
Small business lending
67,275

 
2.3
%
 
61,121

 
2.1
%
 
18,177

 
0.6
%
 
15,697

 
0.5
%
 
13,751

 
0.5
%
Total commercial loans
2,287,460

 
79.1
%
 
2,287,359

 
77.2
%
 
2,193,817

 
76.0
%
 
2,182,858

 
76.3
%
 
2,096,588

 
73.8
%
Consumer loans
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Residential mortgage
218,730

 
7.6
%
 
313,849

 
10.6
%
 
320,451

 
11.1
%
 
318,678

 
11.1
%
 
404,869

 
14.3
%
Home equity
23,855

 
0.8
%
 
24,306

 
0.8
%
 
25,042

 
0.9
%
 
26,825

 
0.9
%
 
27,794

 
1.0
%
Other consumer
296,605

 
10.2
%
 
295,309

 
10.0
%
 
296,573

 
10.4
%
 
294,251

 
10.4
%
 
285,259

 
10.0
%
Total consumer loans
539,190

 
18.6
%
 
633,464

 
21.4
%
 
642,066

 
22.4
%
 
639,754

 
22.4
%
 
717,922

 
25.3
%
Net deferred loan origination costs, premiums and discounts on purchased loans and other (1)
65,443

 
2.3
%
 
42,724

 
1.4
%
 
45,389

 
1.6
%
 
38,544

 
1.3
%
 
25,418

 
0.9
%
Total loans
2,892,093

 
100.0
%
 
2,963,547

 
100.0
%
 
2,881,272

 
100.0
%
 
2,861,156

 
100.0
%
 
2,839,928

 
100.0
%
Allowance for loan losses
(22,857
)
 
 
 
(21,840
)
 
 
 
(21,683
)
 
 
 
(19,976
)
 
 
 
(18,841
)
 
 
Net loans
$
2,869,236

 
 
 
$
2,941,707

 
 
 
$
2,859,589

 
 
 
$
2,841,180

 
 
 
$
2,821,087

 
 

(1) Includes carrying value adjustments of $44.6 million, $21.4 million, $11.5 million, $5.0 million and ($5.2) million as of March 31, 2020, December 31, 2019, September 30, 2019, June 30, 2019 and March 31, 2019, respectively, related to interest rate swaps associated with public finance loans.

Total loans were $2.9 billion as of March 31, 2020, a decrease of $71.5 million, or 2.4%, compared to December 31, 2019. Total commercial balances were $2.3 billion as of March 31, 2020, consistent with December 31, 2019. Compared to December 31, 2019, production in healthcare finance, small business lending and construction was offset by lower balances in the single tenant lease financing and public finance loan portfolios due primarily to sales of $94.4 million of loans in these categories during the first quarter 2020.

Total consumer loan balances were $539.2 million as of March 31, 2020, a decrease of $94.3 million, or 14.9%, compared to December 31, 2019. The decline in consumer loan balances from December 31, 2019 was due primarily to the sale of $90.8 million of portfolio residential mortgage loans, which included seasoned lower-yielding loans.

The Company has identified loan exposures to certain industries that may be impacted by COVID-19. Our healthcare finance portfolio, which represents 12.9% of our total loan portfolio, is comprised primarily of loans to dentists and other specialists that have been impacted by government actions to contain COVID-19. Within the rest of the portfolio, as of March 31, 2020, additional exposures represent approximately 17.6% of our total loan portfolio and include full-service restaurants of $221.2 million, quick-service restaurants of $218.6 million, consumer services of $35.1 million, healthcare and social assistance of $21.1 million and hotels and accommodations of $12.6 million. Given the economic uncertainty related to COVID-19, the ultimate impact of the pandemic on these exposures is unknown at this time. We currently have no exposure to other highly impacted industries such as airlines, cruise ships, oil & gas or multifamily lending.
    





46



Asset Quality

Nonperforming loans are comprised of nonaccrual loans and loans 90 days past due and accruing. Nonperforming assets include nonperforming loans, OREO and other nonperforming assets, which consist of repossessed assets. The following table provides a summary of the Company’s nonperforming assets for the last five completed fiscal quarters.
(dollars in thousands)
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Nonaccrual loans
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
Commercial and industrial
$
218

 
$
226

 
$
585

 
$
1,604

 
$
192

Owner-occupied commercial real estate
464

 
464

 
465

 
478

 

Single tenant lease financing
4,680

 
4,680

 
4,691

 

 

Small business lending
926

 

 

 

 

Total commercial loans
6,288

 
5,370

 
5,741

 
2,082

 
192

Consumer loans:
 
 
 
 
 
 
 
 
 
Residential mortgage
991

 
761

 

 
3,134

 
3,163

Home equity

 

 

 

 

Other consumer
39

 
33

 
41

 
49

 
68

Total consumer loans
1,030

 
794

 
41

 
3,183

 
3,231

Total nonaccrual loans
7,318

 
6,164

 
5,782

 
5,265

 
3,423

 
 
 
 
 
 
 
 
 
 
Past Due 90 days and accruing loans
 
 
 
 
 
 
 
 
 
Commercial loans:
 
 
 
 
 
 
 
 
 
Commercial and industrial
73

 

 

 

 

Total commercial loans
73

 

 

 

 

Consumer loans:
 
 
 
 
 
 
 
 
 
Residential mortgage
51

 
568

 

 
121

 

Other consumer
1

 

 
1

 

 
9

Total consumer loans
52

 
568

 
1

 
121

 
9

Total past due 90 days and accruing loans
125

 
568

 
1

 
121

 
9

 
 
 
 
 
 
 
 
 
 
Total nonperforming loans
7,443

 
6,732

 
5,783

 
5,386

 
3,432

 
 
 
 
 
 
 
 
 
 
Other real estate owned
 
 
 
 
 
 
 
 
 
Investor commercial real estate
2,065

 
2,065

 
2,066

 
2,066

 
2,066

Residential mortgage

 

 
553

 
553

 
553

Total other real estate owned
2,065

 
2,065

 
2,619

 
2,619

 
2,619

 
 
 
 
 
 
 
 
 
 
Other nonperforming assets
114

 
75

 
95

 
36

 
20

 
 
 
 
 
 
 
 
 
 
Total nonperforming assets
$
9,622

 
$
8,872

 
$
8,497

 
$
8,041

 
$
6,071

 
 
 
 
 
 
 
 
 
 
Total nonperforming loans to total loans
0.26
%
 
0.23
%
 
0.20
%
 
0.19
%
 
0.12
%
Total nonperforming assets to total assets
0.23
%
 
0.22
%
 
0.21
%
 
0.20
%
 
0.17
%
Allowance for loan losses to total loans
0.79
%
 
0.74
%
 
0.75
%
 
0.70
%
 
0.66
%
Allowance for loan losses to nonperforming loans
307.1
%
 
324.4
%
 
374.9
%
 
370.9
%
 
549.0
%

47




Troubled Debt Restructurings

The following table provides a summary of troubled debt restructurings for the last five completed fiscal quarters.
(in thousands)
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Troubled debt restructurings – nonaccrual
$
94

 
$
94

 
$
171

 
$
174

 
$

Troubled debt restructurings – performing
378

 
427

 
470

 
1,985

 
404

Total troubled debt restructurings
$
472

 
$
521

 
$
641

 
$
2,159

 
$
404

 
The increase in nonperforming loans of $0.7 million, or 10.6%, to $7.4 million as of March 31, 2020 compared to $6.7 million as of December 31, 2019 was due primarily to a small business lending loan with an unpaid principal balance of $0.9 million that was placed on nonaccrual status in the quarter, partially offset by a decrease in accruing residential mortgage loans that were 90 days past due. Total nonperforming assets increased $0.8 million, or 8.5%, as of March 31, 2020 compared to December 31, 2019. The ratio of nonperforming loans to total loans increased to 0.26% as of March 31, 2020 compared to 0.23% as of December 31, 2019 and the ratio of nonperforming assets to total assets increased to 0.23% as of March 31, 2020 compared to 0.22% as of December 31, 2019, due primarily to the loan mentioned above.

Total TDRs as of March 31, 2020 remained consistent with December 31, 2019 at $0.5 million.

As of March 31, 2020 and December 31, 2019, the Company had one commercial property in OREO with a carrying value of $2.1 million. This property consists of two buildings that are residential units adjacent to a university campus.

As of March 31, 2020, we have experienced little impact on our asset quality as a result of COVID-19. Actions taken to either contain or reduce the impact of the pandemic have had a detrimental effect on the national and our local economies. The ultimate impact it may have on our business and asset quality is highly uncertain, as the extent of the crisis is unknown. We remain optimistic that the combination of government stimulus programs and relief programs we have provided to our clients will lessen the economic stress on our borrowers. However, if the pandemic extends for a prolonged period of time, we may experience negative trends in nonperforming loans and assets.     

Non-TDR Loan Modifications due to COVID-19

The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

Additionally, Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

In accordance with this guidance, the Company offered modifications to borrowers who were both impacted by COVID-19 and current on all principal and interest payments.     





48



The following table shows the Company’s deferrals by loan portfolio type that have been granted through May 1, 2020. The balances shown are as of March 31, 2020.

(dollars in thousands)
 
Deferrals
 
Total Loan Balance
 
% Of Balances With Deferrals
Commercial loans
 
 

 
 
 
 

Commercial and industrial
 
$
16,147

 
$
95,227

 
17.0
%
Owner-occupied commercial real estate
 
15,791

 
74,737

 
21.1
%
Investor commercial real estate
 

 
13,421

 
0.0
%
Construction
 

 
64,581

 
0.0
%
Single tenant lease financing
 
244,731

 
972,275

 
25.2
%
Public finance
 

 
627,678

 
0.0
%
Healthcare finance
 
296,477

 
372,266

 
79.6
%
Small business lending
 
22,346

 
67,275

 
33.2
%
Total commercial loans
 
595,492

 
2,287,460

 
26.0
%
Consumer loans
 
 
 
 
 
 
Residential mortgage
 
11,606

 
218,730

 
5.3
%
Home equity
 
355

 
23,855

 
1.5
%
Other consumer
 
8,591

 
296,605

 
2.9
%
Total consumer loans
 
20,552

 
539,190

 
3.8
%
 
 
 
 
 
 
 
Total commercial and consumer loans
 
$
616,044

 
$
2,826,650

 
21.8
%
    
The single tenant lease financing and healthcare finance portfolios comprise approximately 88% of the total loan deferrals granted. Borrowers in these portfolios have experienced short-term cash flow challenges due to broad-based federal and state government actions to contain COVID-19. Within the single tenant lease financing portfolio, the portfolio average loan-to-value ratio is 50% and all borrowers, except for the single relationship on nonaccrual status, made their April 2020 loan payments in a timely manner. Related to the healthcare finance portfolio, over 90% of the loans are made to dental practices who generally are open only for emergency procedures at the current time. It is expected that dental practices will be among the first to reopen when restrictions are lifted for non-essential businesses. Additionally, we have experienced no delinquencies or losses in this portfolio since inception.

U.S. Small Business Administration Paycheck Protection Program

Section 1102 of the CARES Act created the PPP, which is administered by the SBA. Loans originated under the PPP have a two-year term, bear an interest rate of 1.00% and are designed to provide a direct incentive to small businesses to retain employees on their payroll during COVID-19. These loans will be forgiven if the funds were used for payroll costs and other qualifying business expenses as long as 75% of the forgiven amount was used to maintain payroll costs. The federal government approved an initial appropriation of $349.0 billion for PPP loans and when that was depleted approved an additional $310.0 billion. As a preferred SBA lender, we assisted our clients in participating in both rounds of the PPP. Through May 1, 2020, we provided 437 PPP loans totaling $59.6 million, with an average loan size of $136,000, to help small businesses maintain their workforces in an uncertain and challenging environment. We expect to receive fee revenue from the federal government based on the PPP funding we provided for our clients. The estimated weighted average fee was 3.86% of the amount funded, or approximately $2.3 million in total. This fee revenue will be deferred over the life of the PPP loans and recognized as interest income.
    

    
    
    

49



Allowance for Loan Losses 

The following table provides a rollforward of the allowance for loan losses for the last five completed fiscal quarters.
(dollars in thousands)
Three Months Ended
 
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Balance, beginning of period
$
21,840

 
$
21,683

 
$
19,976

 
$
18,841

 
$
17,896

Provision charged to expense
1,461

 
468

 
2,824

 
1,389

 
1,285

Losses charged off
(498
)
 
(409
)
 
(1,182
)
 
(337
)
 
(429
)
Recoveries
54

 
98

 
65

 
83

 
89

Balance, end of period
$
22,857

 
$
21,840

 
$
21,683

 
$
19,976

 
$
18,841

 
 
 
 
 
 
 
 
 
 
Net charge-offs to average loans
0.06
%
 
0.04
%
 
0.15
%
 
0.05
%
 
0.05
%

The allowance for loan losses was $22.9 million as of March 31, 2020, compared to $21.8 million as of December 31, 2019. While total loan balances declined $71.5 million, or 2.4%, compared to December 31, 2019, the Company made adjustments to qualitative factors related to economic conditions in its allowance model to reflect the economic uncertainty resulting from COVID-19. As a result, both the allowance for loan losses and the allowance as a percentage of total loans increased compared to December 31, 2019. During the first quarter 2020, the Company recorded net charge-offs of $0.4 million, compared to net charge-offs of $0.3 million for the first quarter 2019.

     The allowance for loan losses as a percentage of total loans was 0.79% at March 31, 2020 and 0.74% at December 31, 2019. The allowance for loan losses as a percentage of nonperforming loans decreased to 307.1% as of March 31, 2020, compared to 324.4% as of December 31, 2019. The provision for loan losses in the first quarter 2020 was $1.5 million, compared to $0.5 million for the fourth quarter 2019. The increase of $1.0 million, or 212.2%, compared to the fourth quarter 2019 was due primarily to the adjustments to the economic qualitative factors in the allowance model discussed above.

Investment Securities Portfolio

The following tables present the amortized cost and approximate fair value of our investment portfolio by security type for the last five completed fiscal quarters.   
(in thousands)
 
 
 
 
 
 
 
 
 
Amortized Cost
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Securities available-for-sale
 
 
 
 
 
 
 
 
 
U.S. Government-sponsored agencies
$
71,387

 
$
77,715

 
$
83,024

 
$
89,088

 
$
102,749

Municipal securities
94,981

 
97,447

 
96,076

 
96,202

 
96,328

Agency mortgage-backed securities
279,458

 
264,142

 
278,327

 
257,050

 
256,737

Private label mortgage-backed securities
114,363

 
63,704

 
45,969

 
40,695

 
31,383

Asset-backed securities
5,000

 
5,000

 
5,000

 
5,000

 
5,000

Corporate securities
43,378

 
38,632

 
38,638

 
38,644

 
38,650

Total available-for-sale
608,567

 
546,640

 
547,034

 
526,679

 
530,847

Securities held-to-maturity
 
 
 
 
 
 
 
 
 
Municipal securities
14,617

 
10,142

 
10,145

 
10,147

 
10,150

Corporate securities
51,714

 
51,736

 
36,662

 
25,679

 
21,072

Total held-to-maturity
66,331

 
61,878

 
46,807

 
35,826

 
31,222

Total securities
$
674,898

 
$
608,518

 
$
593,841

 
$
562,505

 
$
562,069


50



(in thousands)
 
 
 
 
 
 
 
 
 
Approximate Fair Value
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Securities available-for-sale
 
 
 
 
 
 
 
 
 
U.S. Government-sponsored agencies
$
70,004

 
$
75,872

 
$
81,435

 
$
87,737

 
$
100,872

Municipal securities
94,819

 
97,652

 
97,942

 
96,988

 
95,445

Agency mortgage-backed securities
282,632

 
261,440

 
277,530

 
254,876

 
251,318

Private label mortgage-backed securities
115,024

 
63,613

 
46,459

 
41,112

 
31,453

Asset-backed securities
4,713

 
4,955

 
4,931

 
4,928

 
4,928

Corporate securities
41,490

 
37,320

 
36,445

 
36,693

 
36,366

Total available-for-sale
608,682

 
540,852

 
544,742

 
522,334

 
520,382

Securities held-to-maturity
 
 
 
 
 
 
 
 
 
Municipal securities
15,678

 
10,368

 
10,490

 
10,296

 
10,062

Corporate securities
53,790

 
52,192

 
37,065

 
25,992

 
21,206

Total held-to-maturity
69,468

 
62,560

 
47,555

 
36,288

 
31,268

Total securities
$
678,150

 
$
603,412

 
$
592,297

 
$
558,622

 
$
551,650


The approximate fair value of available-for-sale investment securities increased $67.8 million, or 12.5%, to $608.7 million as of March 31, 2020, compared to $540.9 million as of December 31, 2019. The increase was due primarily to increases of $51.4 million in private label mortgage-backed securities and $21.2 million in agency mortgage-backed securities. These increases were driven primarily by purchases as liquidity from deposit growth and loan sales was deployed and, to a lesser extent, increases in market value due to changes in interest rates. As of March 31, 2020, the Company had securities with an amortized cost basis of $66.3 million designated as held-to-maturity compared to $61.9 million as of December 31, 2019.

Accrued Income and Other Assets

Accrued income and other assets were $112.3 million at March 31, 2020 compared to $67.1 million at December 31, 2019. The increase of $45.3 million, or 67.5%, was due primarily to cash collateral pledged for interest rate swap agreements. The Company pledged $81.3 million and $42.3 million of cash collateral to counterparties as security for its obligations related to these agreements at March 31, 2020 and December 31, 2019, respectively. Collateral posted and received is dependent on the fair value of the underlying agreements as of the respective date.

Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities were $96.7 million at March 31, 2020 compared to $53.0 million at December 31, 2019. The increase of $43.7 million, or 82.5%, was due primarily to a $40.8 million decrease in the fair value of interest rate swap agreements.

Deposits  

The following table presents the composition of the Company’s deposit base for the last five completed fiscal quarters.
(dollars in thousands)
 
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Noninterest-bearing deposits
 
$
70,562

 
2.2
%
 
$
57,115

 
1.8
%
 
$
50,560

 
1.6
%
 
$
44,040

 
1.5
%
 
$
45,878

 
1.6
%
Interest-bearing demand deposits
 
123,233

 
3.9
%
 
129,020

 
4.1
%
 
122,551

 
3.9
%
 
126,669

 
4.2
%
 
111,626

 
4.0
%
Savings accounts
 
32,485

 
1.0
%
 
29,616

 
0.9
%
 
34,886

 
1.1
%
 
31,445

 
1.0
%
 
41,958

 
1.5
%
Money market accounts
 
930,698

 
29.3
%
 
786,390

 
24.9
%
 
698,077

 
22.2
%
 
607,849

 
20.3
%
 
573,895

 
20.4
%
Certificates of deposits
 
1,493,644

 
47.0
%
 
1,613,453

 
51.2
%
 
1,681,377

 
53.4
%
 
1,629,886

 
54.2
%
 
1,464,543

 
52.1
%
Brokered deposits
 
527,884

 
16.6
%
 
538,369

 
17.1
%
 
560,791

 
17.8
%
 
566,374

 
18.8
%
 
573,208

 
20.4
%
Total deposits
 
$
3,178,506

 
100.0
%
 
$
3,153,963

 
100.0
%
 
$
3,148,242

 
100.0
%
 
$
3,006,263

 
100.0
%
 
$
2,811,108

 
100.0
%
   

51



Total deposits increased $24.5 million, or 0.8%, to $3.2 billion as of March 31, 2020, compared to approximately $3.2 billion as of December 31, 2019. This increase was due primarily to an increase of $144.3 million, or 18.4%, in money market deposits, largely offset by declines of $119.8 million, or 7.4%, in certificates of deposits and $10.5 million, or 2.0%, in brokered deposits. The Company experienced strong growth in money market balances from commercial, small business and consumer depositors. The declines in certificates of deposits and brokered deposits were due to the maturity of higher cost balances and reduced pricing strategies designed to limit the volume of new production.

Recent Debt and Equity Offerings

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding June 30, 2024, and thereafter a floating rate equal to the then-current Benchmark rate (initially three-month LIBOR rate) plus 411 basis points. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines. The 2029 Notes are trading on the Nasdaq Global Select Market under the symbol “INBKZ.”

Regulatory Capital Requirements

The Company and the Bank are subject to various regulatory capital requirements administered by state and federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities, and certain off-balance-sheet items calculated under regulatory accounting practices. Capital amounts and classifications are also subject to qualitative judgments by regulators about components, risk weighting and other factors.

The Basel III Capital Rules became effective for the Company and the Bank on January 1, 2015, subject to a phase-in period for certain provisions. Quantitative measures established by the Basel III Capital Rules to ensure capital adequacy require the maintenance of minimum amounts and ratios of Common Equity Tier 1 capital, Tier 1 capital and Total capital, as defined in the regulations, to risk-weighted assets, and of Tier 1 capital to adjusted quarterly average assets (“Leverage Ratio”).

The Basel III Capital Rules were fully phased in on January 1, 2019 and require the Company and the Bank to maintain: 1) a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 4.5%, plus a 2.5% “capital conservation buffer” (resulting in a minimum ratio of Common Equity Tier 1 capital to risk-weighted assets of 7.0%); 2) a minimum ratio of Tier 1 capital to risk-weighted assets of 6.0%, plus the capital conservation buffer (resulting in a minimum Tier 1 capital ratio of 8.5%); 3) a minimum ratio of Total capital to risk-weighted assets of 8.0%, plus the capital conservation buffer (resulting in a minimum Total capital ratio of 10.5%); and 4) a minimum Leverage Ratio of 4.0%.

The implementation of the capital conservation buffer began on January 1, 2016 at the 0.625% level and was phased in over a four-year period, increasing by increments of that amount on each subsequent January 1 until it reached 2.5% on January 1, 2019. The capital conservation buffer is designed to absorb losses during periods of economic stress. Failure to maintain the minimum Common Equity Tier 1 capital ratio plus the capital conservation buffer will result in potential restrictions on a banking institution’s ability to pay dividends, repurchase stock and/or pay discretionary compensation to its employees.


52



The following tables present actual and required capital ratios as of March 31, 2020 and December 31, 2019 for the Company and the Bank under the Basel III Capital Rules. The minimum required capital amounts presented include the minimum required capital levels as of March 31, 2020 and December 31, 2019 based on the Basel III Capital Rules and the minimum required capital levels as of January 1, 2019. Capital levels required to be considered well capitalized are based upon prompt corrective action regulations, as amended to reflect the changes under the Basel III Capital Rules.
 
Actual
 
Minimum Capital Required - Basel III
 
Minimum Required to be Considered Well Capitalized
(dollars in thousands)
Capital Amount
 
Ratio
 
Capital Amount
 
Ratio
 
Capital Amount
 
Ratio
As of March 31, 2020:
 
 
 
 
 
 
 
 
 
 
 
Common equity tier 1 capital to risk-weighted assets
 
 
 
 
 
 
 
 
 
 
 
Consolidated
$
319,959

 
10.76
%
 
$
207,711

 
7.00
%
 
N/A

 
N/A

Bank
349,499

 
11.77
%
 
207,525

 
7.00
%
 
$
192,702

 
6.50
%
Tier 1 capital to risk-weighted assets
 
 
 
 
 
 
 
 
 
 
 
Consolidated
319,959

 
10.76
%
 
252,220

 
8.50
%
 
N/A

 
N/A

Bank
349,499

 
11.77
%
 
251,995

 
8.50
%
 
231,171

 
8.00
%
Total capital to risk-weighted assets
 
 
 
 
 
 
 
 
 
 
 
Consolidated
412,421

 
13.87
%
 
311,566

 
10.50
%
 
N/A

 
N/A

Bank
372,356

 
12.54
%
 
311,288

 
10.50
%
 
296,464

 
10.00
%
Leverage ratio
 
 
 
 
 
 
 
 
 
 
 
Consolidated
319,959

 
7.82
%
 
163,763

 
4.00
%
 
N/A

 
N/A

Bank
349,499

 
8.54
%
 
163,661

 
4.00
%
 
204,576

 
5.00
%
 
Actual
 
Minimum Capital Required - Basel III
 
Minimum Required to be Considered Well Capitalized
(dollars in thousands)
Capital Amount
 
Ratio
 
Capital Amount
 
Ratio
 
Capital Amount
 
Ratio
As of December 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
Common equity tier 1 capital to risk-weighted assets
 
 
 
 
 
 
 
 
 
 
 
Consolidated
$
313,803

 
10.84
%
 
$
202,661

 
7.00
%
 
N/A

 
N/A

Bank
341,242

 
11.80
%
 
202,480

 
7.00
%
 
$
188,017

 
6.50
%
Tier 1 capital to risk-weighted assets
 
 
 
 
 
 
 
 
 
 
 
Consolidated
313,803

 
10.84
%
 
246,088

 
8.50
%
 
N/A

 
N/A

Bank
341,242

 
11.80
%
 
245,869

 
8.50
%
 
231,406

 
8.00
%
Total capital to risk-weighted assets
 
 
 
 
 
 
 
 
 
 
 
Consolidated
405,171

 
13.99
%
 
303,991

 
10.50
%
 
N/A

 
N/A

Bank
363,082

 
12.55
%
 
303,720

 
10.50
%
 
289,257

 
10.00
%
Leverage ratio
 
 
 
 
 
 
 
 
 
 
 
Consolidated
313,803

 
7.64
%
 
164,219

 
4.00
%
 
N/A

 
N/A

Bank
341,242

 
8.32
%
 
164,121

 
4.00
%
 
205,151

 
5.00
%


53



Shareholders’ Dividends

The Company’s Board of Directors declared a cash dividend of $0.06 per share of common stock payable April 15, 2020 to shareholders of record as of March 31, 2020. The Company expects to continue to pay cash dividends on a quarterly basis; however, the declaration and amount of any future cash dividends will be subject to the sole discretion of the Board of Directors and will depend upon many factors, including its results of operations, financial condition, capital requirements, regulatory and contractual restrictions (including with respect to the Company’s outstanding subordinated debt), business strategy and other factors deemed relevant by the Board of Directors, including any potential impact resulting from COVID-19.

As of March 31, 2020, the Company had $72.0 million principal amount of subordinated debt outstanding pursuant its term loan evidenced by a term note due 2025, its 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 and the 2029 Notes. The agreements that govern our outstanding subordinated debt prohibit the Company from paying any dividends on its common stock or making any other distributions to shareholders at any time when there shall have occurred, and be continuing to occur, an event of default under the applicable agreement. If an event of default were to occur and the Company did not cure it, the Company would be prohibited from paying any dividends or making any other distributions to shareholders or from redeeming or repurchasing any common stock.

Capital Resources

The Company believes it has sufficient liquidity and capital resources to meet its cash and capital expenditure requirements for at least the next twelve months. The Company may explore strategic alternatives, including additional asset, deposit or revenue generation channels that complement our commercial and consumer banking platforms, which may require additional capital. If the Company is unable to secure such capital at favorable terms, its ability to take advantage of such opportunities could be adversely affected.

Liquidity

Liquidity management is the process used by the Company to manage the continuing flow of funds necessary to meet its financial commitments on a timely basis and at a reasonable cost while also maintaining safe and sound operations. Liquidity, represented by cash and investment securities, is a product of the Company’s operating, investing and financing activities. The primary sources of funds are deposits, principal and interest payments on loans and investment securities, maturing loans and investment securities, access to wholesale funding sources and collateralized borrowings. While scheduled payments and maturities of loans and investment securities are relatively predictable sources of funds, deposit flows are greatly influenced by interest rates, general economic conditions and competition. Therefore, the Company supplements deposit growth and enhances interest rate risk management through borrowings and wholesale funding, which are generally advances from the FHLB and brokered deposits.

Additionally, the Company has enhanced its liquidity management process during 2019 and 2020 through increased loan sale activity. During the first quarter 2020, the Company sold $99.9 million of public finance, single tenant lease financing and SBA 7(a) guaranteed loans at premiums to book value, as well as a $90.8 million pool of residential mortgage loans. During 2019, the Company sold $237.5 million of portfolio residential mortgage, single tenant lease financing and public finance loans. These loan sales have provided liquidity to manage overall loan portfolio growth and capital utilization.

The Company holds cash and investment securities that qualify as liquid assets to maintain adequate liquidity to ensure safe and sound operations and meet its financial commitments. Given the uncertainty regarding the length and ultimate economic effect of COVID-19, we believe it may be prudent to maintain higher levels of cash on the balance sheet until the crisis passes. Furthermore, we believe we have more than sufficient on-balance sheet liquidity, supplemented by access to additional funding sources, to manage the potential economic impact of COVID-19. At March 31, 2020, on a consolidated basis, the Company had $960.0 million in cash and cash equivalents and investment securities available-for-sale and $52.4 million in loans held-for-sale that were generally available for its cash needs. The Company can also generate funds from wholesale funding sources and collateralized borrowings. At March 31, 2020, the Bank had the ability to borrow an additional $602.2 million from the FHLB, the Federal Reserve and correspondent bank Fed Funds lines of credit.

The Company is a separate legal entity from the Bank and must provide for its own liquidity. In addition to its operating expenses, the Company is responsible for paying any dividends declared to its common shareholders and interest and principal on outstanding debt. The Company’s primary sources of funds are cash maintained at the holding company level and dividends from the Bank, the payment of which is subject to regulatory limits. At March 31, 2020, the Company, on an unconsolidated basis, had $36.0 million in cash generally available for its cash needs, which is in excess of its current annual regular shareholder dividend and operating expenses.
 

54



The Company uses its sources of funds primarily to meet ongoing financial commitments, including withdrawals by depositors, credit commitments to borrowers, operating expenses and capital expenditures. At March 31, 2020, approved outstanding loan commitments, including unused lines of credit and standby letters of credit, amounted to $295.9 million. Certificates of deposits and brokered deposits scheduled to mature in one year or less at March 31, 2020 totaled $1.18 billion.

Management is not aware of any other events or regulatory requirements that, if implemented, are likely to have a material effect on either the Company’s or the Bank’s liquidity.


55



Reconciliation of Non-GAAP Financial Measures

This Management’s Discussion and Analysis contains financial information determined by methods other than in accordance with GAAP. Non-GAAP financial measures, specifically tangible common equity, tangible assets, tangible book value per common share, average tangible common equity, return on average tangible common equity, tangible common equity to tangible assets ratio, total interest income - FTE, net interest income - FTE and net interest margin - FTE are used by the Company’s management to measure the strength of its capital and analyze profitability, including its ability to generate earnings on tangible capital invested by its shareholders. The Company also believes that it is a standard practice in the banking industry to present total interest income, net interest income and net interest margin on a fully-taxable equivalent basis, as those measures provide useful information for peer comparisons. Although the Company believes these non-GAAP financial measures provide a greater understanding of its business, they should not be considered a substitute for financial measures determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP financial measures that may be presented by other companies. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in the following table for the last five completed fiscal quarters.

(dollars in thousands, except share and per share data)
Three Months Ended
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Total equity - GAAP
$
305,127

 
$
304,913

 
$
295,140

 
$
296,120

 
$
294,013

Adjustments:
 
 
 
 
 
 
 
 
 
     Goodwill
(4,687
)
 
(4,687
)
 
(4,687
)
 
(4,687
)
 
(4,687
)
Tangible common equity
$
300,440

 
$
300,226

 
$
290,453

 
$
291,433

 
$
289,326

 
 
 
 
 
 
 
 
 
 
Total assets - GAAP
$
4,168,146

 
$
4,100,083

 
$
4,095,491

 
$
3,958,829

 
$
3,670,176

Adjustments:
 
 
 
 
 
 
 
 
 
     Goodwill
(4,687
)
 
(4,687
)
 
(4,687
)
 
(4,687
)
 
(4,687
)
Tangible assets
$
4,163,459

 
$
4,095,396

 
$
4,090,804

 
$
3,954,142

 
$
3,665,489

 
 
 
 
 
 
 
 
 
 
Total common shares outstanding
9,801,825

 
9,741,800

 
9,741,800

 
10,016,458

 
10,128,587

 
 
 
 
 
 
 
 
 
 
Book value per common share
$
31.13

 
$
31.30

 
$
30.30

 
$
29.56

 
$
29.03

Effect of goodwill
(0.48
)
 
(0.48
)
 
(0.48
)
 
(0.46
)
 
(0.46
)
Tangible book value per common share
$
30.65

 
$
30.82

 
$
29.82

 
$
29.10

 
$
28.57

 
 
 
 
 
 
 
 
 
 
Total shareholders’ equity to assets
7.32
 %
 
7.44
 %
 
7.21
 %
 
7.48
 %
 
8.01
 %
Effect of goodwill
(0.10
)%
 
(0.11
)%
 
(0.11
)%
 
(0.11
)%
 
(0.12
)%
Tangible common equity to tangible assets
7.22
 %
 
7.33
 %
 
7.10
 %
 
7.37
 %
 
7.89
 %
 
 
 
 
 
 
 
 
 
 
Total average equity - GAAP
$
311,005

 
$
297,623

 
$
298,782

 
$
297,148

 
$
291,883

Adjustments:
 
 
 
 
 
 
 
 
 
     Average goodwill
(4,687
)
 
(4,687
)
 
(4,687
)
 
(4,687
)
 
(4,687
)
Average tangible common equity
$
306,318

 
$
292,936

 
$
294,095

 
$
292,461

 
$
287,196

 
 
 
 
 
 
 
 
 
 
Return on average shareholders’ equity
7.78
 %
 
9.46
 %
 
8.40
 %
 
8.26
 %
 
7.91
 %
Effect of goodwill
0.12
 %
 
0.15
 %
 
0.13
 %
 
0.13
 %
 
0.13
 %
Return on average tangible common equity
7.90
 %
 
9.61
 %
 
8.53
 %
 
8.39
 %
 
8.04
 %

56



(dollars in thousands, except share and per share data)
Three Months Ended
March 31,
2020
 
December 31,
2019
 
September 30,
2019
 
June 30,
2019
 
March 31,
2019
Total interest income
$
36,244

 
$
37,877

 
$
37,694

 
$
36,844

 
$
34,999

Adjustments:
 
 
 
 
 
 
 
 
 
Fully-taxable equivalent adjustments 1
1,535

 
1,570

 
1,595

 
1,612

 
1,557

Total interest income - FTE
$
37,779

 
$
39,447

 
$
39,289

 
$
33,326

 
$
36,556

 
 
 
 
 
 
 
 
 
 
Net interest income
$
15,018

 
$
15,374

 
$
15,244

 
$
16,105

 
$
16,244

Adjustments:
 
 
 
 
 
 
 
 
 
Fully-taxable equivalent adjustments 1
1,535

 
1,570

 
1,595

 
1,612

 
1,557

Net interest income - FTE
$
16,553

 
$
16,944

 
$
16,839

 
$
17,717

 
$
17,801

 
 
 
 
 
 
 
 
 
 
Net interest margin
1.50
%
 
1.51
%
 
1.54
%
 
1.73
%
 
1.86
%
Effect of fully-taxable equivalent adjustments 1
0.15
%
 
0.16
%
 
0.16
%
 
0.18
%
 
0.18
%
Net interest margin - FTE
1.65
%
 
1.67
%
 
1.70
%
 
1.91
%
 
2.04
%

1 Assuming a 21% tax rate


Critical Accounting Policies and Estimates
 
There have been no material changes in the Company’s critical accounting policies or estimates from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2019.
 
Recent Accounting Pronouncements
 
Refer to Note 16 to the condensed consolidated financial statements.

Off-Balance Sheet Arrangements
 
In the ordinary course of business, the Company enters into financial transactions to extend credit, interest rate swap agreements and forms of commitments that may be considered off-balance sheet arrangements. Interest rate swaps are arranged to receive hedge accounting treatment and are classified as either fair value or cash flow hedges. Fair value hedges are purchased to convert certain fixed rate assets to floating rate. Cash flow hedges are used to convert certain variable rate liabilities into fixed rate liabilities. At March 31, 2020 and December 31, 2019, the Company had interest rate swaps with notional amounts of $723.0 million and $725.6 million, respectively. Additionally, we enter into forward contracts relating to our mortgage banking business to hedge the exposures we have from commitments to extend new residential mortgage loans to our customers and from our mortgage loans held-for-sale. At March 31, 2020 and December 31, 2019, the Company had commitments to sell residential real estate loans of $106.8 million and $115.0 million, respectively. These contracts mature in less than one year. Refer to Note 14 to the condensed consolidated financial statements for additional information about derivative financial instruments.

ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
Market risk is the risk of loss arising from adverse changes in the fair value of financial instruments due to changes in interest rates, foreign exchange rates and equity prices. The primary source of market risk for the Company is interest rate risk. Interest rate risk is the risk to earnings and the value of the Company’s equity resulting from changes in market interest rates and arises in the normal course of business to the extent that there are timing and volume differences between the amount of interest-earning assets and the amount of interest-bearing liabilities that are prepaid, withdrawn, re-priced or mature in specified periods. The Company seeks to achieve consistent growth in net interest income and equity while managing volatility arising from shifts in market interest rates.
The Company monitors its interest rate risk position using income simulation models and economic value of equity (“EVE”) sensitivity analysis that capture both short-term and long-term interest rate risk exposure. Income simulation involves forecasting net interest income (“NII”) under a variety of interest rate scenarios. The Company uses EVE sensitivity analysis to understand the impact of changes in interest rates on long-term cash flows, income and capital. EVE is calculated by discounting the cash

57



flows for all balance sheet instruments under different interest-rate scenarios. Modeling the sensitivity of NII and EVE to changes in market interest rates is highly dependent on the assumptions incorporated into the modeling process. The Company continually reviews and refines the assumptions used in its interest rate risk modeling.
Presented below is the estimated impact on the Company’s NII and EVE position as of March 31, 2020, assuming parallel shifts in interest rates and a static balance sheet:
 
% Change from Base Case for Parallel Changes in Rates
 
-50 Basis Points
 
-25 Basis Points
 
+100 Basis Points
 
+200 Basis Points
NII - Year 1
(3.09
)%
 
(1.46
)%
 
6.66
 %
 
5.81
 %
NII - Year 2
2.27
 %
 
4.80
 %
 
(1.72
)%
 
(6.84
)%
EVE
(4.75
)%
 
(2.18
)%
 
(0.46
)%
 
(10.02
)%

The Company’s objective is to manage the balance sheet with a “risk-neutral” position. A “risk-neutral” position refers to the absence of a strong bias toward either asset or liability sensitivity. An “asset sensitive” position refers to when the characteristics of the balance sheet are expected to generate higher NII when interest rates increase as rates earned on interest-earning assets would reprice upward more quickly or in greater quantities than rates paid on interest-bearing liabilities. A “liability sensitive” position refers to when the characteristics of the balance sheet are expected to generate higher NII when interest rates decrease as rates paid on interest-bearing liabilities would reprice downward more quickly or in greater quantities than rates earned on interest-earning assets.

ITEM 4.
CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures
 
The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. These controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosures. In designing and evaluating disclosure controls and procedures, the Company has recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Management is required to apply judgment in evaluating its controls and procedures.
 
The Company performed an evaluation under the supervision and with the participation of management, including the principal executive and principal financial officers, to assess the effectiveness of the design and operation of its disclosure controls and procedures under the Exchange Act. Based on that evaluation, the principal executive and principal financial officers concluded that the disclosure controls and procedures were effective at a reasonable assurance level as of March 31, 2020.
 
Changes in Internal Control Over Financial Reporting
 
There has been no change in the Company’s internal control over financial reporting during the three months ended March 31, 2020 that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

58



PART II
 
ITEM 1.
LEGAL PROCEEDINGS
 
Neither we nor any of our subsidiaries are party to any material legal proceedings. From time to time, the Bank is a party to legal actions arising from its normal business activities.
 
ITEM 1A.
RISK FACTORS
 
There have been no material changes to the risk factors previously disclosed in Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, except as described below. In addition, the COVID-19 pandemic could exacerbate or trigger other risks discussed in our 2019 Form 10-K, any of which could materially affect our business, financial condition and results of operations.
The COVID-19 pandemic is adversely affecting us, our business, customers, employees and third-party service providers, and the ultimate impact on our financial condition, results of operations and prospects will depend on future developments, which are highly uncertain.
Global health concerns related to the ongoing COVID-19 pandemic and related government actions taken to reduce the spread of the virus have had a significant negative impact on the macroeconomic environment and market conditions, including significant disruption of, and volatility in, financial markets, and the pandemic has significantly increased economic uncertainty, reduced economic activity and resulted in lost revenues and increased unemployment throughout the United States, but also specifically in Indiana, where we maintain a significant portion of our operations. Our business is dependent upon the willingness and ability of our customers to conduct banking and other financial transactions. The recent outbreak and continuing effects of the COVID-19 pandemic, or any other highly contagious or infectious disease, could negatively impact the ability of our employees and customers to conduct such transactions and disrupt the business activities and operations in the areas in which we operate. While the spread of the COVID-19 virus has minimally impacted our operations as of March 31, 2020, we could experience temporary closures of our corporate offices and/or suspension of certain services in particular markets. Currently, it is unknown how long the COVID-19 pandemic will last, or when restrictions on individuals and businesses will be lifted and when businesses and their employees will be able to resume normal activities in the markets we operate in and serve. Additionally, new information may emerge regarding the severity of COVID-19 and additional actions may be taken by federal, state and local governments to contain COVID-19 or treat its impact. Should there be sustained disruption in our operations, or that of our customers, our financial condition and results of operations could be negatively impacted.
The COVID-19 pandemic has significantly affected the financial markets and has resulted in a number of Federal Reserve actions, which have resulted in a significant decline in market interest rates. Most of our assets and liabilities are financial in nature and are sensitive to movements in market interest rates. A prolonged period of volatile and unstable market conditions will impact both the level of income and expense recorded on our assets and liabilities and the market value of all interest-earning assets and interest-bearing liabilities, which in turn could have an adverse effect on our net interest income, net interest margin and profitability.

Although we have business continuity plans and other safeguards against pandemics or another contagious disease, the spread of COVID-19 could also negatively impact the availability of our employees who are necessary to conduct business operations, as well as potentially impact the business and operations of our third-party service providers. If the response to contain COVID-19, or another highly infectious or contagious disease, is unsuccessful, we could experience a material adverse effect on our business operations, asset valuations, financial condition and results of operations. Material adverse impacts may include all or a combination of valuation impairments on our intangible assets, investments, loans, loan servicing rights, deferred tax assets, or derivatives. The extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on future developments that are highly uncertain and are difficult to predict, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. After the COVID-19 pandemic has subsided, we may continue to experience materially adverse impacts to our business, financial condition and results of operations as a result of the virus’s global and local economic impact, including the availability of credit, adverse impacts on our liquidity and any recession that has occurred or may occur in the future.

ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
None.

ITEM 3.
DEFAULTS UPON SENIOR SECURITIES
 
None.
 
ITEM 4.
MINE SAFETY DISCLOSURES
 
Not Applicable.
 
ITEM 5.
OTHER INFORMATION

None.
 

59



ITEM 6.
EXHIBITS
 
Unless otherwise indicated, all documents incorporated into this quarterly report on Form 10-Q by reference to a document filed with the SEC pursuant to the Exchange Act are located under SEC file number 1-35750.

Exhibit No.
 
Description
 
Method of Filing
 
Articles of Incorporation of First Internet Bancorp (incorporated by reference to Exhibit 3.1 to registration statement on Form 10 filed November 30, 2012)
 
Incorporated by Reference
 
Amended and Restated Bylaws of First Internet Bancorp as amended March 30, 2020 (incorporated by reference to Exhibit 3.1 to current report on Form 8-K filed March 31, 2020)
 
Incorporated by Reference
 
Fourth Amendment to Office Lease dated as of February 1, 2020, by and between First Internet Bancorp and First Internet Bank of Indiana (incorporated by reference to Exhibit 10.11 to annual report on Form 10-K for the fiscal year ended December 31, 2019)
 
 
 
 
Filed Electronically
 
 
Filed Electronically
 
 
Filed Electronically
101.INS
 
XBRL Instance Document
 
Filed Electronically
101.SCH
 
XBRL Taxonomy Extension Schema
 
Filed Electronically
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
 
Filed Electronically
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase
 
Filed Electronically
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
 
Filed Electronically
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase
 
Filed Electronically


60



SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
FIRST INTERNET BANCORP
 
 
 
Date: May 8, 2020
By
/s/ David B. Becker
 
 
David B. Becker,
Chairman, President and Chief Executive Officer
(on behalf of Registrant)
 
 
 
Date: May 8, 2020
By
/s/ Kenneth J. Lovik
 
 
Kenneth J. Lovik,
Executive Vice President and Chief Financial Officer (principal financial officer)

 

61
Exhibit


Exhibit 31.1

Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David B. Becker, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of First Internet Bancorp;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
May 8, 2020
 
 
 
/s/ David B. Becker
 
 
David B. Becker, Chief Executive Officer




Exhibit


Exhibit 31.2

Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kenneth J. Lovik, certify that:

1.
I have reviewed this Quarterly Report on Form 10-Q of First Internet Bancorp;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

c.
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a.
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
May 8, 2020
 
 
 
/s/ Kenneth J. Lovik
 
 
Kenneth J. Lovik, Chief Financial Officer




Exhibit


Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of First Internet Bancorp (the “Company") on Form 10-Q for the period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David B. Becker
 
David B. Becker
 
Chief Executive Officer
 
May 8, 2020
 
 
 
/s/ Kenneth J. Lovik
 
Kenneth J. Lovik
 
Chief Financial Officer
 
May 8, 2020
 



v3.20.1
Loans (Tables)
3 Months Ended
Mar. 31, 2020
Receivables [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
Loan balances as of March 31, 2020 and December 31, 2019 are summarized in the table below.
 
Categories of loans include:
(in thousands)
 
March 31, 2020
 
December 31, 2019
Commercial loans
 
 

 
 

Commercial and industrial
 
$
95,227

 
$
96,420

Owner-occupied commercial real estate
 
74,737

 
73,392

Investor commercial real estate
 
13,421

 
12,567

Construction
 
64,581

 
60,274

Single tenant lease financing
 
972,275

 
995,879

Public finance
 
627,678

 
687,094

Healthcare finance
 
372,266

 
300,612

Small business lending
 
67,275

 
60,279

Total commercial loans
 
2,287,460

 
2,286,517

Consumer loans
 
 
 
 
Residential mortgage
 
218,730

 
313,849

Home equity
 
23,855

 
24,306

Other consumer
 
296,605

 
295,309

Total consumer loans
 
539,190

 
633,464

Total commercial and consumer loans
 
2,826,650

 
2,919,981

Net deferred loan origination costs and premiums and discounts on purchased loans and other(1)
 
65,443

 
43,566

Total loans
 
2,892,093

 
2,963,547

Allowance for loan losses
 
(22,857
)
 
(21,840
)
Net loans
 
$
2,869,236

 
$
2,941,707



(1) Includes carrying value adjustments of $44.6 million and $21.4 million as of March 31, 2020 and December 31, 2019, respectively, related to interest rate swaps associated with public finance loans. 

Allowance for Credit Losses on Financing Receivables
The following tables present changes in the balance of the ALLL during the three months ended March 31, 2020 and 2019

(in thousands)
Three Months Ended March 31, 2020
Allowance for loan losses:
Balance, Beginning of Period
 
Provision (Credit) Charged to Expense
 
Losses
Charged Off
 
Recoveries
 
Balance,
End of Period
Commercial and industrial
$
1,521

 
$
346

 
$
(197
)
 
$

 
$
1,670

Owner-occupied commercial real estate
561

 
84

 

 

 
645

Investor commercial real estate
109

 
19

 

 

 
128

Construction
380

 
80

 

 

 
460

Single tenant lease financing
11,175

 
(420
)
 

 

 
10,755

Public finance
1,580

 
(97
)
 

 

 
1,483

Healthcare finance
3,247

 
1,071

 

 

 
4,318

Small business lending
54

 
203

 

 
8

 
265

Residential mortgage
657

 
(143
)
 
(15
)
 
1

 
500

Home equity
46

 
5

 

 
2

 
53

Other consumer
2,510

 
313

 
(286
)
 
43

 
2,580

Total
$
21,840

 
$
1,461

 
$
(498
)
 
$
54

 
$
22,857



(in thousands)
Three Months Ended March 31, 2019
Allowance for loan losses:
Balance, Beginning of Period
 
Provision (Credit) Charged to Expense
 
Losses
Charged Off
 
Recoveries
 
Balance,
End of Period
Commercial and industrial
$
1,384

 
$
79

 
$
(112
)
 
$

 
$
1,351

Owner-occupied commercial real estate
783

 
(38
)
 

 

 
745

Investor commercial real estate
61

 
42

 

 

 
103

Construction
251

 
16

 

 

 
267

Single tenant lease financing
8,827

 
541

 

 

 
9,368

Public finance
1,670

 
(20
)
 

 

 
1,650

Healthcare finance
1,264

 
467

 

 

 
1,731

Small business lending
203

 
(8
)
 

 

 
195

Residential mortgage
1,079

 
(36
)
 

 
1

 
1,044

Home equity
53

 
(6
)
 

 
2

 
49

Other consumer
2,321

 
248

 
(317
)
 
86

 
2,338

Total
$
17,896

 
$
1,285

 
$
(429
)
 
$
89

 
$
18,841






Allowance For Credit Losses On Financing Receivables Portfolio Segment
The following tables present the recorded investment in loans based on portfolio segment and impairment method as of March 31, 2020 and December 31, 2019
(in thousands)
Loans
 
Allowance for Loan Losses
March 31, 2020
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
 
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
Commercial and industrial
$
94,329

 
$
898

 
$
95,227

 
$
1,561

 
$
109

 
$
1,670

Owner-occupied commercial real estate
74,142

 
595

 
74,737

 
645

 

 
645

Investor commercial real estate
13,421

 

 
13,421

 
128

 

 
128

Construction
64,581

 

 
64,581

 
460

 

 
460

Single tenant lease financing
967,595

 
4,680

 
972,275

 
9,095

 
1,660

 
10,755

Public finance
627,678

 

 
627,678

 
1,483

 

 
1,483

Healthcare finance
372,266

 

 
372,266

 
4,318

 

 
4,318

Small business lending
63,948

 
3,327

 
67,275

 
265

 
 
 
265

Residential mortgage
217,370

 
1,360

 
218,730

 
500

 

 
500

Home equity
23,855

 

 
23,855

 
53

 

 
53

Other consumer
296,557

 
48

 
296,605

 
2,580

 

 
2,580

Total
$
2,815,742

 
$
10,908

 
$
2,826,650

 
$
21,088

 
$
1,769

 
$
22,857

(in thousands)
Loans
 
Allowance for Loan Losses
December 31, 2019
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
 
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
Commercial and industrial
$
93,520

 
$
2,900

 
$
96,420

 
$
1,412

 
$
109

 
$
1,521

Owner-occupied commercial real estate
71,067

 
2,325

 
73,392

 
561

 

 
561

Investor commercial real estate
12,567

 

 
12,567

 
109

 

 
109

Construction
60,274

 

 
60,274

 
380

 

 
380

Single tenant lease financing
991,199

 
4,680

 
995,879

 
9,515

 
1,660

 
11,175

Public finance
687,094

 

 
687,094

 
1,580

 

 
1,580

Healthcare finance
300,612

 

 
300,612

 
3,247

 

 
3,247

Small business lending
56,941

 
3,338

 
60,279

 
54

 
 
 
54

Residential mortgage
312,714

 
1,135

 
313,849

 
657

 

 
657

Home equity
24,306

 

 
24,306

 
46

 

 
46

Other consumer
295,266

 
43

 
295,309

 
2,510

 

 
2,510

Total
$
2,905,560

 
$
14,421

 
$
2,919,981

 
$
20,071

 
$
1,769

 
$
21,840

Financing Receivable Credit Quality Indicators
The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of March 31, 2020 and December 31, 2019
 
March 31, 2020
(in thousands)
Pass
 
Special Mention
 
Substandard
 
Total
Commercial and industrial
$
91,028

 
$
3,301

 
$
898

 
$
95,227

Owner-occupied commercial real estate
74,142

 

 
595

 
74,737

Investor commercial real estate
13,421

 

 

 
13,421

Construction
64,581

 

 

 
64,581

Single tenant lease financing
959,161

 
8,434

 
4,680

 
972,275

Public finance
627,678

 

 

 
627,678

Healthcare finance
371,203

 
1,063

 

 
372,266

Small business lending
62,226

 
1,722

 
3,327

 
67,275

Total commercial loans
$
2,263,440

 
$
14,520

 
$
9,500

 
$
2,287,460

 
March 31, 2020
(in thousands)
Performing
 
Nonaccrual
 
Total
Residential mortgage
$
217,739

 
$
991

 
$
218,730

Home equity
23,855

 

 
23,855

Other consumer
296,566

 
39

 
296,605

Total consumer loans
$
538,160

 
$
1,030

 
$
539,190

 
December 31, 2019
(in thousands)
Pass
 
Special Mention
 
Substandard
 
Total
Commercial and industrial
$
89,818

 
$
3,973

 
$
2,629

 
$
96,420

Owner-occupied commercial real estate
71,068

 
1,727

 
597

 
73,392

Investor commercial real estate
12,567

 

 

 
12,567

Construction
60,274

 

 

 
60,274

Single tenant lease financing
983,448

 
7,751

 
4,680

 
995,879

Public finance
687,094

 

 

 
687,094

Healthcare finance
300,612

 

 

 
300,612

Small business lending
55,206

 
1,735

 
3,338

 
60,279

Total commercial loans
$
2,260,087

 
$
15,186

 
$
11,244

 
$
2,286,517

 
December 31, 2019
(in thousands)
Performing
 
Nonaccrual
 
Total
Residential mortgage
$
313,088

 
$
761

 
$
313,849

Home equity
24,306

 

 
24,306

Other consumer
295,276

 
33

 
295,309

Total consumer loans
$
632,670

 
$
794

 
$
633,464

Past Due Financing Receivables
The following tables present the Company’s loan portfolio delinquency analysis as of March 31, 2020 and December 31, 2019

 
 
March 31, 2020
(in thousands)
 
30-59
Days
Past Due
 
60-89
Days
Past Due
 
90 Days 
or More
Past Due
 
Total 
Past Due
 
Current
 
Total
Loans
 
Non-
accrual
Loans
 
Total Loans
90 Days or
More Past
Due and
Accruing
Commercial and industrial
 
$

 
$

 
$
285

 
$
285

 
$
94,942

 
$
95,227

 
$
218

 
$
73

Owner-occupied commercial real estate
 

 

 
464

 
464

 
74,273

 
74,737

 
464

 

Investor commercial real estate
 

 

 

 

 
13,421

 
13,421

 

 

Construction
 

 

 

 

 
64,581

 
64,581

 

 

Single tenant lease financing
 

 

 
4,680

 
4,680

 
967,595

 
972,275

 
4,680

 

Public finance
 

 

 

 

 
627,678

 
627,678

 

 

Healthcare finance
 

 

 

 

 
372,266

 
372,266

 

 

Small business lending
 
676

 
43

 
926

 
1,645

 
65,630

 
67,275

 
926

 

Residential mortgage
 
870

 

 
1,042

 
1,912

 
216,818

 
218,730

 
991

 
51

Home equity
 

 

 

 

 
23,855

 
23,855

 

 

Other consumer
 
95

 
149

 
1

 
245

 
296,360

 
296,605

 
39

 
1

Total
 
$
1,641

 
$
192

 
$
7,398

 
$
9,231

 
$
2,817,419

 
$
2,826,650

 
$
7,318

 
$
125

 
 
December 31, 2019
(in thousands)
 
30-59
Days
Past Due
 
60-89
Days
Past Due
 
90 Days 
or More
Past Due
 
Total 
Past Due
 
Current
 
Total
Loans
 
Non-
accrual
Loans
 
Total Loans
90 Days or
More Past
Due and
Accruing
Commercial and industrial
 
$
15

 
$
96

 
$
122

 
$
233

 
$
96,187

 
$
96,420

 
$
226

 
$

Owner-occupied commercial real estate
 

 

 
464

 
464

 
72,928

 
73,392

 
464

 

Investor commercial real estate
 

 

 

 

 
12,567

 
12,567

 

 

Construction
 

 

 

 

 
60,274

 
60,274

 

 

Single tenant lease financing
 

 
4,680

 

 
4,680

 
991,199

 
995,879

 
4,680

 

Public finance
 

 

 

 

 
687,094

 
687,094

 

 

Healthcare finance
 

 

 

 

 
300,612

 
300,612

 

 

Small business lending
 
54

 
 
 

 
54

 
60,225

 
60,279

 

 

Residential mortgage
 

 

 
1,177

 
1,177

 
312,672

 
313,849

 
761

 
416

Home equity
 

 

 

 

 
24,306

 
24,306

 

 

Other consumer
 
240

 
107

 

 
347

 
294,962

 
295,309

 
33

 

Total
 
$
309

 
$
4,883

 
$
1,763

 
$
6,955

 
$
2,913,026

 
$
2,919,981

 
$
6,164

 
$
416

Impaired Financing Receivables
The following table presents the Company’s impaired loans as of March 31, 2020 and December 31, 2019
 
 
March 31, 2020
 
December 31, 2019
(in thousands)
 
Recorded
Balance
 
Unpaid
Principal
Balance
 
Specific
Allowance
 
Recorded
Balance
 
Unpaid
Principal
Balance
 
Specific
Allowance
Loans without a specific valuation allowance
 
 

 
 

 
 

 
 

 
 

 
 

Commercial and industrial
 
$
695

 
$
697

 
$

 
$
2,693

 
$
2,694

 
$

Owner-occupied commercial real estate
 
595

 
598

 

 
2,325

 
2,327

 

Small business lending
 
3,327

 
3,327

 

 
3,338

 
3,338

 

Residential mortgage
 
1,360

 
1,450

 

 
1,135

 
1,209

 

Other consumer
 
48

 
116

 

 
43

 
107

 

Total
 
6,025

 
6,188

 

 
9,534

 
9,675

 

Loans with a specific valuation allowance
 
 

 
 

 
 

 
 

 
 

 
 

Commercial and industrial
 
203

 
240

 
109

 
207

 
244

 
109

Single tenant lease financing
 
4,680

 
4,680

 
1,660

 
4,680

 
4,680

 
1,660

Total
 
4,883

 
4,920

 
1,769

 
4,887

 
4,924

 
1,769

Total impaired loans
 
$
10,908

 
$
11,108

 
$
1,769

 
$
14,421

 
$
14,599

 
$
1,769

 
The table below presents average balances and interest income recognized for impaired loans during the three months ended March 31, 2020 and 2019.
 
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
(in thousands)
 
Average
Balance
 
Interest
Income
 
Average
Balance
 
Interest
Income
Loans without a specific valuation allowance
 
 

 
 

 
 

 
 

Commercial and industrial
 
$
2,066

 
$
18

 
$
4,699

 
$
81

Owner-occupied commercial real estate
 
1,890

 
2

 
1,253

 
13

Small business lending
 
3,332

 

 
952

 
14

Residential mortgage
 
1,274

 

 
2,054

 

Home equity
 

 

 
41

 

Other consumer
 
45

 

 
76

 

Total
 
8,607

 
20

 
9,075

 
108

Loans with a specific valuation allowance
 
 

 
 

 
 

 
 

Commercial and industrial
 
204

 

 

 

Single tenant lease financing
 
4,680

 

 

 

Total
 
4,884

 

 

 

Total impaired loans
 
$
13,491

 
$
20

 
$
9,075

 
$
108

v3.20.1
Recent Accounting Pronouncements
3 Months Ended
Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]  
Recent Accounting Pronouncements
Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In October 2019, the FASB voted to delay the effective date for smaller reporting companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update.

The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s condensed consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies.

ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018)

The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU are effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance and it did not have a material impact on the condensed consolidated financial statements.

ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019)

The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the condensed consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company elected the temporary relief in the CARES Act not to apply the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.
v3.20.1
Fair Value of Financial Instruments
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments
Fair Value of Financial Instruments
 
ASC Topic 820, Fair Value Measurement, defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also specifies a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1
Quoted prices in active markets for identical assets or liabilities

Level 2
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities

Level 3
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities

Following is a description of the valuation methodologies and inputs used for assets measured at fair value on a recurring basis and recognized in the accompanying condensed consolidated balance sheets, as well as the general classification of such assets pursuant to the valuation hierarchy.

Available-for-Sale Securities
 
Where quoted market prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities include highly liquid mutual funds. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.
 
Level 2 securities include U.S. Government-sponsored agencies, municipal securities, mortgage and asset-backed securities and certain corporate securities. Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but also on the investment securities’ relationship to other benchmark quoted investment securities.
 
In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy. Fair values are calculated using discounted cash flows. Discounted cash flows are calculated based off of the anticipated future cash flows updated to incorporate loss severities. Rating agency and industry research reports as well as default and deferral activity are reviewed and incorporated into the calculation. The Company did not own any securities classified within Level 3 of the hierarchy as of March 31, 2020 or December 31, 2019.

Loans Held-for-Sale (mandatory pricing agreements)

The fair value of loans held-for-sale is determined using quoted prices for similar assets, adjusted for specific attributes of that loan (Level 2).
 
Servicing Asset

Fair value is based on a loan-by-loan basis taking into consideration the original maturity of the loans, the current age of the loans and the remaining term to maturity. The valuation methodology utilized for the servicing assets begins with generating estimated future cash flows for each servicing asset, based on their unique characteristics and market-based assumptions for prepayment speeds and costs to service. The present value of the future cash flows is then calculated utilizing market-based discount rate assumptions (Level 3).

Interest Rate Swap Agreements

The fair value of interest rate swap agreements is estimated using current market interest rates as of the balance sheet date and calculated using discounted cash flows that are observable or that can be corroborated by observable market data and, therefore, are classified within Level 2 of the valuation hierarchy.

Forward Contracts

The fair values of forward contracts on to-be-announced securities are determined using quoted prices in active markets or benchmarked thereto (Level 1).
 
Interest Rate Lock Commitments
 
The fair values of interest rate lock commitments (“IRLCs”) are determined using the projected sale price of individual loans based on changes in market interest rates, projected pull-through rates (the probability that an IRLC will ultimately result in an originated loan), the reduction in the value of the applicant’s option due to the passage of time, and the remaining origination costs to be incurred based on management’s estimate of market costs (Level 3).

The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2020 and December 31, 2019.
 
 
 
 
March 31, 2020 Fair Value Measurements Using
(in thousands)
 
Fair
Value
 
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
U.S. Government-sponsored agencies
 
$
70,004

 
$

 
$
70,004

 
$

Municipal securities
 
94,819

 

 
94,819

 

Agency mortgage-backed securities
 
282,632

 

 
282,632

 

Private label mortgage-backed securities
 
115,024

 
 
 
115,024

 

Asset-backed securities
 
4,713

 

 
4,713

 

Corporate securities
 
41,490

 

 
41,490

 

Total available-for-sale securities
 
608,682

 

 
608,682

 

Servicing asset
 
2,415

 

 

 
2,415

Interest rate swap liabilities
 
(78,552
)
 

 
(78,552
)
 

Loans held-for-sale (mandatory pricing agreements)
 
52,394

 

 
52,394

 

Forward contracts
 
(2,298
)
 
(2,298
)
 

 

IRLCs
 
2,064

 

 

 
2,064

 
 
 
 
December 31, 2019
Fair Value Measurements Using
(in thousands)
 
Fair
Value
 
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
U.S. Government-sponsored agencies
 
$
75,872

 
$

 
$
75,872

 
$

Municipal securities
 
97,652

 

 
97,652

 

Agency mortgage-backed securities
 
261,440

 

 
261,440

 

Private label mortgage-backed securities
 
63,613

 

 
63,613

 

Asset-backed securities
 
4,955

 

 
4,955

 

Corporate securities
 
37,320

 

 
37,320

 

Total available-for-sale securities
 
540,852

 

 
540,852

 

Servicing asset
 
2,481

 

 

 
2,481

Interest rate swap liabilities
 
(37,786
)
 

 
(37,786
)
 

Loans held-for-sale (mandatory pricing agreements)
 
56,097

 

 
56,097

 

Forward contracts
 
(153
)
 
(153
)
 

 

IRLCs
 
910

 

 

 
910



The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three months ended March 31, 2020 and 2019.

 
 
Three Months Ended
(in thousands)
 
Servicing Asset
 
Interest Rate Lock
Commitments
Balance, January 1, 2020
 
$
2,481

 
$
910

Total realized (losses) gains
 


 
 
Additions
 
113

 

Change in fair value
 
(179
)
 
1,154

Balance, March 31, 2020
 
2,415

 
2,064

 
 
 
 
 
Balance as of January 1, 2019
 
$

 
$
389

Total realized gains
 
 
 
 
Change in fair value
 

 
392

Balance, March 31, 2019
 
$

 
$
781




The following describes the valuation methodologies and inputs used for assets measured at fair value on a nonrecurring basis, as well as the general classification of such assets pursuant to the valuation hierarchy.

Impaired Loans (Collateral Dependent)

Loans for which it is probable that the Company will not collect all principal and interest due according to contractual terms are measured for impairment. The amount of impairment may be determined based on the fair value of the underlying collateral, less costs to sell, the estimated present value of future cash flows or the loan’s observable market price.

If the impaired loan is identified as collateral dependent, the fair value of the underlying collateral, less costs to sell, is used to measure impairment. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. If the impaired loan is not collateral dependent, the Company utilizes a discounted cash flow analysis to measure impairment.

Impaired loans with a specific valuation allowance based on the value of the underlying collateral or a discounted cash flow analysis are classified as Level 3 assets.

The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at March 31, 2020 and December 31, 2019.


 
 
 
 
December 31, 2019
(in thousands)
 
 
 
Fair Value Measurements Using
 
 
Fair
Value
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Impaired loans
 
$
3,019

 
$

 
$

 
$
3,019



 Significant Unobservable (Level 3) Inputs
 
The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)
 
Fair Value at
March 31, 2020
 
Valuation
Technique
 
Significant Unobservable
Inputs
 
Range
 
Weighted-Average Range
IRLCs
 
$
2,064

 
Discounted cash flow
 
Loan closing rates
 
36% - 100%
 
56%
Servicing asset
 
2,415

 
Discounted cash flow
 
Prepayment speeds
 
0% - 25%
 
14.4%
 
 
 
 
 
 
Expected weighted-average loan life
 
3.3 - 5.3 years
 
4.7 years

(dollars in thousands)
 
Fair Value at
December 31, 2019
 
Valuation
Technique
 
Significant Unobservable
Inputs
 
Range
 
Weighted-Average Range
Impaired loans
 
$
3,019

 
Fair value of collateral
 
Discount for type of property and current market conditions
 
10%
 
10%
IRLCs
 
910

 
Discounted cash flow
 
Loan closing rates
 
50% - 100%
 
84%
Servicing asset
 
2,481

 
Discounted cash flow
 
Prepayment speeds
 
0% - 25%
 
13.5%
 
 
 
 
 
 
Expected weighted-average loan life
 
3.2 - 5.7 years
 
5.0 years


The following methods were used to estimate the fair value of all other financial instruments recognized in the accompanying condensed consolidated balance sheets at amounts other than fair value.
 
Cash and Cash Equivalents
 
For these instruments, the carrying amount is a reasonable estimate of fair value.
 
Securities Held-to-Maturity
 
Fair values are determined by using models that are based on security-specific details, as well as relevant industry and economic factors. The most significant of these inputs are quoted market prices and interest rate spreads on relevant benchmark securities.
 
Loans Held-for-Sale (best efforts pricing agreements)
 
The fair value of these loans approximates carrying value.

Loans
 
The fair value of loans is estimated on an exit price basis incorporating discounts for credit, liquidity and marketability factors.
 
Accrued Interest Receivable
 
The fair value of these financial instruments approximates carrying value.
 
Federal Home Loan Bank of Indianapolis Stock
 
The fair value approximates carrying value.
 
Deposits 
The fair value of noninterest-bearing and interest-bearing demand deposits, savings and money market accounts approximates carrying value. The fair value of fixed maturity certificates of deposit and brokered deposits are estimated using rates currently offered for deposits of similar remaining maturities.

Advances from Federal Home Loan Bank
 
The fair value of fixed rate advances is estimated using rates currently available for advances with similar remaining maturities. The carrying value of variable rate advances approximates fair value.
 
Subordinated Debt
 
The fair value of the Company’s publicly traded subordinated debt is obtained from quoted market prices. The fair value of the Company’s remaining subordinated debt is estimated using discounted cash flow analysis, based on current borrowing rates for similar types of debt instruments.

 Accrued Interest Payable
 
The fair value of these financial instruments approximates carrying value.

Commitments
 
The fair value of commitments to extend credit are based on fees currently charged to enter into similar agreements with similar maturities and interest rates. The Company determined that the fair value of commitments was zero based on the contractual value of outstanding commitments at each of March 31, 2020 and December 31, 2019.
  
The following tables present the carrying value and estimated fair value of all financial assets and liabilities at March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
Fair Value Measurements Using
(in thousands)
 
Carrying
Amount
 
Fair Value
 
Quoted Prices
In Active
Market for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Cash and cash equivalents
 
$
351,268

 
$
351,268

 
$
351,268

 
$

 
$

Securities held-to-maturity
 
66,331

 
69,468

 

 
69,468

 

Net loans
 
2,869,236

 
2,842,894

 

 

 
2,842,894

Accrued interest receivable
 
16,960

 
16,960

 
16,960

 

 

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

 

 
25,650

 

Deposits
 
3,178,506

 
3,245,748

 
1,156,978

 

 
2,088,770

Advances from Federal Home Loan Bank
 
514,911

 
546,378

 

 
546,378

 

Subordinated debt
 
69,605

 
61,092

 
50,890

 
10,202

 

Accrued interest payable
 
3,293

 
3,293

 
3,293

 

 

 
 
December 31, 2019
Fair Value Measurements Using
(in thousands)
 
Carrying
Amount
 
Fair Value
 
Quoted Prices
In Active
Market for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Cash and cash equivalents
 
$
327,361

 
$
327,361

 
$
327,361

 
$

 
$

Securities held-to-maturity
 
61,878

 
62,560

 

 
62,560

 

Net loans
 
2,941,707

 
2,876,688

 

 

 
2,876,688

Accrued interest receivable
 
18,607

 
18,607

 
18,607

 

 

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

 

 
25,650

 

Deposits
 
3,153,963

 
3,232,065

 
1,002,141

 

 
2,229,924

Advances from Federal Home Loan Bank
 
514,910

 
520,950

 

 
520,950

 

Subordinated debt
 
69,528

 
75,206

 
64,996

 
10,210

 

Accrued interest payable
 
3,767

 
3,767

 
3,767

 

 

v3.20.1
Securities - Carrying Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Amortized Cost    
Within one year $ 15  
One to five years 19,032  
Five to ten years 81,662  
After ten years 109,037  
Amortized Cost 209,746  
Amortized cost 608,567 $ 546,640
Held-to-maturity securities, One to five years 1,505  
Held-to-maturity securities, Five to ten years 52,301  
Held-to-maturity securities, After ten years 12,525  
Held-to-maturity securities, Amortized Cost 66,331  
Fair Value    
Within one year 15  
One to five years 15,068  
Five to ten years 80,465  
After ten years 110,765  
Fair Value 206,313  
Fair Value 608,682 540,852
Held-to-maturity securities, One to five years 1,584  
Held-to-maturity securities, Five to ten years 54,610  
Held-to-maturity securities, After ten years 13,274  
Held-to-maturity securities, Fair Value 69,468  
Agency mortgage-backed securities    
Amortized Cost    
Amortized cost 279,458 264,142
Fair Value    
Fair Value 282,632 261,440
Private label mortgage-backed securities    
Amortized Cost    
Amortized cost 114,363 63,704
Fair Value    
Fair Value 115,024 63,613
Asset-backed securities    
Amortized Cost    
Amortized cost 5,000 5,000
Fair Value    
Fair Value $ 4,713 $ 4,955
v3.20.1
Loans - Categories (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans $ 2,826,650 $ 2,919,981    
Net deferred loan origination costs and premiums and discounts on purchased loans and other(1) 65,443 43,566    
Total loans 2,892,093 2,963,547    
Allowance for loan losses (22,857) (21,840) $ (18,841) $ (17,896)
Net loans 2,869,236 2,941,707    
Commercial and industrial        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (1,670) (1,521) (1,351) (1,384)
Owner-occupied commercial real estate        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (645) (561) (745) (783)
Investor commercial real estate        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (128) (109) (103) (61)
Construction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (460) (380) (267) (251)
Single tenant lease financing        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (10,755) (11,175) (9,368) (8,827)
Public finance        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (1,483) (1,580) (1,650) (1,670)
Healthcare finance        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (4,318) (3,247) (1,731) (1,264)
Small business lending        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (265) (54) (195) (203)
Residential mortgage        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (500) (657) (1,044) (1,079)
Home equity        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (53) (46) (49) (53)
Other consumer        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Allowance for loan losses (2,580) (2,510) $ (2,338) $ (2,321)
Commercial Portfolio Segment        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 2,287,460 2,286,517    
Commercial Portfolio Segment | Commercial and industrial        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 95,227 96,420    
Commercial Portfolio Segment | Owner-occupied commercial real estate        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 74,737 73,392    
Commercial Portfolio Segment | Investor commercial real estate        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 13,421 12,567    
Commercial Portfolio Segment | Construction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 64,581 60,274    
Commercial Portfolio Segment | Single tenant lease financing        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 972,275 995,879    
Commercial Portfolio Segment | Public finance        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 627,678 687,094    
Commercial Portfolio Segment | Healthcare finance        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 372,266 300,612    
Commercial Portfolio Segment | Small business lending        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 67,275 60,279    
Consumer Portfolio        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 539,190 633,464    
Consumer Portfolio | Residential mortgage        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 218,730 313,849    
Consumer Portfolio | Home equity        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 23,855 24,306    
Consumer Portfolio | Other consumer        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans 296,605 295,309    
Interest rate swaps | Commercial Portfolio Segment | Public finance        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total commercial loans $ 44,600 $ 21,400    
v3.20.1
Loans Loans - Internal Credit Assessment (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable $ 2,826,650 $ 2,919,981
Nonaccrual    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 7,318 6,164
Consumer Portfolio    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 539,190 633,464
Consumer Portfolio | Performing    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 538,160 632,670
Consumer Portfolio | Nonaccrual    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 1,030 794
Consumer Portfolio | Residential mortgage    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 218,730 313,849
Consumer Portfolio | Residential mortgage | Performing    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 217,739 313,088
Consumer Portfolio | Residential mortgage | Nonaccrual    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 991 761
Consumer Portfolio | Home equity    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 23,855 24,306
Consumer Portfolio | Home equity | Performing    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 23,855 24,306
Consumer Portfolio | Home equity | Nonaccrual    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 0 0
Consumer Portfolio | Other consumer    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 296,605 295,309
Consumer Portfolio | Other consumer | Performing    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable 296,566 295,276
Consumer Portfolio | Other consumer | Nonaccrual    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total Loans Receivable $ 39 $ 33
v3.20.1
Commitments and Credit Risk (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Other Commitments [Line Items]    
Loan commitments $ 295.9 $ 254.4
Capital committed to Small Business Investment Company fund, not contributed 1.7  
Capital Addition Purchase Commitments    
Other Commitments [Line Items]    
Construction related contract commitment 65.1  
Construction related contract commitment, not yet incurred $ 58.9  
Construction related contract commitment, term 2 years  
v3.20.1
Subordinated Debt - Schedule of Subordinated Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Unamortized Debt Issuance Costs $ (2,395) $ (2,472)
Subordinated Debt    
Debt Instrument [Line Items]    
Principal 72,000 72,000
Unamortized Debt Issuance Costs (2,395) (2,472)
Subordinated Debt | 2025 Note    
Debt Instrument [Line Items]    
Principal 10,000 10,000
Unamortized Debt Issuance Costs (132) (138)
Subordinated Debt | 2026 Notes    
Debt Instrument [Line Items]    
Principal 25,000 25,000
Unamortized Debt Issuance Costs (808) (839)
Subordinated Debt | 2029 Notes    
Debt Instrument [Line Items]    
Principal 37,000 37,000
Unamortized Debt Issuance Costs $ (1,455) $ (1,495)
v3.20.1
Servicing Asset (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Servicing Asset at Fair Value, Amount [Roll Forward]    
Beginning balance $ 2,481 $ 0
Additions 113 0
Changes in fair value (179) 0
Ending balance $ 2,415 $ 0
v3.20.1
Basis of Presentation
3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
 
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information or footnotes necessary for a complete presentation of financial condition, results of operations, changes in shareholders’ equity, or cash flows in accordance with GAAP. In our opinion, all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation have been included. The results of operations for the three months ended March 31, 2020 are not necessarily indicative of the results expected for the year ending December 31, 2020 or any other period. The March 31, 2020 condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the First Internet Bancorp Annual Report on Form 10-K for the year ended December 31, 2019.
 
The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, or assumptions that could have a material effect on the carrying value of certain assets and liabilities. These estimates, judgments, and assumptions affect the amounts reported in the condensed consolidated financial statements and the disclosures provided. The determination of the allowance for loan losses, valuations and impairments of investment securities, and the accounting for income tax expense are highly dependent upon management’s estimates, judgments, and assumptions, and changes in any of these could have a significant impact on the condensed consolidated financial statements.

The condensed consolidated financial statements include the accounts of First Internet Bancorp (the “Company”), its wholly owned subsidiary, First Internet Bank of Indiana (the “Bank”), and the Bank’s three wholly owned subsidiaries, First Internet Public Finance Corp., JKH Realty Services, LLC and SPF15, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.
 
The Company is subject to claims and lawsuits that arise primarily in the ordinary course of business. It is the opinion of management that the disposition or ultimate resolution of such claims and lawsuits will not have a material adverse effect on the consolidated financial position, results of operations, and cash flows of the Company.
 
Certain reclassifications have been made to the 2019 financial statements to conform to the presentation of the 2020 financial statements. These reclassifications had no effect on net income.
v3.20.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2020
May 01, 2020
Document And Entity Information [Abstract]    
Entity Registrant Name First Internet Bancorp  
Entity Central Index Key 0001562463  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   9,801,825
Document Type 10-Q  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Current Reporting Status Yes  
Entity Small Business true  
Amendment Flag false  
Document Period End Date Mar. 31, 2020  
Document Fiscal Period Focus (Q1,Q2,Q3,FY) Q1  
Document Fiscal Year Focus 2020  
v3.20.1
Leases (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
lease
Mar. 31, 2019
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Number of leases | lease 2  
Operating lease cost $ 215 $ 187
Operating cash flows from operating leases $ 231 $ 200
Minimum    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Remaining term of contract 2 years  
Maximum    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Remaining term of contract 4 years  
v3.20.1
Loans - Loan Portfolio Aging (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due $ 9,231 $ 6,955
Current 2,817,419 2,913,026
Total Loans Receivable 2,826,650 2,919,981
Total Loans 90 Days or More Past Due and Accruing 125 416
Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 73 0
Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Residential mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 51 416
Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 0 0
Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans 90 Days or More Past Due and Accruing 1 0
30-59 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 1,641 309
60-89 Days Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 192 4,883
90 Days or More Past Due    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 7,398 1,763
Commercial Portfolio Segment    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 2,287,460 2,286,517
Commercial Portfolio Segment | Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 285 233
Current 94,942 96,187
Total Loans Receivable 95,227 96,420
Commercial Portfolio Segment | Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 464 464
Current 74,273 72,928
Total Loans Receivable 74,737 73,392
Commercial Portfolio Segment | Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Current 13,421 12,567
Total Loans Receivable 13,421 12,567
Commercial Portfolio Segment | Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Current 64,581 60,274
Total Loans Receivable 64,581 60,274
Commercial Portfolio Segment | Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 4,680 4,680
Current 967,595 991,199
Total Loans Receivable 972,275 995,879
Commercial Portfolio Segment | Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Current 627,678 687,094
Total Loans Receivable 627,678 687,094
Commercial Portfolio Segment | Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Current 372,266 300,612
Total Loans Receivable 372,266 300,612
Commercial Portfolio Segment | Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 1,645 54
Current 65,630 60,225
Total Loans Receivable 67,275 60,279
Commercial Portfolio Segment | 30-59 Days Past Due | Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 15
Commercial Portfolio Segment | 30-59 Days Past Due | Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 30-59 Days Past Due | Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 30-59 Days Past Due | Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 30-59 Days Past Due | Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 30-59 Days Past Due | Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 30-59 Days Past Due | Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 30-59 Days Past Due | Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 676 54
Commercial Portfolio Segment | 60-89 Days Past Due | Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 96
Commercial Portfolio Segment | 60-89 Days Past Due | Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 60-89 Days Past Due | Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 60-89 Days Past Due | Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 60-89 Days Past Due | Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 4,680
Commercial Portfolio Segment | 60-89 Days Past Due | Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 60-89 Days Past Due | Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 60-89 Days Past Due | Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 43  
Commercial Portfolio Segment | 90 Days or More Past Due | Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 285 122
Commercial Portfolio Segment | 90 Days or More Past Due | Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 464 464
Commercial Portfolio Segment | 90 Days or More Past Due | Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 90 Days or More Past Due | Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 90 Days or More Past Due | Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 4,680 0
Commercial Portfolio Segment | 90 Days or More Past Due | Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 90 Days or More Past Due | Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Commercial Portfolio Segment | 90 Days or More Past Due | Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 926 0
Consumer Portfolio    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 539,190 633,464
Consumer Portfolio | Residential mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 1,912 1,177
Current 216,818 312,672
Total Loans Receivable 218,730 313,849
Consumer Portfolio | Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Current 23,855 24,306
Total Loans Receivable 23,855 24,306
Consumer Portfolio | Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 245 347
Current 296,360 294,962
Total Loans Receivable 296,605 295,309
Consumer Portfolio | 30-59 Days Past Due | Residential mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 870 0
Consumer Portfolio | 30-59 Days Past Due | Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Consumer Portfolio | 30-59 Days Past Due | Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 95 240
Consumer Portfolio | 60-89 Days Past Due | Residential mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Consumer Portfolio | 60-89 Days Past Due | Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Consumer Portfolio | 60-89 Days Past Due | Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 149 107
Consumer Portfolio | 90 Days or More Past Due | Residential mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 1,042 1,177
Consumer Portfolio | 90 Days or More Past Due | Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 0 0
Consumer Portfolio | 90 Days or More Past Due | Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Past Due 1 0
Nonaccrual    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 7,318 6,164
Nonaccrual | Commercial Portfolio Segment | Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 218 226
Nonaccrual | Commercial Portfolio Segment | Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 464 464
Nonaccrual | Commercial Portfolio Segment | Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Nonaccrual | Commercial Portfolio Segment | Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Nonaccrual | Commercial Portfolio Segment | Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 4,680 4,680
Nonaccrual | Commercial Portfolio Segment | Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Nonaccrual | Commercial Portfolio Segment | Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Nonaccrual | Commercial Portfolio Segment | Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 926 0
Nonaccrual | Consumer Portfolio    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 1,030 794
Nonaccrual | Consumer Portfolio | Residential mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 991 761
Nonaccrual | Consumer Portfolio | Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Nonaccrual | Consumer Portfolio | Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable $ 39 $ 33
v3.20.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Comprehensive Income [Abstract]    
Net income $ 6,019 $ 5,696
Net unrealized holding gains on securities available-for-sale recorded within other comprehensive income before income tax 6,299 6,910
Reclassification adjustment for gains realized (41) 0
Net unrealized holding losses on cash flow hedging derivatives recorded within other comprehensive (loss) income before tax (13,458) (3,572)
Other comprehensive (loss) income before income tax (7,200) 3,338
Income tax (benefit) provision (1,525) 965
Other comprehensive (loss) income (5,675) 2,373
Comprehensive income $ 344 $ 8,069
v3.20.1
Derivative Financial Instruments - Interest Swap Derivatives (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Notional Value $ 829,784   $ 840,646
Fair Value (80,850)   (37,939)
Interest expense 21,226 $ 18,755  
Interest rate swaps | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Notional Value $ 513,034   $ 515,646
Weighted Average Remaining Maturity (years) 5 years   5 years 3 months 18 days
Fair Value $ (51,665)   $ (24,357)
Weighted-Average Rate 2.80%   2.80%
Cash collateral received     $ 81,300
Cash collateral pledged     42,300
Loans | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Fair Value $ 44,586   21,440
Loans | Interest rate swaps | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Notional Value $ 424,834   $ 427,446
Weighted Average Remaining Maturity (years) 5 years 3 months 18 days   5 years 6 months
Fair Value $ (44,872)   $ (21,551)
Weighted-Average Rate 2.86%   2.86%
Securities available-for-sale | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Fair Value $ 6,790   $ 2,802
Securities available-for-sale | Interest rate swaps | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Notional Value $ 88,200   $ 88,200
Weighted Average Remaining Maturity (years) 3 years 10 months 24 days   4 years 1 month 6 days
Fair Value $ (6,793)   $ (2,806)
Weighted-Average Rate 2.54%   2.54%
3-month LIBOR | Interest rate swaps | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Notional Value $ 110,000   $ 110,000
Weighted Average Remaining Maturity (years) 6 years 9 months 18 days   7 years 1 month 6 days
Fair Value $ (17,509)   $ (8,390)
Derivative, variable interest rate 2.88%   2.88%
1-month LIBOR | Interest rate swaps | Derivatives designated as hedging instruments      
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Notional Value $ 100,000   $ 100,000
Weighted Average Remaining Maturity (years) 3 years 8 months 12 days   4 years
Fair Value $ (9,378)   $ (5,040)
Derivative, variable interest rate 2.88%   2.88%
v3.20.1
Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance, beginning of period $ 304,913 $ 288,735
Net change in unrealized gain (7,159) 3,338
Reclassification of net loss realized and included in earnings (41)  
Accumulated other comprehensive loss before income tax (21,391) (13,203)
Income tax provision (benefit) (1,525) 965
Balance, end of period 305,127 294,013
Available-For-Sale Securities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance, beginning of period (4,388) (13,360)
Net change in unrealized gain 6,299 6,910
Reclassification of net loss realized and included in earnings (41)  
Accumulated other comprehensive loss before income tax 1,870 (6,450)
Income tax provision (benefit) 2,109 1,930
Balance, end of period (239) (8,380)
Cash Flow Hedges    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance, beginning of period (9,803) (3,181)
Net change in unrealized gain (13,458) (3,572)
Reclassification of net loss realized and included in earnings 0  
Accumulated other comprehensive loss before income tax (23,261) (6,753)
Income tax provision (benefit) (3,634) (965)
Balance, end of period (19,627) (5,788)
Accumulated Other Comprehensive Loss    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Balance, beginning of period (14,191) (16,541)
Balance, end of period $ (19,866) $ (14,168)
v3.20.1
Servicing Asset
3 Months Ended
Mar. 31, 2020
Transfers and Servicing [Abstract]  
Servicing Asset
Servicing Asset

Activity for the servicing asset and the related changes in fair value for the three months ended March 31, 2020 and 2019 are shown in the table below.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Beginning balance
 
$
2,481

 
$

Additions
 
113

 

Changes in fair value
 
(179
)
 

     Ending balance
 
$
2,415

 
$



Loans serviced for others are not included in the condensed consolidated balance sheets. The unpaid principal balances of these loans serviced for others as of March 31, 2020 and December 31, 2019 are shown in the table below.

(in thousands)
 
 
 
 
March 31, 2020
 
December 31, 2019
Loan portfolios serviced for:
 
 
 
 
   SBA guaranteed loans
 
$
103,878

 
$
103,981

     Total
 
$
103,878

 
$
103,981



Loan servicing revenue totaled $0.3 million for the three months ended March 31, 2020. There was no loan servicing revenue for the three months ended March 31, 2019. Loan servicing asset revaluation, which represents the change in fair value of the servicing asset, resulted in a $0.2 million downward valuation for the three months ended March 31, 2020.

The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Though fluctuations in prepayment speeds and changes in secondary market premiums generally have the most substantial impact on the fair value of servicing rights, other influencing factors include changing economic conditions, changes to the discount rate assumption and the weighted average life of the servicing portfolio. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time; however, those assumptions may change over time. Refer to Note 12 - Fair Value of Financial Instruments for further details.
v3.20.1
Loans
3 Months Ended
Mar. 31, 2020
Receivables [Abstract]  
Loans
Loans
 
Loan balances as of March 31, 2020 and December 31, 2019 are summarized in the table below.
 
Categories of loans include:
(in thousands)
 
March 31, 2020
 
December 31, 2019
Commercial loans
 
 

 
 

Commercial and industrial
 
$
95,227

 
$
96,420

Owner-occupied commercial real estate
 
74,737

 
73,392

Investor commercial real estate
 
13,421

 
12,567

Construction
 
64,581

 
60,274

Single tenant lease financing
 
972,275

 
995,879

Public finance
 
627,678

 
687,094

Healthcare finance
 
372,266

 
300,612

Small business lending
 
67,275

 
60,279

Total commercial loans
 
2,287,460

 
2,286,517

Consumer loans
 
 
 
 
Residential mortgage
 
218,730

 
313,849

Home equity
 
23,855

 
24,306

Other consumer
 
296,605

 
295,309

Total consumer loans
 
539,190

 
633,464

Total commercial and consumer loans
 
2,826,650

 
2,919,981

Net deferred loan origination costs and premiums and discounts on purchased loans and other(1)
 
65,443

 
43,566

Total loans
 
2,892,093

 
2,963,547

Allowance for loan losses
 
(22,857
)
 
(21,840
)
Net loans
 
$
2,869,236

 
$
2,941,707



(1) Includes carrying value adjustments of $44.6 million and $21.4 million as of March 31, 2020 and December 31, 2019, respectively, related to interest rate swaps associated with public finance loans. 

The risk characteristics of each loan portfolio segment are as follows:

Commercial and Industrial: Commercial and industrial loans’ sources of repayment are primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected, and the collateral securing these loans may fluctuate in value. Loans are made for working capital, equipment purchases, or other purposes. Most commercial and industrial loans are secured by the assets being financed and may incorporate a personal guarantee. This portfolio segment is generally concentrated in Central Indiana and adjacent markets and the greater Phoenix, Arizona market.

Owner-Occupied Commercial Real Estate: The primary source of repayment is the cash flow from the ongoing operations and activities conducted by the borrower, or an affiliate of the borrower, who owns the property. This portfolio segment is generally concentrated in Central Indiana and adjacent markets and the greater Phoenix, Arizona market and its loans are often secured by manufacturing and service facilities, as well as office buildings.

Investor Commercial Real Estate: These loans are underwritten primarily based on the cash flow expected to be generated from the property and are secondarily supported by the value of the real estate. These loans typically incorporate a personal guarantee from the primary sponsor or sponsors. This portfolio segment generally involves larger loan amounts with repayment primarily dependent on the successful leasing and operation of the property securing the loan or the business conducted on the property securing the loan. Investor commercial real estate loans may be more adversely affected by changing economic conditions in the real estate markets, industry dynamics or the overall health of the local economy where the property is located. The properties securing the Company’s investor commercial real estate portfolio tend to be diverse in terms of property type and are generally located in the state of Indiana or markets immediately adjacent to Indiana. Management monitors and evaluates commercial real estate loans based on property financial performance, collateral value, guarantor strength, economic and industry conditions together with other risk grade criteria. As a general rule, the Company avoids financing special use projects or properties outside of its designated market areas unless other underwriting factors are present to mitigate these additional risks.

Construction: Construction loans are secured by land and related improvements and are made to assist in the construction of new structures, which may include commercial (retail, industrial, office, multi-family) properties or single family residential properties offered for sale by the builder. These loans generally finance a variety of project costs, including land, site preparation, architectural services, construction, closing and soft costs and interim financing needs. The cash flows of builders, while initially predictable, may fluctuate with market conditions, and the value of the collateral securing these loans may be subject to fluctuations based on general economic changes. This portfolio segment is generally concentrated in Central Indiana.
Single Tenant Lease Financing: These loans are made on a nationwide basis to property owners of real estate subject to long-term lease arrangements with single tenant operators. The real estate is typically operated by regionally, nationally or globally branded businesses.  The loans are underwritten based on the financial strength of the borrower, characteristics of the real estate, cash flows generated from the lease arrangements and the financial strength of the tenant.  Similar to the other loan portfolio segments, management monitors and evaluates these loans based on borrower and tenant financial performance, collateral value, industry trends and other risk grade criteria.

Public Finance: These loans are made to governmental and not-for-profit entities to provide both tax-exempt and taxable loans for a variety of purposes including: short-term cash-flow needs; debt refinancing; economic development; quality of life projects; infrastructure improvements; and equipment financing. The primary sources of repayment for public finance loans include pledged revenue sources including but not limited to: general obligations; property taxes; income taxes; tax increment revenue; utility revenue; gaming revenues; sales tax; and pledged general revenue. Certain loans may also include an additional collateral pledge of mortgaged property or a security interest in financed equipment. Public finance loans have been completed primarily in the Midwest, with plans to continue expanding nationwide.

Healthcare Finance: These loans are made to healthcare providers, primarily dentists, for practice acquisition refinancing that occasionally includes owner-occupied commercial real estate and equipment purchases. The sources of repayment are primarily based on the identified cash flows from operations of the borrower and related entities if the real estate is held in a separate entity and secondarily on the underlying collateral provided by the borrower. This portfolio segment was initially concentrated in the Western United States but has been growing rapidly throughout the rest of the country with the addition of a growing sales force located in Eastern and Midwestern markets.

Small Business Lending: These loans are to small businesses and generally carry a partial guaranty from the U.S. Small Business Administration ("SBA"). We generally sell the government guaranteed portion of SBA loans into the secondary market while retaining the non-guaranteed portion of the loan and the servicing rights. Loans in the small business lending portfolio have sources of repayment that are primarily based on the identified cash flows of the borrower and secondarily on any underlying collateral provided by the borrower. Loans may, but do not always, have a collateral shortfall. For SBA loans where the guaranteed portion is retained, the SBA guaranty provides a tertiary source of repayment to the Bank in event of borrower default. Cash flows of borrowers, however, may not be as expected and collateral securing these loans may fluctuate in value. Loans are made for a broad array of purposes including, but not limited to, providing operating cash flow, funding ownership changes, and facilitating equipment purchases. This portfolio segment has an emerging geography, with a nationwide focus.

Residential Mortgage: With respect to residential loans that are secured by 1-to-4 family residences and are generally owner occupied, the Company typically establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Repayment of these loans is primarily dependent on the financial circumstances of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment can also be impacted by changes in residential property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
Home Equity: Home equity loans and lines of credit are typically secured by a subordinate interest in 1-to-4 family residences. The properties securing the home equity portfolio segment are generally geographically diverse as the Company offers these products on a nationwide basis. Repayment of these loans and lines of credit is primarily dependent on the financial circumstances of the borrowers and may be impacted by changes in unemployment levels and property values on residential properties, among other economic conditions in the market.
Other Consumer: These loans primarily consist of consumer loans and credit cards. Consumer loans may be secured by consumer assets such as horse trailers or recreational vehicles. Some consumer loans are unsecured, such as small installment loans, home improvement loans and certain lines of credit. Repayment of consumer loans is primarily dependent upon the personal income of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers in geographically diverse locations throughout the country.
Allowance for Loan Losses Methodology
 
Company policy is designed to maintain an adequate allowance for loan losses (“ALLL”). The portfolio is segmented by loan type, and the required ALLL for types of performing homogeneous loans which do not have a specific reserve is determined by applying a factor based on average historical losses, adjusted for current economic factors and portfolio trends. Management adds qualitative factors for observable trends, changes in internal practices, changes in delinquencies and impairments, and external factors. Observable factors include changes in the composition and size of portfolios, as well as loan terms or concentration levels. The Company evaluates the impact of internal changes such as management and staff experience levels or modification to loan underwriting processes. Delinquency trends are scrutinized for both volume and severity of past due, nonaccrual, or classified loans, as well as any changes in the value of underlying collateral. Finally, the Company considers the effect of other external factors such as national, regional, and local economic and business conditions, as well as competitive, legal, and regulatory requirements. Loans that are considered to be impaired are evaluated to determine the need for a specific allowance by applying at least one of three methodologies: present value of future cash flows; fair value of collateral less costs to sell; or the loan’s observable market price. All troubled debt restructurings (“TDR”) are considered impaired loans. Loans evaluated for impairment are removed from other pools to prevent double-counting. Accounting Standards Codification (“ASC”) Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral less costs to sell and allows existing methods for recognizing interest income.
 
Provision for Loan Losses
 
A provision for estimated losses on loans is charged to income based upon management’s evaluation of the potential losses. Such an evaluation, which includes a review of all loans for which full repayment may not be reasonably assured, considers, among other matters, the estimated net realizable value of the underlying collateral, as applicable, economic conditions, loan loss experience, and other factors that are particularly susceptible to changes that could result in a material adjustment in the near term. While management attempts to use the best information available in making its evaluations, future allowance adjustments may be necessary if economic conditions change substantially from the assumptions used in making the evaluations.
 
Policy for Charging Off Loans
 
The Company’s policy is to charge off a loan at any point in time when it no longer can be considered a bankable asset, meaning collectible within the parameters of policy. A secured loan is generally charged down to the estimated fair value of the collateral, less costs to sell, no later than when it is 120 days past due as to principal or interest. An unsecured loan generally is charged off no later than when it is 180 days past due as to principal or interest. A home improvement loan generally is charged off no later than when it is 90 days past due as to principal or interest.

The following tables present changes in the balance of the ALLL during the three months ended March 31, 2020 and 2019

(in thousands)
Three Months Ended March 31, 2020
Allowance for loan losses:
Balance, Beginning of Period
 
Provision (Credit) Charged to Expense
 
Losses
Charged Off
 
Recoveries
 
Balance,
End of Period
Commercial and industrial
$
1,521

 
$
346

 
$
(197
)
 
$

 
$
1,670

Owner-occupied commercial real estate
561

 
84

 

 

 
645

Investor commercial real estate
109

 
19

 

 

 
128

Construction
380

 
80

 

 

 
460

Single tenant lease financing
11,175

 
(420
)
 

 

 
10,755

Public finance
1,580

 
(97
)
 

 

 
1,483

Healthcare finance
3,247

 
1,071

 

 

 
4,318

Small business lending
54

 
203

 

 
8

 
265

Residential mortgage
657

 
(143
)
 
(15
)
 
1

 
500

Home equity
46

 
5

 

 
2

 
53

Other consumer
2,510

 
313

 
(286
)
 
43

 
2,580

Total
$
21,840

 
$
1,461

 
$
(498
)
 
$
54

 
$
22,857



(in thousands)
Three Months Ended March 31, 2019
Allowance for loan losses:
Balance, Beginning of Period
 
Provision (Credit) Charged to Expense
 
Losses
Charged Off
 
Recoveries
 
Balance,
End of Period
Commercial and industrial
$
1,384

 
$
79

 
$
(112
)
 
$

 
$
1,351

Owner-occupied commercial real estate
783

 
(38
)
 

 

 
745

Investor commercial real estate
61

 
42

 

 

 
103

Construction
251

 
16

 

 

 
267

Single tenant lease financing
8,827

 
541

 

 

 
9,368

Public finance
1,670

 
(20
)
 

 

 
1,650

Healthcare finance
1,264

 
467

 

 

 
1,731

Small business lending
203

 
(8
)
 

 

 
195

Residential mortgage
1,079

 
(36
)
 

 
1

 
1,044

Home equity
53

 
(6
)
 

 
2

 
49

Other consumer
2,321

 
248

 
(317
)
 
86

 
2,338

Total
$
17,896

 
$
1,285

 
$
(429
)
 
$
89

 
$
18,841








The following tables present the recorded investment in loans based on portfolio segment and impairment method as of March 31, 2020 and December 31, 2019
(in thousands)
Loans
 
Allowance for Loan Losses
March 31, 2020
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
 
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
Commercial and industrial
$
94,329

 
$
898

 
$
95,227

 
$
1,561

 
$
109

 
$
1,670

Owner-occupied commercial real estate
74,142

 
595

 
74,737

 
645

 

 
645

Investor commercial real estate
13,421

 

 
13,421

 
128

 

 
128

Construction
64,581

 

 
64,581

 
460

 

 
460

Single tenant lease financing
967,595

 
4,680

 
972,275

 
9,095

 
1,660

 
10,755

Public finance
627,678

 

 
627,678

 
1,483

 

 
1,483

Healthcare finance
372,266

 

 
372,266

 
4,318

 

 
4,318

Small business lending
63,948

 
3,327

 
67,275

 
265

 
 
 
265

Residential mortgage
217,370

 
1,360

 
218,730

 
500

 

 
500

Home equity
23,855

 

 
23,855

 
53

 

 
53

Other consumer
296,557

 
48

 
296,605

 
2,580

 

 
2,580

Total
$
2,815,742

 
$
10,908

 
$
2,826,650

 
$
21,088

 
$
1,769

 
$
22,857

(in thousands)
Loans
 
Allowance for Loan Losses
December 31, 2019
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
 
Ending Balance:  
Collectively Evaluated for Impairment
 
Ending Balance:  
Individually Evaluated for Impairment
 
Ending Balance
Commercial and industrial
$
93,520

 
$
2,900

 
$
96,420

 
$
1,412

 
$
109

 
$
1,521

Owner-occupied commercial real estate
71,067

 
2,325

 
73,392

 
561

 

 
561

Investor commercial real estate
12,567

 

 
12,567

 
109

 

 
109

Construction
60,274

 

 
60,274

 
380

 

 
380

Single tenant lease financing
991,199

 
4,680

 
995,879

 
9,515

 
1,660

 
11,175

Public finance
687,094

 

 
687,094

 
1,580

 

 
1,580

Healthcare finance
300,612

 

 
300,612

 
3,247

 

 
3,247

Small business lending
56,941

 
3,338

 
60,279

 
54

 
 
 
54

Residential mortgage
312,714

 
1,135

 
313,849

 
657

 

 
657

Home equity
24,306

 

 
24,306

 
46

 

 
46

Other consumer
295,266

 
43

 
295,309

 
2,510

 

 
2,510

Total
$
2,905,560

 
$
14,421

 
$
2,919,981

 
$
20,071

 
$
1,769

 
$
21,840



The Company utilizes a risk grading matrix to assign a risk grade to each of its commercial loans. A description of the general characteristics of the risk grades is as follows:
 
“Pass” - Higher quality loans that do not fit any of the other categories described below.

“Special Mention” - Loans that possess some credit deficiency or potential weakness, which deserve close attention.

“Substandard” - Loans that possess a defined weakness or weaknesses that jeopardize the liquidation of the debt. Loans characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected. Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any.

“Doubtful” - Such loans have been placed on nonaccrual status and may be heavily dependent upon collateral possessing a value that is difficult to determine or based upon some near-term event that lacks clear certainty. These loans have all of the weaknesses of those classified as Substandard; however, based on existing conditions, these weaknesses make full collection of the principal balance highly improbable.

“Loss” - Loans that are considered uncollectible and of such little value that continuing to carry them as assets is not warranted.

Nonaccrual Loans
 
Any loan which becomes 90 days delinquent or for which the full collection of principal and interest may be in doubt will be considered for nonaccrual status. At the time a loan is placed on nonaccrual status, all accrued but unpaid interest will be reversed from interest income. Placing the loan on nonaccrual status does not relieve the borrower of the obligation to repay interest. A loan placed on nonaccrual status may be restored to accrual status when all delinquent principal and interest has been brought current, and the Company expects full payment of the remaining contractual principal and interest.

The following tables present the credit risk profile of the Company’s commercial and consumer loan portfolios based on rating category and payment activity as of March 31, 2020 and December 31, 2019
 
March 31, 2020
(in thousands)
Pass
 
Special Mention
 
Substandard
 
Total
Commercial and industrial
$
91,028

 
$
3,301

 
$
898

 
$
95,227

Owner-occupied commercial real estate
74,142

 

 
595

 
74,737

Investor commercial real estate
13,421

 

 

 
13,421

Construction
64,581

 

 

 
64,581

Single tenant lease financing
959,161

 
8,434

 
4,680

 
972,275

Public finance
627,678

 

 

 
627,678

Healthcare finance
371,203

 
1,063

 

 
372,266

Small business lending
62,226

 
1,722

 
3,327

 
67,275

Total commercial loans
$
2,263,440

 
$
14,520

 
$
9,500

 
$
2,287,460

 
March 31, 2020
(in thousands)
Performing
 
Nonaccrual
 
Total
Residential mortgage
$
217,739

 
$
991

 
$
218,730

Home equity
23,855

 

 
23,855

Other consumer
296,566

 
39

 
296,605

Total consumer loans
$
538,160

 
$
1,030

 
$
539,190

 
December 31, 2019
(in thousands)
Pass
 
Special Mention
 
Substandard
 
Total
Commercial and industrial
$
89,818

 
$
3,973

 
$
2,629

 
$
96,420

Owner-occupied commercial real estate
71,068

 
1,727

 
597

 
73,392

Investor commercial real estate
12,567

 

 

 
12,567

Construction
60,274

 

 

 
60,274

Single tenant lease financing
983,448

 
7,751

 
4,680

 
995,879

Public finance
687,094

 

 

 
687,094

Healthcare finance
300,612

 

 

 
300,612

Small business lending
55,206

 
1,735

 
3,338

 
60,279

Total commercial loans
$
2,260,087

 
$
15,186

 
$
11,244

 
$
2,286,517

 
December 31, 2019
(in thousands)
Performing
 
Nonaccrual
 
Total
Residential mortgage
$
313,088

 
$
761

 
$
313,849

Home equity
24,306

 

 
24,306

Other consumer
295,276

 
33

 
295,309

Total consumer loans
$
632,670

 
$
794

 
$
633,464

  
The following tables present the Company’s loan portfolio delinquency analysis as of March 31, 2020 and December 31, 2019

 
 
March 31, 2020
(in thousands)
 
30-59
Days
Past Due
 
60-89
Days
Past Due
 
90 Days 
or More
Past Due
 
Total 
Past Due
 
Current
 
Total
Loans
 
Non-
accrual
Loans
 
Total Loans
90 Days or
More Past
Due and
Accruing
Commercial and industrial
 
$

 
$

 
$
285

 
$
285

 
$
94,942

 
$
95,227

 
$
218

 
$
73

Owner-occupied commercial real estate
 

 

 
464

 
464

 
74,273

 
74,737

 
464

 

Investor commercial real estate
 

 

 

 

 
13,421

 
13,421

 

 

Construction
 

 

 

 

 
64,581

 
64,581

 

 

Single tenant lease financing
 

 

 
4,680

 
4,680

 
967,595

 
972,275

 
4,680

 

Public finance
 

 

 

 

 
627,678

 
627,678

 

 

Healthcare finance
 

 

 

 

 
372,266

 
372,266

 

 

Small business lending
 
676

 
43

 
926

 
1,645

 
65,630

 
67,275

 
926

 

Residential mortgage
 
870

 

 
1,042

 
1,912

 
216,818

 
218,730

 
991

 
51

Home equity
 

 

 

 

 
23,855

 
23,855

 

 

Other consumer
 
95

 
149

 
1

 
245

 
296,360

 
296,605

 
39

 
1

Total
 
$
1,641

 
$
192

 
$
7,398

 
$
9,231

 
$
2,817,419

 
$
2,826,650

 
$
7,318

 
$
125

 
 
December 31, 2019
(in thousands)
 
30-59
Days
Past Due
 
60-89
Days
Past Due
 
90 Days 
or More
Past Due
 
Total 
Past Due
 
Current
 
Total
Loans
 
Non-
accrual
Loans
 
Total Loans
90 Days or
More Past
Due and
Accruing
Commercial and industrial
 
$
15

 
$
96

 
$
122

 
$
233

 
$
96,187

 
$
96,420

 
$
226

 
$

Owner-occupied commercial real estate
 

 

 
464

 
464

 
72,928

 
73,392

 
464

 

Investor commercial real estate
 

 

 

 

 
12,567

 
12,567

 

 

Construction
 

 

 

 

 
60,274

 
60,274

 

 

Single tenant lease financing
 

 
4,680

 

 
4,680

 
991,199

 
995,879

 
4,680

 

Public finance
 

 

 

 

 
687,094

 
687,094

 

 

Healthcare finance
 

 

 

 

 
300,612

 
300,612

 

 

Small business lending
 
54

 
 
 

 
54

 
60,225

 
60,279

 

 

Residential mortgage
 

 

 
1,177

 
1,177

 
312,672

 
313,849

 
761

 
416

Home equity
 

 

 

 

 
24,306

 
24,306

 

 

Other consumer
 
240

 
107

 

 
347

 
294,962

 
295,309

 
33

 

Total
 
$
309

 
$
4,883

 
$
1,763

 
$
6,955

 
$
2,913,026

 
$
2,919,981

 
$
6,164

 
$
416



Impaired Loans
 
A loan is designated as impaired, in accordance with the impairment accounting guidance, when, based on current information or events, it is probable that the Company will be unable to collect all amounts due (principal and interest) according to the contractual terms of the loan agreement. Payments with delays generally not exceeding 90 days outstanding are not considered impaired. Certain nonaccrual and substantially all delinquent loans more than 90 days past due may be considered to be impaired. Generally, loans are placed on nonaccrual status at 90 days past due and accrued interest is reversed against earnings, unless the loan is well-secured and in the process of collection. The accrual of interest on impaired and nonaccrual loans is discontinued when, in management’s opinion, the borrower may be unable to meet payments as they become due.
 
Impaired loans include nonperforming loans as well as loans modified in TDRs where concessions have been granted to borrowers experiencing financial difficulties. These concessions could include a reduction in the interest rate on the loan, payment extensions, forgiveness of principal, forbearance, or other actions intended to maximize collection.
 
ASC Topic 310, Receivables, requires that impaired loans be measured based on the present value of expected future cash flows discounted at the loans’ effective interest rates or the fair value of the underlying collateral, less costs to sell, and allows existing methods for recognizing interest income.
 
The following table presents the Company’s impaired loans as of March 31, 2020 and December 31, 2019
 
 
March 31, 2020
 
December 31, 2019
(in thousands)
 
Recorded
Balance
 
Unpaid
Principal
Balance
 
Specific
Allowance
 
Recorded
Balance
 
Unpaid
Principal
Balance
 
Specific
Allowance
Loans without a specific valuation allowance
 
 

 
 

 
 

 
 

 
 

 
 

Commercial and industrial
 
$
695

 
$
697

 
$

 
$
2,693

 
$
2,694

 
$

Owner-occupied commercial real estate
 
595

 
598

 

 
2,325

 
2,327

 

Small business lending
 
3,327

 
3,327

 

 
3,338

 
3,338

 

Residential mortgage
 
1,360

 
1,450

 

 
1,135

 
1,209

 

Other consumer
 
48

 
116

 

 
43

 
107

 

Total
 
6,025

 
6,188

 

 
9,534

 
9,675

 

Loans with a specific valuation allowance
 
 

 
 

 
 

 
 

 
 

 
 

Commercial and industrial
 
203

 
240

 
109

 
207

 
244

 
109

Single tenant lease financing
 
4,680

 
4,680

 
1,660

 
4,680

 
4,680

 
1,660

Total
 
4,883

 
4,920

 
1,769

 
4,887

 
4,924

 
1,769

Total impaired loans
 
$
10,908

 
$
11,108

 
$
1,769

 
$
14,421

 
$
14,599

 
$
1,769

 
The table below presents average balances and interest income recognized for impaired loans during the three months ended March 31, 2020 and 2019.
 
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
(in thousands)
 
Average
Balance
 
Interest
Income
 
Average
Balance
 
Interest
Income
Loans without a specific valuation allowance
 
 

 
 

 
 

 
 

Commercial and industrial
 
$
2,066

 
$
18

 
$
4,699

 
$
81

Owner-occupied commercial real estate
 
1,890

 
2

 
1,253

 
13

Small business lending
 
3,332

 

 
952

 
14

Residential mortgage
 
1,274

 

 
2,054

 

Home equity
 

 

 
41

 

Other consumer
 
45

 

 
76

 

Total
 
8,607

 
20

 
9,075

 
108

Loans with a specific valuation allowance
 
 

 
 

 
 

 
 

Commercial and industrial
 
204

 

 

 

Single tenant lease financing
 
4,680

 

 

 

Total
 
4,884

 

 

 

Total impaired loans
 
$
13,491

 
$
20

 
$
9,075

 
$
108



The Company had no residential mortgage other real estate owned as of March 31, 2020 and December 31, 2019. There were no loans in the process of foreclosure at March 31, 2020 and December 31, 2019.

Troubled Debt Restructurings
 
The loan portfolio includes TDRs, which are loans that have been modified to grant economic concessions to borrowers who have experienced financial difficulties. These concessions typically result from loss mitigation efforts and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs are classified as nonperforming at the time of restructuring and typically are returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally not less than six consecutive months.
 
When loans are modified in a TDR, any possible impairment similar to other impaired loans is evaluated based on the present value of expected future cash flows, discounted at the contractual interest rate of the original loan agreement, or using the current fair value of the collateral, less selling costs, for collateral dependent loans. If it is determined that the value of the modified loan is less than the recorded balance of the loan, impairment is recognized through a specific allowance or charge-off to the allowance. In periods subsequent to modification, all TDRs, including those that have payment defaults, are evaluated for possible impairment, and impairment is recognized through the allowance.
 
In the course of working with troubled borrowers, the Company may choose to restructure the contractual terms of certain loans in an effort to work out an alternative payment schedule with the borrower in order to optimize the collectability of the loan. Any loan modification is reviewed by the Company to identify whether a TDR has occurred when the Company grants a concession to the borrower that it would not otherwise consider based on economic or legal reasons related to a borrower’s financial difficulties. Terms may be modified to fit the ability of the borrower to repay in line with its current financial status or the loan may be restructured to secure additional collateral and/or guarantees to support the debt, or a combination of the two.

There were no commercial and industrial loans classified as new TDRs during the three months ended March 31, 2020 and 2019. There were no performing TDRs that had payment defaults within the twelve months following modification during the three months ended March 31, 2020 and 2019.

Non-TDR Loan Modifications due to COVID-19

The “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” was issued by our banking regulators on March 22, 2020. This guidance encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19.

Additionally, Section 4013 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

In accordance with this guidance, the Company offered modifications to borrowers who were both impacted by COVID-19 and current on all principal and interest payments. The modifications completed in the three months ended March 31, 2020 consisted of only loans in the healthcare finance portfolio with total balances of $233.5 million.
v3.20.1
Servicing Asset (Tables)
3 Months Ended
Mar. 31, 2020
Transfers and Servicing [Abstract]  
Schedule of Servicing Assets at Fair Value
Activity for the servicing asset and the related changes in fair value for the three months ended March 31, 2020 and 2019 are shown in the table below.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Beginning balance
 
$
2,481

 
$

Additions
 
113

 

Changes in fair value
 
(179
)
 

     Ending balance
 
$
2,415

 
$

Schedule Of Unpaid Principal Balances Of Loans Serviced For Others
The unpaid principal balances of these loans serviced for others as of March 31, 2020 and December 31, 2019 are shown in the table below.

(in thousands)
 
 
 
 
March 31, 2020
 
December 31, 2019
Loan portfolios serviced for:
 
 
 
 
   SBA guaranteed loans
 
$
103,878

 
$
103,981

     Total
 
$
103,878

 
$
103,981

v3.20.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule Of Derivative Instruments, Cumulative Basis Adjustments
The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of March 31, 2020 and December 31, 2019.  

(in thousands)
 
Carrying amount of the hedged asset
 
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included
 
March 31, 2020
 
December 31, 2019
 
March 31, 2020
 
December 31, 2019
Loans
 
$
494,019

 
$
474,957

 
$
44,586

 
$
21,440

Securities available-for-sale (1)
 
152,551

 
151,538

 
6,790

 
2,802

(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item
is the last layer expected to be remaining at the end of the hedging relationship. At both March 31, 2020 and December 31, 2019, the amounts of the designated hedged items were $88.2 million.
Schedule Of Derivative Instruments Of Fixed Rate Receivables
The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at March 31, 2020 and December 31, 2019, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands)

 
March 31, 2020
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Instruments Associated With
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Loans
 
$
424,834

 
5.3
 
$
(44,872
)
 
3-month LIBOR
 
2.86
%
Securities available-for-sale
 
88,200

 
3.9
 
(6,793
)
 
3-month LIBOR
 
2.54
%
Total at March 31, 2020
 
$
513,034

 
5.0
 
$
(51,665
)
 
3-month LIBOR
 
2.80
%

(dollars in thousands)


December 31, 2019
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Instruments Associated With
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Loans
 
$
427,446

 
5.5
 
$
(21,551
)
 
3-month LIBOR
 
2.86
%
Securities available-for-sale
 
88,200

 
4.1
 
(2,806
)
 
3-month LIBOR
 
2.54
%
Total at December 31, 2019
 
$
515,646

 
5.3
 
$
(24,357
)
 
3-month LIBOR
 
2.80
%
Schedule Of Derivative Instruments Of Variable Rate Liabilities
The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at March 31, 2020 and December 31, 2019.

(dollars in thousands)

 
March 31, 2020
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Cash Flow Hedges
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Interest rate swaps
 
$
110,000

 
6.8
 
$
(17,509
)
 
3-month LIBOR
 
2.88
%
Interest rate swaps
 
100,000

 
3.7
 
(9,378
)
 
1-month LIBOR
 
2.88
%

(dollars in thousands)


December 31, 2019
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Cash Flow Hedges
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Interest rate swaps
 
$
110,000

 
7.1
 
$
(8,390
)
 
3-month LIBOR
 
2.88
%
Interest rate swaps
 
100,000

 
4.0
 
(5,040
)
 
1-month LIBOR
 
2.88
%
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at March 31, 2020 and December 31, 2019.

 
 
March 31, 2020
 
December 31, 2019
(in thousands)
 
Notional
Amount
 
Fair
Value
 
Notional
Amount
 
Fair
Value
Asset Derivatives
 
 

 
 

 
 

 
 

Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Interest rate swaps associated with loans
 
$

 
$

 
$

 
$

Interest rate swaps associated with securities available-for-sale
 

 

 

 

Derivatives not designated as hedging instruments
 
 

 
 

 
 

 
 

IRLCs
 
139,907

 
2,064

 
56,256

 
910

Total contracts
 
$
139,907

 
$
2,064

 
$
56,256

 
$
910

Liability Derivatives
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Interest rate swaps associated with loans
 
$
424,834

 
$
(44,872
)
 
$
427,446

 
$
(21,551
)
Interest rate swaps associated with securities available-for-sale
 
88,200

 
(6,793
)
 
88,200

 
(2,806
)
Interest rate swaps associated with liabilities
 
210,000

 
(26,887
)
 
210,000

 
(13,429
)
Derivatives not designated as hedging instruments
 
 
 
 
 
 
 
 
Forward contracts
 
106,750

 
(2,298
)
 
115,000

 
(153
)
Total contracts
 
$
829,784

 
$
(80,850
)
 
$
840,646

 
$
(37,939
)
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three months ended March 31, 2020 and 2019.

 
 
Amount of Loss Recognized in Other Comprehensive (Loss) Income in The Three Months Ended
(in thousands)
 
March 31, 2020
 
March 31, 2019
Interest rate swap agreements
 
$
(13,458
)
 
$
(3,572
)
Schedule of Derivative Instruments in Statements of Income Fair Value
The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three months ended March 31, 2020 and 2019.

 
 
Amount of Gain / (Loss) Recognized in the Three Months Ended
(in thousands)
 
March 31, 2020
 
March 31, 2019
Asset Derivatives
 
 

 
 

Derivatives not designated as hedging instruments
 
 

 
 

IRLCs
 
$
1,154

 
$
392

 
 
 
 
 
Liability Derivatives
 
 

 
 

Derivatives not designated as hedging instruments
 
 
 
 
Forward contracts
 
$
(2,145
)
 
$
(67
)
Schedule Of Effects Of Interest Rate Swap Agreements On Statements Of Income
The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three months ended March 31, 2020 and 2019.

(in thousands)

Line item in the condensed consolidated statements of income
 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
Interest income
 
 
 
 
Loans
 
$
(1,224
)
 
$
21

Securities - taxable
 
(91
)
 
(7
)
Securities - non-taxable
 
(67
)
 
45

Total interest income
 
(1,382
)
 
59

Interest expense
 
 

 
 

Deposits
 
307

 
90

Other borrowed funds
 
322

 
34

Total interest expense
 
629

 
124

Net interest income
 
$
(2,011
)
 
$
(65
)
v3.20.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Basic earnings per share    
Net income $ 6,019 $ 5,696
Weighted-average common shares (in shares) 9,721,485 10,217,637
Basic earnings per common share ( in dollars per share) $ 0.62 $ 0.56
Diluted earnings per share    
Net income $ 6,019 $ 5,696
Weighted-average common shares (in shares) 9,721,485 10,217,637
Dilutive effect of equity compensation (in shares) 29,043 12,894
Weighted-average common and incremental shares (in shares) 9,750,528 10,230,531
Diluted earnings per common share (in dollars per share) $ 0.62 $ 0.56
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 8,575 45,565
v3.20.1
Leases - Balance Sheet Amounts (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Operating lease right-of-use assets $ (1,485) $ 1,602
Operating lease liabilities $ (1,485) $ 1,602
Weighted-average remaining lease term (years) 2 years 2 months 12 days 2 years 4 months 24 days
Weighted-average discount rate 2.00% 2.00%
v3.20.1
Loans - Impaired Loans (Details)
3 Months Ended
Mar. 31, 2020
USD ($)
contract
Mar. 31, 2019
USD ($)
contract
Dec. 31, 2019
USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Recorded Balance $ 6,025,000   $ 9,534,000
Loans without a specific valuation allowance - Unpaid Principal Balance 6,188,000   9,675,000
Loans without a specific valuation allowance 0   0
Impaired loans 4,883,000   4,887,000
Loans with a specific valuation allowance - Unpaid Principal Balance 4,920,000   4,924,000
Loans with a specific valuation allowance 1,769,000   1,769,000
Impaired Financing Receivable, Recorded Investment 10,908,000   14,421,000
Impaired Financing Receivable, Unpaid Principal Balance 11,108,000   14,599,000
Impaired Financing Receivable, Related Allowance 1,769,000   1,769,000
Loans without a specific valuation allowance - Average Balance 8,607,000 $ 9,075,000  
Loans without a specific valuation allowance - Interest Income 20,000 108,000  
Loans with a specific valuation allowance - Average Balance 4,884,000 0  
Loans with a specific valuation allowance - Interest Income 0 0  
Impaired Financing Receivable, Average Recorded Investment 13,491,000 9,075,000  
Impaired Financing Receivable, Interest Income, Accrual Method 20,000 108,000  
Other real estate owned 2,065,000   2,065,000
Mortgage loans in process of foreclosure, amount 0   0
Commercial and industrial      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Recorded Balance 695,000   2,693,000
Loans without a specific valuation allowance - Unpaid Principal Balance 697,000   2,694,000
Loans without a specific valuation allowance 0   0
Impaired loans 203,000   207,000
Loans with a specific valuation allowance - Unpaid Principal Balance 240,000   244,000
Loans with a specific valuation allowance 109,000   109,000
Loans without a specific valuation allowance - Average Balance 2,066,000 4,699,000  
Loans without a specific valuation allowance - Interest Income 18,000 81,000  
Loans with a specific valuation allowance - Average Balance 204,000 0  
Loans with a specific valuation allowance - Interest Income $ 0 $ 0  
Number of contracts classified as TDRs | contract 0 0  
Owner-occupied commercial real estate      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Recorded Balance $ 595,000   2,325,000
Loans without a specific valuation allowance - Unpaid Principal Balance 598,000   2,327,000
Loans without a specific valuation allowance 0   0
Loans without a specific valuation allowance - Average Balance 1,890,000 $ 1,253,000  
Loans without a specific valuation allowance - Interest Income 2,000 13,000  
Small business lending      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Recorded Balance 3,327,000   3,338,000
Loans without a specific valuation allowance - Unpaid Principal Balance 3,327,000   3,338,000
Loans without a specific valuation allowance 0   0
Loans without a specific valuation allowance - Average Balance 3,332,000 952,000  
Loans without a specific valuation allowance - Interest Income 0 14,000  
Residential mortgage      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Recorded Balance 1,360,000   1,135,000
Loans without a specific valuation allowance - Unpaid Principal Balance 1,450,000   1,209,000
Loans without a specific valuation allowance 0   0
Loans without a specific valuation allowance - Average Balance 1,274,000 2,054,000  
Loans without a specific valuation allowance - Interest Income 0 0  
Other real estate owned 0   0
Home equity      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Average Balance 0 41,000  
Loans without a specific valuation allowance - Interest Income 0 0  
Other consumer      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Loans without a specific valuation allowance - Recorded Balance 48,000   43,000
Loans without a specific valuation allowance - Unpaid Principal Balance 116,000   107,000
Loans without a specific valuation allowance 0   0
Loans without a specific valuation allowance - Average Balance 45,000 76,000  
Loans without a specific valuation allowance - Interest Income 0 0  
Single tenant lease financing      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Impaired loans 4,680,000   4,680,000
Loans with a specific valuation allowance - Unpaid Principal Balance 4,680,000   4,680,000
Loans with a specific valuation allowance 1,660,000   $ 1,660,000
Loans with a specific valuation allowance - Average Balance 4,680,000 0  
Loans with a specific valuation allowance - Interest Income 0 $ 0  
COVID-19 | Commercial Portfolio Segment | Healthcare finance      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Financing receivable, troubled debt restructuring $ 233,500,000    
v3.20.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Interest Income    
Loans $ 30,408,000 $ 29,218,000
Securities – taxable 3,619,000 3,324,000
Securities – non-taxable 572,000 684,000
Other earning assets 1,645,000 1,773,000
Total interest income 36,244,000 34,999,000
Interest Expense    
Deposits 17,208,000 15,386,000
Other borrowed funds 4,018,000 3,369,000
Total interest expense 21,226,000 18,755,000
Net Interest Income 15,018,000 16,244,000
Provision for Loan Losses 1,461,000 1,285,000
Net Interest Income After Provision for Loan Losses 13,557,000 14,959,000
Noninterest Income    
Gain (loss) on sale of loans 1,801,000 (104,000)
Gain on sale of securities 41,000 0
Other 417,000 623,000
Total noninterest income 6,211,000 2,372,000
Noninterest Expense    
Salaries and employee benefits 7,774,000 6,321,000
Marketing, advertising and promotion 375,000 469,000
Consulting and professional services 1,177,000 814,000
Data processing 375,000 317,000
Loan expenses 599,000 314,000
Premises and equipment 1,625,000 1,500,000
Deposit insurance premium 485,000 555,000
Other 1,076,000 819,000
Total noninterest expense 13,486,000 11,109,000
Income Before Income Taxes 6,282,000 6,222,000
Income Tax Provision 263,000 526,000
Net Income $ 6,019,000 $ 5,696,000
Income Per Share of Common Stock    
Basic (in dollars per share) $ 0.62 $ 0.56
Diluted (in dollars per share) $ 0.62 $ 0.56
Weighted-Average Number of Common Shares Outstanding    
Basic (in shares) 9,721,485 10,217,637
Diluted (in shares) 9,750,528 10,230,531
Dividends Declared Per Share (in dollars per share) $ 0.06 $ 0.06
Service charges and fees    
Noninterest Income    
Noninterest income $ 212,000 $ 236,000
Loan servicing revenue    
Noninterest Income    
Noninterest income 251,000 0
Loan servicing asset revaluation    
Noninterest Income    
Noninterest income (179,000) 0
Mortgage banking activities    
Noninterest Income    
Noninterest income $ 3,668,000 $ 1,617,000
v3.20.1
Servicing Asset - Unpaid principal balance (Details) - Loan servicing - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Servicing Assets at Fair Value [Line Items]    
Loans serviced for others $ 103,878 $ 103,981
SBA guaranteed loans    
Servicing Assets at Fair Value [Line Items]    
Loans serviced for others $ 103,878 $ 103,981
v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Activities    
Net income $ 6,019 $ 5,696
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 1,644 2,271
Increase in cash surrender value of bank-owned life insurance (236) (234)
Provision for loan losses 1,461 1,285
Share-based compensation expense 555 478
Gain on sale of available-for-sale securities (41) 0
Loans originated for sale (215,385) (75,239)
Proceeds from sale of loans 225,547 81,048
Gain on loans sold (6,144) (1,369)
(Increase) decrease in fair value of loans held-for-sale (316) 182
Loss (gain) on derivatives 1,163 (314)
Net change in servicing asset 66 0
Amortization of operating lease right-of-use assets 152 176
Net change in accrued income and other assets (40,631) (20,833)
Net change in accrued expenses and other liabilities 311 1,570
Net cash used in operating activities (25,835) (5,283)
Investing Activities    
Net loan activity, excluding purchases (1,305) (73,783)
Maturities and calls of securities available-for-sale 30,851 13,840
Proceeds from sale of securities available-for-sale 795 0
Purchase of securities available-for-sale (95,835) (46,562)
Purchase of securities held-to-maturity 0 (8,500)
Purchase of premises and equipment (4,856) (1,564)
Loans purchased (97,306) (79,343)
Net proceeds from sale of portfolio loans 193,533 35,673
Net cash provided by (used in) investing activities 25,877 (160,239)
Financing Activities    
Net increase in deposits 24,543 139,757
Cash dividends paid (585) (613)
Repurchase of common stock 0 (1,746)
Proceeds from advances from Federal Home Loan Bank 110,000 165,000
Repayment of advances from Federal Home Loan Bank (110,000) (195,000)
Other, net (93) (94)
Net cash provided by financing activities 23,865 107,304
Net Increase (Decrease) in Cash and Cash Equivalents 23,907 (58,218)
Cash and Cash Equivalents, Beginning of Period 327,361 188,712
Cash and Cash Equivalents, End of Period 351,268 130,494
Supplemental Disclosures    
Initial recognition of right-of-use asset 0 2,096
Initial recognition of operating lease liabilities 0 2,096
Cash paid during the period for interest 21,699 18,314
Loans transferred to held-for-sale from portfolio 192,768 35,599
Cash dividends declared, paid in subsequent period 585 606
Transfer of available-for-sale municipal securities to held-to-maturity municipal securities $ 4,479 $ 0
v3.20.1
Mortgage Banking Activities (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Principal Transaction Revenue [Line Items]    
Loans originated for sale $ 215,385 $ 75,239
Proceeds from sale of loans 225,547 81,048
Proceeds from sale of loans held-for-investment, Gross 90,800 5,200
Mortgage banking activities    
Principal Transaction Revenue [Line Items]    
Gain on loans sold 4,343 1,473
Gain (loss) resulting from the change in fair value of loans held-for-sale 316 (182)
(Loss) gain resulting from the change in fair value of derivatives (991) 326
Net revenue from mortgage banking activities $ 3,668 $ 1,617
v3.20.1
Derivative Financial Instruments - Effect Of Derivatives on Income (Details) - Interest rate swaps - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Loss Recognized in Other Comprehensive Income $ (13,458)  
Amount of Loss Recognized in Other Comprehensive Income   $ (3,572)
Loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income (1,224)  
Gain (loss) recognized on the condensed consolidated statements of income   21
Securities - taxable    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income (91)  
Gain (loss) recognized on the condensed consolidated statements of income   (7)
Securities - non-taxable    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income (67)  
Gain (loss) recognized on the condensed consolidated statements of income   45
Total interest income    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income (1,382)  
Gain (loss) recognized on the condensed consolidated statements of income   59
Deposits    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income 307  
Gain (loss) recognized on the condensed consolidated statements of income   90
Other borrowed funds    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income 322  
Gain (loss) recognized on the condensed consolidated statements of income   34
Total interest expense    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income 629  
Gain (loss) recognized on the condensed consolidated statements of income   124
Net interest income    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on the condensed consolidated statements of income $ (2,011)  
Gain (loss) recognized on the condensed consolidated statements of income   $ (65)
v3.20.1
Subordinated Debt
3 Months Ended
Mar. 31, 2020
Debt Disclosure [Abstract]  
Subordinated Debt
Subordinated Debt
 
In October 2015, the Company entered into a term loan in the principal amount of $10.0 million, evidenced by a term note due 2025 (the “2025 Note”). The 2025 Note bears a fixed interest rate of 6.4375% per year, payable quarterly, and is scheduled to mature on October 1, 2025. The 2025 Note is an unsecured subordinated obligation of the Company and may be repaid, without penalty, on any interest payment date on or after October 15, 2020. The 2025 Note is intended to qualify as Tier 2 capital under regulatory guidelines.

In September 2016, the Company issued $25.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026 (the “2026 Notes”) in a public offering. The 2026 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding September 30, 2021, and thereafter a floating rate equal to the then-current three-month LIBOR rate plus 485 basis points. All interest on the 2026 Notes is payable quarterly. The 2026 Notes are scheduled to mature on September 30, 2026. The 2026 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after September 30, 2021. The 2026 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

In June 2019, the Company issued $37.0 million aggregate principal amount of 6.0% Fixed-to-Floating Rate Subordinated Notes due 2029 (the “2029 Notes”) in a public offering. The 2029 Notes initially bear a fixed interest rate of 6.0% per year to, but excluding, June 30, 2024, and thereafter a floating rate equal to the then-current benchmark rate (initially three-month LIBOR rate) plus 411 basis points. All interest on the 2029 Notes is payable quarterly. The 2029 Notes are scheduled to mature on June 30, 2029. The 2029 Notes are unsecured subordinated obligations of the Company and may be repaid, without penalty, on any interest payment date on or after June 30, 2024. The 2029 Notes are intended to qualify as Tier 2 capital under regulatory guidelines.

The following table presents the principal balance and unamortized debt issuance costs for the 2025 Note, the 2026 Notes and the 2029 Notes as of March 31, 2020 and December 31, 2019.
 
March 31, 2020
 
December 31, 2019
(in thousands)
Principal
 
Unamortized Debt Issuance Costs
 
Principal
 
Unamortized Debt Issuance Costs
2025 Note
10,000

 
(132
)
 
10,000

 
(138
)
2026 Notes
25,000

 
(808
)
 
25,000

 
(839
)
2029 Notes
37,000

 
(1,455
)
 
37,000

 
(1,495
)
Total
$
72,000

 
$
(2,395
)
 
$
72,000

 
$
(2,472
)
v3.20.1
Premises and Equipment
3 Months Ended
Mar. 31, 2020
Property, Plant and Equipment [Abstract]  
Premises and Equipment
Premises and Equipment
 
The following table summarizes premises and equipment at March 31, 2020 and December 31, 2019.
(in thousands)
 
March 31,
2020
 
December 31,
2019
Land
 
$
2,500

 
$
2,500

Right of use leased asset
 
1,450

 
1,602

Building and improvements
 
14,291

 
10,004

Furniture and equipment
 
10,258

 
9,689

Less: accumulated depreciation
 
(9,616
)
 
(9,165
)
Total
 
$
18,883

 
$
14,630


  

During 2018, the Bank's subsidiary, SPF15, Inc., (“SPF15”) acquired several parcels of land consisting of approximately 3.3 acres located in Fishers, Indiana for approximately $10.2 million, inclusive of acquisition costs.  Pursuant to a Land Acquisition Agreement with the City of Fishers, Indiana (the “City”), and its Redevelopment Commission, among others, the City agreed to reimburse SPF15 for the purchase price and other specified land acquisition costs. The Land Acquisition Agreement was replaced by a Project Agreement in December 2018, which extended the reimbursement deadline to October 31, 2019 and made additional financial incentives available to the Company for constructing an office building and associated parking garage on the property. As contemplated under the Project Agreement, the City transferred to SPF15 two additional parcels of land consisting of approximately 0.75 acres and SPF15 transferred to the Fishers Town Hall Building Corporation and third parties a certain parcel of land consisting of approximately 1.65 acres in connection with the development of the property. On October 25, 2019, the City satisfied its reimbursement obligation, resulting in the payment of SPF15 of an aggregate of $11.1 million for purchase prices and other specified land acquisition costs.

Site demolition has been completed and construction of a multi-use development, to include the Company's future headquarters, began on October 7, 2019. Development of the site is estimated to be substantially completed by September 30, 2021.
v3.20.1
Basis of Presentation (Details)
Mar. 31, 2020
subsidiary
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of wholly-owned subsidiaries 3
v3.20.1
Leases (Tables)
3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
Lease, Cost
The following table shows the components of lease expense.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Operating lease cost
 
$
215

 
$
187

Lessee, Supplemental Cash Flow
The following table shows supplemental cash flow information related to leases.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
 
 
     Operating cash flows from operating leases
 
$
231

 
$
200

Lessee, Supplemental Balance Sheet
The following table shows the operating leases’ impact on the condensed consolidated balance sheets. The Company elected not to include short-term leases (leases with original terms of 12 months or less) or equipment leases, as those amounts are insignificant. The Company’s leases do not provide an implicit rate. The discount rate utilized to determine the present value of lease payments is the Company’s incremental borrowing rate based on the information available at the lease inception date. The incremental borrowing rate is the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.
(dollars in thousands)
 
 
 
 
March 31, 2020
 
December 31, 2019
Operating lease right-of-use assets
 
$
(1,485
)
 
$
1,602

Operating lease liabilities
 
(1,485
)
 
1,602

 
 
 
 
 
Weighted-average remaining lease term (years)
 
 
 
 
     Operating leases
 
2.2

 
2.4

 
 
 
 
 
Weighted-average discount rate
 
 
 
 
     Operating leases
 
2.0
%
 
2.0
%
Lessee, Operating Lease, Liability, Maturity
The following table shows the future minimum payments of operating leases with initial or remaining terms of one year or more as of March 31, 2020.

(in thousands)
 
 
Twelve months ended March 31,
 
 
2021
 
$
824

2022
 
315

2023
 
230

2024
 
58

2025
 

Thereafter
 

Total lease payments
 
1,427

     Less: imputed interest
 
(39
)
Total
 
$
1,388

v3.20.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value, Assets Measured on Recurring Basis
The following tables present the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a recurring basis and the level within the fair value hierarchy in which the fair value measurements fall at March 31, 2020 and December 31, 2019.
 
 
 
 
March 31, 2020 Fair Value Measurements Using
(in thousands)
 
Fair
Value
 
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
U.S. Government-sponsored agencies
 
$
70,004

 
$

 
$
70,004

 
$

Municipal securities
 
94,819

 

 
94,819

 

Agency mortgage-backed securities
 
282,632

 

 
282,632

 

Private label mortgage-backed securities
 
115,024

 
 
 
115,024

 

Asset-backed securities
 
4,713

 

 
4,713

 

Corporate securities
 
41,490

 

 
41,490

 

Total available-for-sale securities
 
608,682

 

 
608,682

 

Servicing asset
 
2,415

 

 

 
2,415

Interest rate swap liabilities
 
(78,552
)
 

 
(78,552
)
 

Loans held-for-sale (mandatory pricing agreements)
 
52,394

 

 
52,394

 

Forward contracts
 
(2,298
)
 
(2,298
)
 

 

IRLCs
 
2,064

 

 

 
2,064

 
 
 
 
December 31, 2019
Fair Value Measurements Using
(in thousands)
 
Fair
Value
 
Quoted Prices
in Active Markets for Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
U.S. Government-sponsored agencies
 
$
75,872

 
$

 
$
75,872

 
$

Municipal securities
 
97,652

 

 
97,652

 

Agency mortgage-backed securities
 
261,440

 

 
261,440

 

Private label mortgage-backed securities
 
63,613

 

 
63,613

 

Asset-backed securities
 
4,955

 

 
4,955

 

Corporate securities
 
37,320

 

 
37,320

 

Total available-for-sale securities
 
540,852

 

 
540,852

 

Servicing asset
 
2,481

 

 

 
2,481

Interest rate swap liabilities
 
(37,786
)
 

 
(37,786
)
 

Loans held-for-sale (mandatory pricing agreements)
 
56,097

 

 
56,097

 

Forward contracts
 
(153
)
 
(153
)
 

 

IRLCs
 
910

 

 

 
910

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The following tables reconcile the beginning and ending balances of recurring fair value measurements recognized in the accompanying condensed consolidated balance sheets using significant unobservable (Level 3) inputs for the three months ended March 31, 2020 and 2019.

 
 
Three Months Ended
(in thousands)
 
Servicing Asset
 
Interest Rate Lock
Commitments
Balance, January 1, 2020
 
$
2,481

 
$
910

Total realized (losses) gains
 


 
 
Additions
 
113

 

Change in fair value
 
(179
)
 
1,154

Balance, March 31, 2020
 
2,415

 
2,064

 
 
 
 
 
Balance as of January 1, 2019
 
$

 
$
389

Total realized gains
 
 
 
 
Change in fair value
 

 
392

Balance, March 31, 2019
 
$

 
$
781

Schedule Of Impaired Loans, Including Valuation Allowance, Fair Value, Unobservable Inputs Reconciliation
The following table presents the fair value measurements of assets and liabilities recognized in the accompanying condensed consolidated balance sheets measured at fair value on a nonrecurring basis and the level within the fair value hierarchy in which the fair value measurement falls at March 31, 2020 and December 31, 2019.


 
 
 
 
December 31, 2019
(in thousands)
 
 
 
Fair Value Measurements Using
 
 
Fair
Value
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Impaired loans
 
$
3,019

 
$

 
$

 
$
3,019

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques
The following tables present quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements.

(dollars in thousands)
 
Fair Value at
March 31, 2020
 
Valuation
Technique
 
Significant Unobservable
Inputs
 
Range
 
Weighted-Average Range
IRLCs
 
$
2,064

 
Discounted cash flow
 
Loan closing rates
 
36% - 100%
 
56%
Servicing asset
 
2,415

 
Discounted cash flow
 
Prepayment speeds
 
0% - 25%
 
14.4%
 
 
 
 
 
 
Expected weighted-average loan life
 
3.3 - 5.3 years
 
4.7 years

(dollars in thousands)
 
Fair Value at
December 31, 2019
 
Valuation
Technique
 
Significant Unobservable
Inputs
 
Range
 
Weighted-Average Range
Impaired loans
 
$
3,019

 
Fair value of collateral
 
Discount for type of property and current market conditions
 
10%
 
10%
IRLCs
 
910

 
Discounted cash flow
 
Loan closing rates
 
50% - 100%
 
84%
Servicing asset
 
2,481

 
Discounted cash flow
 
Prepayment speeds
 
0% - 25%
 
13.5%
 
 
 
 
 
 
Expected weighted-average loan life
 
3.2 - 5.7 years
 
5.0 years
Fair Value, by Balance Sheet Grouping
The following tables present the carrying value and estimated fair value of all financial assets and liabilities at March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
Fair Value Measurements Using
(in thousands)
 
Carrying
Amount
 
Fair Value
 
Quoted Prices
In Active
Market for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Cash and cash equivalents
 
$
351,268

 
$
351,268

 
$
351,268

 
$

 
$

Securities held-to-maturity
 
66,331

 
69,468

 

 
69,468

 

Net loans
 
2,869,236

 
2,842,894

 

 

 
2,842,894

Accrued interest receivable
 
16,960

 
16,960

 
16,960

 

 

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

 

 
25,650

 

Deposits
 
3,178,506

 
3,245,748

 
1,156,978

 

 
2,088,770

Advances from Federal Home Loan Bank
 
514,911

 
546,378

 

 
546,378

 

Subordinated debt
 
69,605

 
61,092

 
50,890

 
10,202

 

Accrued interest payable
 
3,293

 
3,293

 
3,293

 

 

 
 
December 31, 2019
Fair Value Measurements Using
(in thousands)
 
Carrying
Amount
 
Fair Value
 
Quoted Prices
In Active
Market for
Identical
Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Cash and cash equivalents
 
$
327,361

 
$
327,361

 
$
327,361

 
$

 
$

Securities held-to-maturity
 
61,878

 
62,560

 

 
62,560

 

Net loans
 
2,941,707

 
2,876,688

 

 

 
2,876,688

Accrued interest receivable
 
18,607

 
18,607

 
18,607

 

 

Federal Home Loan Bank of Indianapolis stock
 
25,650

 
25,650

 

 
25,650

 

Deposits
 
3,153,963

 
3,232,065

 
1,002,141

 

 
2,229,924

Advances from Federal Home Loan Bank
 
514,910

 
520,950

 

 
520,950

 

Subordinated debt
 
69,528

 
75,206

 
64,996

 
10,210

 

Accrued interest payable
 
3,767

 
3,767

 
3,767

 

 

v3.20.1
Basis of Presentation (Policies)
3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Recent Accounting Pronouncements
Recent Accounting Pronouncements

ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (June 2016)

The main objective of this update is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.

The amendments affect entities holding financial assets that are not accounted for at fair value through net income. The amendments affect loans, debt securities, off-balance-sheet credit exposures, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update affect an entity to varying degrees depending on the credit quality of the assets held by the entity, their duration, and how the entity applies current GAAP. There is diversity in practice in applying the incurred loss methodology, which means that before transition some entities may be more aligned under current GAAP than others to the new measure of expected credit losses. The following describes the main provisions of this update.

Assets Measured at Amortized Cost: The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The statements of income reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increase or decrease of credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances.

Available-for-Sale Debt Securities: Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. Available-for-sale accounting recognizes that value may be realized either through collection of contractual cash flows or through sale of the security. Therefore, the amendments limit the amount of the allowance for credit losses to the amount by which fair value is below amortized cost because the classification as available-for-sale is premised on an investment strategy that recognizes that the investment could be sold at fair value if cash collection would result in the realization of an amount less than fair value.

In May 2019, the FASB issued ASU 2019-05 - Financial Instruments - Credit Losses (Topic 326) - Targeted Transition Relief. This ASU allows an option for preparers to irrevocably elect the fair value option, on an instrument-by-instrument basis, for eligible financial assets measured at amortized cost basis upon adoption of the credit losses standard. This increases the comparability of financial statement information provided by institutions that otherwise would have reported similar financial instruments using different measurement methodologies, potentially decreasing costs for financial statement preparers while providing more useful information to investors and other users.

For public business entities that are SEC filers, the amendments in this update are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. All entities may early adopt the amendments in this update as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. In October 2019, the FASB voted to delay the effective date for smaller reporting companies to fiscal years beginning after December 15, 2022. An entity will apply the amendments in this update through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). A prospective transition approach is required for debt securities for which an OTTI had been recognized before the effective date. The effect of a prospective transition approach is to maintain the same amortized cost basis before and after the effective date of this update.

The Company does not expect to early adopt and is currently evaluating the impact of the amendments on the Company’s condensed consolidated financial statements. The Company currently cannot determine or reasonably quantify the impact of the adoption of the amendments due to the complexity and extensive changes. The Company intends to develop processes and procedures prior to the effective date to ensure it is fully compliant with the amendments at the adoption date. The Company has formed an implementation committee and has engaged a third-party consultant to assist in developing current expected credit losses (“CECL”) models using appropriate methodologies.

ASU 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (August 2018)

The amendments in this update modify the disclosure requirements on fair value measurements in ASC Topic 820. This ASU eliminates the requirements to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements. In addition, this ASU requires entities that calculate net asset value to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. This ASU also adds new requirements, which include the disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The amendments in this ASU are effective for public companies for fiscal years, and interim fiscal periods within those fiscal years, beginning after December 15, 2019. The Company adopted this guidance and it did not have a material impact on the condensed consolidated financial statements.

ASU 2019-04 - Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (April 2019)

The amendments in this ASU clarify or correct the guidance in ASC Topic 326, Topic 815 and Topic 825. With respect to Topic 326, ASU 2019-04 addresses a number of issues as it relates to the CECL standard including consideration of accrued interest, recoveries, variable-rate financial instruments, prepayments, extension and renewal options, among other things, in the measurement of expected credit losses. The amendments to Topic 326 have the same effective dates as ASU 2016-13 and the Company is currently evaluating the potential impact of these amendments on the condensed consolidated financial statements. With respect to Topic 815, ASU 2019-04 clarifies issues related to partial-term hedges, hedged debt securities, and transitioning from a quantitative method of assessing hedge effectiveness to a more simplified method. The amendments to Topic 815 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements. With respect to Topic 825, ASU 2019-04 addresses the scope of the guidance, the requirement for remeasurement under ASC Topic 820 when using the measurement alternative, certain disclosure requirements, and which equity securities must be remeasured at historical exchanges rates. The amendments to Topic 825 are effective for interim and annual reporting periods beginning after December 15, 2019 and are not expected to have a material impact on the condensed consolidated financial statements.

Coronavirus Aid, Relief and Economic Security Act (“CARES Act”)

In March 2020 in connection with the implementation of the CARES Act and related provisions, the Company elected the temporary relief in the CARES Act not to apply the guidance in ASC 310-40 on accounting for TDRs to loan modifications related to COVID-19. Section 4013 of the CARES Act further provides that loan modifications due to the impact of COVID-19 that would otherwise be classified as TDRs under GAAP will not be so classified. Modifications within the scope of this relief are in effect from the period beginning March 1, 2020 until the earlier of December 31, 2020 or 60 days after the date on which the national emergency related to the COVID-19 pandemic formally terminates.

v3.20.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
 
The Company uses derivative financial instruments to help manage exposure to interest rate risk and the effects that changes in interest rates may have on net income and the fair value of assets and liabilities. The Company enters into interest rate swap agreements as part of its asset/liability management strategy to help manage its interest rate risk position. Additionally, the Company enters into forward contracts for the future delivery of mortgage loans to third-party investors and enters into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. The forward contracts are entered into in order to economically hedge the effect of changes in interest rates resulting from the Company’s commitment to fund the loans.
 
The Company entered into various interest rate swap agreements designated and qualifying as accounting hedges during the reported periods. Designating an interest rate swap as an accounting hedge allows the Company to recognize gains and losses, less any ineffectiveness, in the condensed consolidated statements of income within the same period that the hedged item affects earnings. The Company includes the gain or loss on the hedged items in the same line item as the offsetting loss or gain on the related interest rate swaps. For derivative instruments that are designated and qualify as cash flow hedges, any gains or losses related to changes in fair value are recorded in accumulated other comprehensive loss, net of tax. The fair value of interest rate swaps with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while interest rate swaps with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The IRLCs and forward contracts are not designated as accounting hedges and are recorded at fair value with changes in fair value reflected in noninterest income on the condensed consolidated statements of income. The fair value of derivative instruments with a positive fair value are reported in accrued income and other assets in the condensed consolidated balance sheets, while derivative instruments with a negative fair value are reported in accrued expenses and other liabilities in the condensed consolidated balance sheets.

The following table presents amounts that were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for interest rate swap derivatives designated as fair value accounting hedges as of March 31, 2020 and December 31, 2019.  

(in thousands)
 
Carrying amount of the hedged asset
 
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets
Line item in the condensed consolidated balance sheets in which the hedged item is included
 
March 31, 2020
 
December 31, 2019
 
March 31, 2020
 
December 31, 2019
Loans
 
$
494,019

 
$
474,957

 
$
44,586

 
$
21,440

Securities available-for-sale (1)
 
152,551

 
151,538

 
6,790

 
2,802

(1) These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item
is the last layer expected to be remaining at the end of the hedging relationship. At both March 31, 2020 and December 31, 2019, the amounts of the designated hedged items were $88.2 million.

The following tables present a summary of interest rate swap derivatives designated as fair value accounting hedges of fixed-rate receivables used in the Company’s asset/liability management activities at March 31, 2020 and December 31, 2019, identified by the underlying interest rate-sensitive instruments.

(dollars in thousands)

 
March 31, 2020
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Instruments Associated With
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Loans
 
$
424,834

 
5.3
 
$
(44,872
)
 
3-month LIBOR
 
2.86
%
Securities available-for-sale
 
88,200

 
3.9
 
(6,793
)
 
3-month LIBOR
 
2.54
%
Total at March 31, 2020
 
$
513,034

 
5.0
 
$
(51,665
)
 
3-month LIBOR
 
2.80
%

(dollars in thousands)


December 31, 2019
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Instruments Associated With
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Loans
 
$
427,446

 
5.5
 
$
(21,551
)
 
3-month LIBOR
 
2.86
%
Securities available-for-sale
 
88,200

 
4.1
 
(2,806
)
 
3-month LIBOR
 
2.54
%
Total at December 31, 2019
 
$
515,646

 
5.3
 
$
(24,357
)
 
3-month LIBOR
 
2.80
%


The following tables present a summary of interest rate swap derivatives designated as cash flow accounting hedges of variable-rate liabilities used in the Company’s asset/liability management activities at March 31, 2020 and December 31, 2019.

(dollars in thousands)

 
March 31, 2020
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Cash Flow Hedges
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Interest rate swaps
 
$
110,000

 
6.8
 
$
(17,509
)
 
3-month LIBOR
 
2.88
%
Interest rate swaps
 
100,000

 
3.7
 
(9,378
)
 
1-month LIBOR
 
2.88
%

(dollars in thousands)


December 31, 2019
 
Notional
 
Weighted- Average Remaining Maturity
 
 
 
Weighted-Average Ratio
Cash Flow Hedges
 
Value
 
(years)
 
Fair Value
 
Receive
 
Pay
Interest rate swaps
 
$
110,000

 
7.1
 
$
(8,390
)
 
3-month LIBOR
 
2.88
%
Interest rate swaps
 
100,000

 
4.0
 
(5,040
)
 
1-month LIBOR
 
2.88
%


These derivative financial instruments were entered into for the purpose of managing the interest rate risk of certain assets and liabilities. The Company pledged $81.3 million and $42.3 million of cash collateral to counterparties as security for its obligations related to these interest rate swap transactions at March 31, 2020 and December 31, 2019, respectively. Collateral posted and received is dependent on the market valuation of the underlying hedges.

The following table presents the notional amount and fair value of interest rate swaps, IRLCs and forward contracts utilized by the Company at March 31, 2020 and December 31, 2019.

 
 
March 31, 2020
 
December 31, 2019
(in thousands)
 
Notional
Amount
 
Fair
Value
 
Notional
Amount
 
Fair
Value
Asset Derivatives
 
 

 
 

 
 

 
 

Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Interest rate swaps associated with loans
 
$

 
$

 
$

 
$

Interest rate swaps associated with securities available-for-sale
 

 

 

 

Derivatives not designated as hedging instruments
 
 

 
 

 
 

 
 

IRLCs
 
139,907

 
2,064

 
56,256

 
910

Total contracts
 
$
139,907

 
$
2,064

 
$
56,256

 
$
910

Liability Derivatives
 
 
 
 
 
 
 
 
Derivatives designated as hedging instruments
 
 
 
 
 
 
 
 
Interest rate swaps associated with loans
 
$
424,834

 
$
(44,872
)
 
$
427,446

 
$
(21,551
)
Interest rate swaps associated with securities available-for-sale
 
88,200

 
(6,793
)
 
88,200

 
(2,806
)
Interest rate swaps associated with liabilities
 
210,000

 
(26,887
)
 
210,000

 
(13,429
)
Derivatives not designated as hedging instruments
 
 
 
 
 
 
 
 
Forward contracts
 
106,750

 
(2,298
)
 
115,000

 
(153
)
Total contracts
 
$
829,784

 
$
(80,850
)
 
$
840,646

 
$
(37,939
)


The fair value of interest rate swaps was estimated using a discounted cash flow method that incorporates current market interest rates as of the balance sheet date. Fair values of IRLCs and forward contracts were estimated using changes in mortgage interest rates from the date the Company entered into the IRLC and the balance sheet date.

The following table presents the effects of the Company’s cash flow hedge relationships on the condensed consolidated statements of comprehensive income during the three months ended March 31, 2020 and 2019.

 
 
Amount of Loss Recognized in Other Comprehensive (Loss) Income in The Three Months Ended
(in thousands)
 
March 31, 2020
 
March 31, 2019
Interest rate swap agreements
 
$
(13,458
)
 
$
(3,572
)


The following table summarizes the periodic changes in the fair value of derivatives not designated as hedging instruments on the condensed consolidated statements of income for the three months ended March 31, 2020 and 2019.

 
 
Amount of Gain / (Loss) Recognized in the Three Months Ended
(in thousands)
 
March 31, 2020
 
March 31, 2019
Asset Derivatives
 
 

 
 

Derivatives not designated as hedging instruments
 
 

 
 

IRLCs
 
$
1,154

 
$
392

 
 
 
 
 
Liability Derivatives
 
 

 
 

Derivatives not designated as hedging instruments
 
 
 
 
Forward contracts
 
$
(2,145
)
 
$
(67
)

  
The following table presents the effects of the Company’s interest rate swap agreements on the condensed consolidated statements of income during the three months ended March 31, 2020 and 2019.

(in thousands)

Line item in the condensed consolidated statements of income
 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
Interest income
 
 
 
 
Loans
 
$
(1,224
)
 
$
21

Securities - taxable
 
(91
)
 
(7
)
Securities - non-taxable
 
(67
)
 
45

Total interest income
 
(1,382
)
 
59

Interest expense
 
 

 
 

Deposits
 
307

 
90

Other borrowed funds
 
322

 
34

Total interest expense
 
629

 
124

Net interest income
 
$
(2,011
)
 
$
(65
)
v3.20.1
Premises and Equipment (Tables)
3 Months Ended
Mar. 31, 2020
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
The following table summarizes premises and equipment at March 31, 2020 and December 31, 2019.
(in thousands)
 
March 31,
2020
 
December 31,
2019
Land
 
$
2,500

 
$
2,500

Right of use leased asset
 
1,450

 
1,602

Building and improvements
 
14,291

 
10,004

Furniture and equipment
 
10,258

 
9,689

Less: accumulated depreciation
 
(9,616
)
 
(9,165
)
Total
 
$
18,883

 
$
14,630

v3.20.1
Loans - Nonaccrual Loans (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable $ 2,826,650 $ 2,919,981
Commercial Portfolio Segment    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 2,287,460 2,286,517
Commercial Portfolio Segment | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 2,263,440 2,260,087
Commercial Portfolio Segment | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 14,520 15,186
Commercial Portfolio Segment | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 9,500 11,244
Commercial Portfolio Segment | Commercial and industrial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 95,227 96,420
Commercial Portfolio Segment | Commercial and industrial | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 91,028 89,818
Commercial Portfolio Segment | Commercial and industrial | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 3,301 3,973
Commercial Portfolio Segment | Commercial and industrial | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 898 2,629
Commercial Portfolio Segment | Owner-occupied commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 74,737 73,392
Commercial Portfolio Segment | Owner-occupied commercial real estate | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 74,142 71,068
Commercial Portfolio Segment | Owner-occupied commercial real estate | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 1,727
Commercial Portfolio Segment | Owner-occupied commercial real estate | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 595 597
Commercial Portfolio Segment | Investor commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 13,421 12,567
Commercial Portfolio Segment | Investor commercial real estate | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 13,421 12,567
Commercial Portfolio Segment | Investor commercial real estate | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Investor commercial real estate | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Construction    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 64,581 60,274
Commercial Portfolio Segment | Construction | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 64,581 60,274
Commercial Portfolio Segment | Construction | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Construction | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Single tenant lease financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 972,275 995,879
Commercial Portfolio Segment | Single tenant lease financing | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 959,161 983,448
Commercial Portfolio Segment | Single tenant lease financing | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 8,434 7,751
Commercial Portfolio Segment | Single tenant lease financing | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 4,680 4,680
Commercial Portfolio Segment | Public finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 627,678 687,094
Commercial Portfolio Segment | Public finance | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 627,678 687,094
Commercial Portfolio Segment | Public finance | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Public finance | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Healthcare finance    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 372,266 300,612
Commercial Portfolio Segment | Healthcare finance | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 371,203 300,612
Commercial Portfolio Segment | Healthcare finance | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 1,063 0
Commercial Portfolio Segment | Healthcare finance | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 0 0
Commercial Portfolio Segment | Small business lending    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 67,275 60,279
Commercial Portfolio Segment | Small business lending | Pass    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 62,226 55,206
Commercial Portfolio Segment | Small business lending | Special Mention    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable 1,722 1,735
Commercial Portfolio Segment | Small business lending | Substandard    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total Loans Receivable $ 3,327 $ 3,338
v3.20.1
Securities (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Available-for-sale Securities [Abstract]    
Amortized cost $ 608,567 $ 546,640
Gross Unrealized Gains 12,523 3,426
Gross Unrealized Losses (12,408) (9,214)
Fair Value 608,682 540,852
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]    
Held-to-maturity securities, amortized cost 66,331 61,878
Held-to-maturity securities, Gross Unrealized Gains 3,323 814
Held-to-maturity securities, Gross Unrealized Losses (186) (132)
Held-to-maturity, at fair value 69,468 62,560
U.S. Government-sponsored agencies    
Available-for-sale Securities [Abstract]    
Amortized cost 71,387 77,715
Gross Unrealized Gains 438 99
Gross Unrealized Losses (1,821) (1,942)
Fair Value 70,004 75,872
Municipal securities    
Available-for-sale Securities [Abstract]    
Amortized cost 94,981 97,447
Gross Unrealized Gains 4,049 1,706
Gross Unrealized Losses (4,211) (1,501)
Fair Value 94,819 97,652
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]    
Held-to-maturity securities, amortized cost 14,617 10,142
Held-to-maturity securities, Gross Unrealized Gains 1,061 226
Held-to-maturity securities, Gross Unrealized Losses 0 0
Held-to-maturity, at fair value 15,678 10,368
Agency mortgage-backed securities    
Available-for-sale Securities [Abstract]    
Amortized cost 279,458 264,142
Gross Unrealized Gains 6,901 1,304
Gross Unrealized Losses (3,727) (4,006)
Fair Value 282,632 261,440
Private label mortgage-backed securities    
Available-for-sale Securities [Abstract]    
Amortized cost 114,363 63,704
Gross Unrealized Gains 813 97
Gross Unrealized Losses (152) (188)
Fair Value 115,024 63,613
Asset-backed securities    
Available-for-sale Securities [Abstract]    
Amortized cost 5,000 5,000
Gross Unrealized Gains 0 0
Gross Unrealized Losses (287) (45)
Fair Value 4,713 4,955
Corporate securities    
Available-for-sale Securities [Abstract]    
Amortized cost 43,378 38,632
Gross Unrealized Gains 322 220
Gross Unrealized Losses (2,210) (1,532)
Fair Value 41,490 37,320
Debt Securities, Held-to-maturity, Fair Value to Amortized Cost [Abstract]    
Held-to-maturity securities, amortized cost 51,714 51,736
Held-to-maturity securities, Gross Unrealized Gains 2,262 588
Held-to-maturity securities, Gross Unrealized Losses (186) (132)
Held-to-maturity, at fair value $ 53,790 $ 52,192
v3.20.1
Securities Securities - Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]    
Gain realized in earnings $ 41 $ 0
Total reclassified amount before tax 41 $ 0
Tax expense 11  
Total reclassifications out of accumulated other comprehensive loss $ 30  
v3.20.1
Fair Value of Financial Instruments - Fair Value Hierarchy (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Total available-for-sale securities $ 608,682 $ 540,852
Servicing asset 2,415 2,481
Loans held-for-sale (mandatory pricing agreements) 52,394 56,097
Derivative, fair value (80,850) (37,939)
Loans held-for-sale (mandatory pricing agreements)    
Loans held-for-sale (mandatory pricing agreements) 52,394 56,097
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities 0 0
Servicing asset 0 0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Loans held-for-sale (mandatory pricing agreements)    
Loans held-for-sale (mandatory pricing agreements) 0 0
Significant Other Observable Inputs (Level 2)    
Total available-for-sale securities 608,682 540,852
Servicing asset 0 0
Significant Other Observable Inputs (Level 2) | Loans held-for-sale (mandatory pricing agreements)    
Loans held-for-sale (mandatory pricing agreements) 52,394 56,097
Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
Servicing asset 2,415 2,481
Significant Unobservable Inputs (Level 3) | Loans held-for-sale (mandatory pricing agreements)    
Loans held-for-sale (mandatory pricing agreements) 0 0
U.S. Government-sponsored agencies    
Total available-for-sale securities 70,004 75,872
U.S. Government-sponsored agencies | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities 0 0
U.S. Government-sponsored agencies | Significant Other Observable Inputs (Level 2)    
Total available-for-sale securities 70,004 75,872
U.S. Government-sponsored agencies | Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
Municipal securities    
Total available-for-sale securities 94,819 97,652
Municipal securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities 0 0
Municipal securities | Significant Other Observable Inputs (Level 2)    
Total available-for-sale securities 94,819 97,652
Municipal securities | Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
Agency mortgage-backed securities    
Total available-for-sale securities 282,632 261,440
Agency mortgage-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities 0 0
Agency mortgage-backed securities | Significant Other Observable Inputs (Level 2)    
Total available-for-sale securities   261,440
Agency mortgage-backed securities | Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
Private label mortgage-backed securities    
Total available-for-sale securities 115,024 63,613
Private label mortgage-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities   0
Private label mortgage-backed securities | Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
Asset-backed securities    
Total available-for-sale securities 4,713 4,955
Asset-backed securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities 0 0
Asset-backed securities | Significant Other Observable Inputs (Level 2)    
Total available-for-sale securities 4,713 4,955
Asset-backed securities | Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
Corporate securities    
Total available-for-sale securities 41,490 37,320
Corporate securities | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Total available-for-sale securities 0 0
Corporate securities | Significant Other Observable Inputs (Level 2)    
Total available-for-sale securities 41,490 37,320
Corporate securities | Significant Unobservable Inputs (Level 3)    
Total available-for-sale securities 0 0
IRLCs    
Derivative, fair value 2,064 910
IRLCs | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Derivative, fair value 0 0
IRLCs | Significant Other Observable Inputs (Level 2)    
Derivative, fair value 0 0
IRLCs | Significant Unobservable Inputs (Level 3)    
Derivative, fair value 2,064 910
Interest rate swaps | Interest rate swaps    
Derivative liability, fair value (78,552) (37,786)
Interest rate swaps | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swaps    
Derivative liability, fair value 0 0
Interest rate swaps | Significant Other Observable Inputs (Level 2) | Interest rate swaps    
Derivative liability, fair value (78,552) (37,786)
Interest rate swaps | Significant Unobservable Inputs (Level 3) | Interest rate swaps    
Derivative liability, fair value 0 0
Forward contracts | Forward contracts    
Derivative, fair value (2,298) (153)
Forward contracts | Quoted Prices in Active Markets for Identical Assets (Level 1) | Forward contracts    
Derivative, fair value (2,298) (153)
Forward contracts | Significant Other Observable Inputs (Level 2) | Forward contracts    
Derivative, fair value 0 0
Forward contracts | Significant Unobservable Inputs (Level 3) | Forward contracts    
Derivative, fair value $ 0 $ 0
v3.20.1
Benefit Plans - Activity (Details)
3 Months Ended
Mar. 31, 2020
$ / shares
shares
Restricted Stock Awards  
Awards/Units Outstanding (in shares)  
Balance at beginning of period | shares 0
Granted | shares 13,164
Vested | shares (3,336)
Vested | shares (1,638)
Balance at end of period | shares 8,190
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)  
Balance at beginning of period | $ / shares $ 0.00
Granted | $ / shares 27.56
Vested | $ / shares 27.56
Vested | $ / shares 27.56
Balance at end of period | $ / shares $ 27.56
Deferred Stock Units  
Awards/Units Outstanding (in shares)  
Balance at beginning of period | shares 0
Granted | shares 3
Vested | shares (3)
Vested | shares 0
Balance at end of period | shares 0
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)  
Balance at beginning of period | $ / shares $ 0.00
Granted | $ / shares 23.48
Vested | $ / shares 23.48
Vested | $ / shares 0.00
Balance at end of period | $ / shares $ 0.00
Restricted Stock Units  
Awards/Units Outstanding (in shares)  
Balance at beginning of period | shares 107,244
Granted | shares 66,756
Vested | shares (48,499)
Vested | shares 0
Balance at end of period | shares 125,501
Weighted-Average Grant Date Fair Value Per Share (in dollars per share)  
Balance at beginning of period | $ / shares $ 29.03
Granted | $ / shares 27.56
Vested | $ / shares 30.34
Vested | $ / shares 0.00
Balance at end of period | $ / shares $ 27.74
v3.20.1
Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Cash and cash equivalents, Carrying Amount $ 351,268 $ 327,361
Debt Securities, Held-to-maturity 66,331 61,878
Held-to-maturity, at fair value 69,468 62,560
Loans held for sale, Fair Value 52,394 56,097
Loans receivable 2,869,236 2,941,707
Accrued interest receivable, Carrying Amount 16,960 18,607
FHLB stock, Carrying Amount 25,650 25,650
Deposits, Carrying Amount 3,178,506 3,153,963
Accrued interest payable, Carrying Amount 3,293 3,767
Reported Value Measurement    
Cash and cash equivalents, Carrying Amount 351,268 327,361
Debt Securities, Held-to-maturity 66,331 61,878
Loans receivable 2,869,236 2,941,707
Accrued interest receivable, Carrying Amount 16,960 18,607
FHLB stock, Carrying Amount 25,650 25,650
Deposits, Carrying Amount 3,178,506 3,153,963
Advances from Federal Home Loan Bank, Fair Value 514,911 514,910
Subordinated debt, Carrying Value 3,293 69,528
Accrued interest payable, Carrying Amount 69,605 3,767
Fair Value    
Cash and cash equivalents, Fair Value 351,268 327,361
Held-to-maturity, at fair value 69,468 62,560
Loans receivable, fair value 2,842,894 2,876,688
Accrued interest receivable, Fair Value 16,960 18,607
FHLB stock, Fair Value 25,650 25,650
Deposits, Fair Value 3,245,748 3,232,065
Advances from Federal Home Loan Bank, Fair Value 546,378 520,950
Subordinated debt, Fair Value 61,092 75,206
Accrued interest payable, Fair Value 3,293 3,767
Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Cash and cash equivalents, Fair Value 351,268 327,361
Held-to-maturity, at fair value 0 0
Loans receivable, fair value 0 0
Accrued interest receivable, Fair Value 16,960 18,607
FHLB stock, Fair Value 0 0
Deposits, Fair Value 1,156,978 1,002,141
Advances from Federal Home Loan Bank, Fair Value 0 0
Subordinated debt, Fair Value 50,890 64,996
Accrued interest payable, Fair Value 3,293 3,767
Fair Value | Significant Other Observable Inputs (Level 2)    
Cash and cash equivalents, Fair Value 0 0
Held-to-maturity, at fair value 69,468 62,560
Loans receivable, fair value 0 0
Accrued interest receivable, Fair Value 0 0
FHLB stock, Fair Value 25,650 25,650
Deposits, Fair Value 0 0
Advances from Federal Home Loan Bank, Fair Value 546,378 520,950
Subordinated debt, Fair Value 10,202 10,210
Accrued interest payable, Fair Value 0 0
Fair Value | Significant Unobservable Inputs (Level 3)    
Cash and cash equivalents, Fair Value 0 0
Held-to-maturity, at fair value 0 0
Loans receivable, fair value 2,842,894 2,876,688
Accrued interest receivable, Fair Value 0 0
FHLB stock, Fair Value 0 0
Deposits, Fair Value 2,088,770 2,229,924
Advances from Federal Home Loan Bank, Fair Value 0 0
Subordinated debt, Fair Value 0 0
Accrued interest payable, Fair Value $ 0 $ 0
v3.20.1
Derivative Financial Instruments - Notional Amounts and Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Asset Derivatives    
Notional Amount $ 139,907 $ 56,256
Fair Value 2,064 910
Derivative Liability [Abstract]    
Notional Amount 829,784 840,646
Derivative, fair value (80,850) (37,939)
Interest Rate Lock Commitments    
Derivative Liability [Abstract]    
Derivative, fair value 2,064 910
Derivatives designated as hedging instruments | Interest rate swaps    
Derivative Liability [Abstract]    
Notional Amount 513,034 515,646
Derivatives not designated as hedging instruments | Interest Rate Lock Commitments    
Asset Derivatives    
Notional Amount 139,907 56,256
Fair Value 2,064 910
Derivatives not designated as hedging instruments | Forward contracts    
Derivative Liability [Abstract]    
Notional Amount 106,750 115,000
Fair Value (2,298) (153)
Loans | Derivatives designated as hedging instruments | Interest rate swaps    
Asset Derivatives    
Notional Amount 0 0
Fair Value 0 0
Derivative Liability [Abstract]    
Notional Amount 424,834 427,446
Loans | Derivatives designated as hedging instruments | Forward contracts    
Derivative Liability [Abstract]    
Notional Amount 424,834 427,446
Fair Value (44,872) (21,551)
Securities available-for-sale | Derivatives designated as hedging instruments | Interest rate swaps    
Asset Derivatives    
Notional Amount 0 0
Fair Value 0 0
Derivative Liability [Abstract]    
Notional Amount 88,200 88,200
Securities available-for-sale | Derivatives designated as hedging instruments | Forward contracts    
Derivative Liability [Abstract]    
Notional Amount 88,200 88,200
Fair Value (6,793) (2,806)
Liability | Derivatives designated as hedging instruments | Forward contracts    
Derivative Liability [Abstract]    
Notional Amount 210,000 210,000
Fair Value $ (26,887) $ (13,429)
v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Assets    
Cash and due from banks $ 5,726 $ 5,061
Interest-bearing deposits 345,542 322,300
Total cash and cash equivalents 351,268 327,361
Securities available-for-sale, at fair value (amortized cost of $608,567 and $546,640 in 2020 and 2019, respectively) 608,682 540,852
Securities held-to-maturity, at amortized cost (fair value of $69,468 and $62,560 in 2020 and 2019, respectively) 66,331 61,878
Loans held-for-sale (includes $52,394 and $56,097 at fair value in 2020 and 2019, respectively) 52,394 56,097
Loans 2,892,093 2,963,547
Allowance for loan losses (22,857) (21,840)
Net loans 2,869,236 2,941,707
Accrued interest receivable 16,960 18,607
Federal Home Loan Bank of Indianapolis stock 25,650 25,650
Cash surrender value of bank-owned life insurance 37,238 37,002
Premises and equipment, net 18,883 14,630
Goodwill 4,687 4,687
Servicing asset, at fair value 2,415 2,481
Other real estate owned 2,065 2,065
Accrued income and other assets 112,337 67,066
Total assets 4,168,146 4,100,083
Liabilities and Shareholders’ Equity    
Noninterest-bearing deposits 70,562 57,115
Interest-bearing deposits 3,107,944 3,096,848
Total deposits 3,178,506 3,153,963
Advances from Federal Home Loan Bank 514,911 514,910
Subordinated debt, net of unamortized debt issuance costs of $2,395 and $2,472 in 2020 and 2019, respectively 69,605 69,528
Accrued interest payable 3,293 3,767
Accrued expenses and other liabilities 96,704 53,002
Total liabilities 3,863,019 3,795,170
Commitments and Contingencies
Shareholders’ Equity    
Preferred stock, no par value; 4,913,779 shares authorized; issued and outstanding - none 0 0
Retained earnings 105,100 99,681
Accumulated other comprehensive loss (19,866) (14,191)
Total shareholders’ equity 305,127 304,913
Total liabilities and shareholders’ equity 4,168,146 4,100,083
Voting Common Stock    
Shareholders’ Equity    
Common stock 219,893 219,423
Nonvoting Common Stock    
Shareholders’ Equity    
Common stock $ 0 $ 0
v3.20.1
Goodwill (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill $ 4,687 $ 4,687
v3.20.1
Premises and Equipment - Narrative (Details) - Land Acquisition - SPF15, Inc.
$ in Millions
12 Months Ended
Oct. 25, 2019
USD ($)
Dec. 31, 2018
USD ($)
a
parcel
Property, Plant and Equipment [Line Items]    
Area of land   3.3
Payments to acquire land | $   $ 10.2
Number of additional parcels of land transferred | parcel   2
Proceeds from purchase price reimbursement | $ $ 11.1  
Fishers Town Hall Building Corporation    
Property, Plant and Equipment [Line Items]    
Area of land   0.75
Third Parties    
Property, Plant and Equipment [Line Items]    
Area of land   1.65
v3.20.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Voting and Nonvoting Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Balance, beginning of period at Dec. 31, 2018 $ 288,735 $ 227,587 $ 77,689 $ (16,541)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,696   5,696  
Other comprehensive income (loss) 2,373     2,373
Dividends declared (618)   (618)  
Recognition of the fair value of share-based compensation 478 478    
Repurchase of common stock (1,746) (1,746)    
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units 10 10    
Common stock redeemed for the net settlement of share-based awards (94) (94)    
Balance, end of period at Mar. 31, 2019 294,013 226,235 81,946 (14,168)
Balance, beginning of period at Dec. 31, 2019 304,913 219,423 99,681 (14,191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,019   6,019  
Other comprehensive income (loss) (5,675)     (5,675)
Dividends declared (600)   (600)  
Recognition of the fair value of share-based compensation 555 555    
Deferred stock rights and restricted stock units issued in lieu of cash dividends payable on outstanding deferred stock rights and restricted stock units 8 8    
Common stock redeemed for the net settlement of share-based awards (93) (93)    
Balance, end of period at Mar. 31, 2020 $ 305,127 $ 219,893 $ 105,100 $ (19,866)
v3.20.1
Subordinated Debt (Tables)
3 Months Ended
Mar. 31, 2020
Debt Disclosure [Abstract]  
Schedule of Subordinated Borrowing
 
March 31, 2020
 
December 31, 2019
(in thousands)
Principal
 
Unamortized Debt Issuance Costs
 
Principal
 
Unamortized Debt Issuance Costs
2025 Note
10,000

 
(132
)
 
10,000

 
(138
)
2026 Notes
25,000

 
(808
)
 
25,000

 
(839
)
2029 Notes
37,000

 
(1,455
)
 
37,000

 
(1,495
)
Total
$
72,000

 
$
(2,395
)
 
$
72,000

 
$
(2,472
)
v3.20.1
Mortgage Banking Activities (Tables)
3 Months Ended
Mar. 31, 2020
Mortgage Banking [Abstract]  
Schedule of Participating Mortgage Loans
The following table presents the components of income from mortgage banking activities for the three months ended March 31, 2020 and 2019.
 
Three Months Ended March 31,
(in thousands)
2020
 
2019
Gain on loans sold
$
4,343

 
$
1,473

Gain (loss) resulting from the change in fair value of loans held-for-sale
316

 
(182
)
(Loss) gain resulting from the change in fair value of derivatives
(991
)
 
326

Net revenue from mortgage banking activities
$
3,668

 
$
1,617

v3.20.1
Label Element Value
Accounting Standards Update 2017-08 [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ (821,000)
Accounting Standards Update 2017-08 [Member] | Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ (821,000)
v3.20.1
Commitments and Credit Risk
3 Months Ended
Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Credit Risk
Commitments and Credit Risk
 
 
In the normal course of business, the Company makes various commitments to extend credit which are not reflected in the accompanying consolidated financial statements. At March 31, 2020 and December 31, 2019, the Company had outstanding loan commitments totaling approximately $295.9 million and $254.4 million, respectively.

In addition, the Company is a limited partner in a Small Business Investment Company fund (the “SBIC Fund”). As of March 31, 2020, the Company has committed to contribute up to $1.7 million of capital to the SBIC Fund.

Capital Commitments

Capital expenditures contracted to at the balance sheet date but not yet recognized in the financial statements are associated with the construction of premises intended to house our future corporate headquarters. The Company has entered into construction-related contracts in the amount of $65.1 million. As of March 31, 2020, $58.9 million of such contract commitments had not yet been incurred. These commitments are due within two years.
v3.20.1
Goodwill
3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill
Goodwill        
 
As of March 31, 2020 and December 31, 2019, the carrying amount of goodwill was $4.7 million. There have been no changes in the carrying amount of goodwill for the three months ended March 31, 2020.  Goodwill is tested for impairment on an annual basis as of August 31, or whenever events or changes in circumstances indicate the carrying amount of goodwill exceeds its implied fair value. The annual test indicated no impairment existed as of August 31, 2019.

Due to the impact of COVID-19 on the economy and the financial markets, the Company evaluated goodwill and determined no triggering event has occurred since the last goodwill impairment test was conducted.
v3.20.1
Securities
3 Months Ended
Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
Securities
Securities
 
The following tables summarize securities available-for-sale and securities held-to-maturity as of March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
71,387

 
$
438

 
$
(1,821
)
 
$
70,004

Municipal securities
 
94,981

 
4,049

 
(4,211
)
 
94,819

Agency mortgage-backed securities
 
279,458

 
6,901

 
(3,727
)
 
282,632

Private label mortgage-backed securities
 
114,363

 
813

 
(152
)
 
115,024

Asset-backed securities
 
5,000

 

 
(287
)
 
4,713

Corporate securities
 
43,378

 
322

 
(2,210
)
 
41,490

Total available-for-sale
 
$
608,567

 
$
12,523

 
$
(12,408
)
 
$
608,682


 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
14,617

 
$
1,061

 
$

 
$
15,678

Corporate securities
 
51,714

 
2,262

 
(186
)
 
53,790

Total held-to-maturity
 
$
66,331

 
$
3,323

 
$
(186
)
 
$
69,468

 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
77,715

 
$
99

 
$
(1,942
)
 
$
75,872

Municipal securities
 
97,447

 
1,706

 
(1,501
)
 
97,652

Agency mortgage-backed securities
 
264,142

 
1,304

 
(4,006
)
 
261,440

Private label mortgage-backed securities
 
63,704

 
97

 
(188
)
 
63,613

Asset-backed securities
 
5,000

 

 
(45
)
 
4,955

Corporate securities
 
38,632

 
220

 
(1,532
)
 
37,320

Total available-for-sale
 
$
546,640

 
$
3,426

 
$
(9,214
)
 
$
540,852


 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
10,142

 
$
226

 
$

 
$
10,368

Corporate securities
 
51,736

 
588

 
(132
)
 
52,192

Total held-to-maturity
 
$
61,878

 
$
814

 
$
(132
)
 
$
62,560



The Company elected to transfer ten available-for-sale (“AFS”) securities with an aggregate fair value of $4.5 million to a classification of held-to-maturity (“HTM”) on March 1, 2020. The net unrealized holding gain of $0.1 million, net of tax, as the date of the transfer was retained in accumulated other comprehensive loss, with the associated pretax amount retained in the carrying value of the HTM securities. Such amounts will be amortized to interest income over the remaining life of the securities. The fair value of the transferred AFS securities became the book value of the HTM securities as of March 1, 2020, with no unrealized gain or loss at that date.

The carrying value of securities at March 31, 2020 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
 
 
Available-for-Sale
(in thousands)
 
Amortized
Cost
 
Fair
Value
Within one year
 
$
15

 
$
15

One to five years
 
19,032

 
15,068

Five to ten years
 
81,662

 
80,465

After ten years
 
109,037

 
110,765

 
 
209,746

 
206,313

Agency mortgage-backed securities
 
279,458

 
282,632

Private label mortgage-backed securities
 
114,363

 
115,024

Asset-backed securities
 
5,000

 
4,713

Total
 
$
608,567

 
$
608,682


 
 
Held-to-Maturity
(in thousands)
 
Amortized
Cost
 
Fair
Value
One to five years
 
$
1,505

 
$
1,584

Five to ten years
 
52,301

 
54,610

After ten years
 
12,525

 
13,274

Total
 
$
66,331

 
$
69,468



There were less than $0.1 million gross gains resulting from sales of available securities during the three months ended March 31, 2020 and no gross gains or losses resulting from sales of available-for-sale securities during the three months ended March 31, 2019.

Certain investments in debt securities are reported in the condensed consolidated financial statements at an amount less than their historical cost. The total fair value of these investments at March 31, 2020 and December 31, 2019 was $205.1 million and $317.5 million, which was approximately 30% and 53%, respectively, of the Company’s available-for-sale and held-to-maturity securities portfolios. These declines resulted primarily from fluctuations in market interest rates after purchase. Management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced, with the resulting loss recognized in net income in the period the other-than-temporary impairment (“OTTI”) is identified.

U. S. Government-Sponsored Agencies, Municipal Securities and Corporate Securities

The unrealized losses on the Company’s investments in securities issued by U.S. Government-sponsored agencies, municipal organizations and corporate entities were caused primarily by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost bases of the investments. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2020.
 
Agency Mortgage-Backed, Private Label Mortgage-Backed and Asset-Backed Securities
 
The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost bases over the term of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2020.

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities available-for-sale
 
 

 
 

 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
3,274

 
$
(96
)
 
$
57,775

 
$
(1,725
)
 
$
61,049

 
$
(1,821
)
Municipal securities
 
61,974

 
(4,211
)
 

 

 
61,974

 
(4,211
)
Agency mortgage-backed securities
 
18,798

 
(317
)
 
13,516

 
(3,410
)
 
32,314

 
(3,727
)
Private label mortgage-backed securities
 
10,201

 
(122
)
 
2,639

 
(30
)
 
12,840

 
(152
)
Asset-backed securities
 

 

 
4,713

 
(287
)
 
4,713

 
(287
)
Corporate securities
 
9,274

 
(286
)
 
20,076

 
(1,924
)
 
29,350

 
(2,210
)
Total
 
$
103,521

 
$
(5,032
)
 
$
98,719

 
$
(7,376
)
 
$
202,240

 
$
(12,408
)
 
 
March 31, 2020
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities held-to-maturity
 
 

 
 

 
 

 
 

 
 

 
 

Corporate securities
 
$
2,814

 
$
(186
)
 
$

 
$

 
$
2,814

 
$
(186
)
Total
 
$
2,814

 
$
(186
)
 
$

 
$

 
$
2,814

 
$
(186
)

 
 
 
December 31, 2019
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities available-for-sale
 
 

 
 

 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
4,820

 
$
(61
)
 
$
62,182

 
$
(1,881
)
 
$
67,002

 
$
(1,942
)
Municipal securities
 
1,279

 
(1,501
)
 

 

 
1,279

 
(1,501
)
Agency mortgage-backed securities
 
91,159

 
(829
)
 
83,212

 
(3,177
)
 
174,371

 
(4,006
)
Private label mortgage-backed securities
 
30,077

 
(180
)
 
2,884

 
(8
)
 
32,961

 
(188
)
Asset-backed securities
 

 

 
4,955

 
(45
)
 
4,955

 
(45
)
Corporate securities
 

 

 
22,985

 
(1,532
)
 
22,985

 
(1,532
)
Total
 
$
127,335

 
$
(2,571
)
 
$
176,218

 
$
(6,643
)
 
$
303,553

 
$
(9,214
)

 
 
December 31, 2019
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities held-to-maturity
 
 

 
 

 
 

 
 

 
 

 
 

Corporate securities
 
13,977

 
(132
)
 

 

 
13,977

 
(132
)
Total
 
$
13,977

 
$
(132
)
 
$

 
$

 
$
13,977

 
$
(132
)


There were no amounts reclassified from accumulated other comprehensive loss to the condensed consolidated statements of income during the three months ended March 31, 2019. Amounts reclassified from accumulated other comprehensive loss and the affected line items in the condensed consolidated statements of income during the three months ended March 31, 2020 were as follows:

(in thousands)



Details About Accumulated Other Comprehensive Loss Components
 
 
 
Affected Line Item in the
Statements of Income
 
Three Months Ended March 31, 2020
 
Realized gains on securities available-for-sale
 
 

 
 
Gain realized in earnings
 
$
41

 
Gain on sale of securities
Total reclassified amount before tax
 
41

 
Income Before Income Taxes
Tax expense
 
11

 
Income Tax Provision
Total reclassifications out of accumulated other comprehensive loss
 
$
30

 
Net Income
v3.20.1
Securities (Tables)
3 Months Ended
Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
Schedule of Available-for-sale Securities Reconciliation
The following tables summarize securities available-for-sale and securities held-to-maturity as of March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
71,387

 
$
438

 
$
(1,821
)
 
$
70,004

Municipal securities
 
94,981

 
4,049

 
(4,211
)
 
94,819

Agency mortgage-backed securities
 
279,458

 
6,901

 
(3,727
)
 
282,632

Private label mortgage-backed securities
 
114,363

 
813

 
(152
)
 
115,024

Asset-backed securities
 
5,000

 

 
(287
)
 
4,713

Corporate securities
 
43,378

 
322

 
(2,210
)
 
41,490

Total available-for-sale
 
$
608,567

 
$
12,523

 
$
(12,408
)
 
$
608,682

Schedule Of Held-To-Maturity Securities Reconciliation
 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
10,142

 
$
226

 
$

 
$
10,368

Corporate securities
 
51,736

 
588

 
(132
)
 
52,192

Total held-to-maturity
 
$
61,878

 
$
814

 
$
(132
)
 
$
62,560

 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
14,617

 
$
1,061

 
$

 
$
15,678

Corporate securities
 
51,714

 
2,262

 
(186
)
 
53,790

Total held-to-maturity
 
$
66,331

 
$
3,323

 
$
(186
)
 
$
69,468

 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
77,715

 
$
99

 
$
(1,942
)
 
$
75,872

Municipal securities
 
97,447

 
1,706

 
(1,501
)
 
97,652

Agency mortgage-backed securities
 
264,142

 
1,304

 
(4,006
)
 
261,440

Private label mortgage-backed securities
 
63,704

 
97

 
(188
)
 
63,613

Asset-backed securities
 
5,000

 

 
(45
)
 
4,955

Corporate securities
 
38,632

 
220

 
(1,532
)
 
37,320

Total available-for-sale
 
$
546,640

 
$
3,426

 
$
(9,214
)
 
$
540,852


Schedule of Classification of Available for Sale Securities Investment
The following tables summarize securities available-for-sale and securities held-to-maturity as of March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
71,387

 
$
438

 
$
(1,821
)
 
$
70,004

Municipal securities
 
94,981

 
4,049

 
(4,211
)
 
94,819

Agency mortgage-backed securities
 
279,458

 
6,901

 
(3,727
)
 
282,632

Private label mortgage-backed securities
 
114,363

 
813

 
(152
)
 
115,024

Asset-backed securities
 
5,000

 

 
(287
)
 
4,713

Corporate securities
 
43,378

 
322

 
(2,210
)
 
41,490

Total available-for-sale
 
$
608,567

 
$
12,523

 
$
(12,408
)
 
$
608,682


 
 
March 31, 2020
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities held-to-maturity
 
 

 
 

 
 

 
 

Municipal securities
 
$
14,617

 
$
1,061

 
$

 
$
15,678

Corporate securities
 
51,714

 
2,262

 
(186
)
 
53,790

Total held-to-maturity
 
$
66,331

 
$
3,323

 
$
(186
)
 
$
69,468

 
 
December 31, 2019
 
 
Amortized
 
Gross Unrealized
 
Fair
(in thousands)
 
Cost
 
Gains
 
Losses
 
Value
Securities available-for-sale
 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
77,715

 
$
99

 
$
(1,942
)
 
$
75,872

Municipal securities
 
97,447

 
1,706

 
(1,501
)
 
97,652

Agency mortgage-backed securities
 
264,142

 
1,304

 
(4,006
)
 
261,440

Private label mortgage-backed securities
 
63,704

 
97

 
(188
)
 
63,613

Asset-backed securities
 
5,000

 

 
(45
)
 
4,955

Corporate securities
 
38,632

 
220

 
(1,532
)
 
37,320

Total available-for-sale
 
$
546,640

 
$
3,426

 
$
(9,214
)
 
$
540,852

Available-for-sale Securities
The carrying value of securities at March 31, 2020 is shown below by their contractual maturity date. Actual maturities will differ because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
 
 
Available-for-Sale
(in thousands)
 
Amortized
Cost
 
Fair
Value
Within one year
 
$
15

 
$
15

One to five years
 
19,032

 
15,068

Five to ten years
 
81,662

 
80,465

After ten years
 
109,037

 
110,765

 
 
209,746

 
206,313

Agency mortgage-backed securities
 
279,458

 
282,632

Private label mortgage-backed securities
 
114,363

 
115,024

Asset-backed securities
 
5,000

 
4,713

Total
 
$
608,567

 
$
608,682

Held-to-maturity Securities
 
 
Held-to-Maturity
(in thousands)
 
Amortized
Cost
 
Fair
Value
One to five years
 
$
1,505

 
$
1,584

Five to ten years
 
52,301

 
54,610

After ten years
 
12,525

 
13,274

Total
 
$
66,331

 
$
69,468

Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
The unrealized losses on the Company’s investments in agency mortgage-backed, private label mortgage-backed and asset-backed securities were caused primarily by interest rate changes. The Company expects to recover the amortized cost bases over the term of the securities. Because the Company does not intend to sell the investments and it is not likely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be upon maturity, the Company does not consider those investments to be other-than-temporarily impaired at March 31, 2020.

The following tables show the securities portfolio’s gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position at March 31, 2020 and December 31, 2019.
 
 
March 31, 2020
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities available-for-sale
 
 

 
 

 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
3,274

 
$
(96
)
 
$
57,775

 
$
(1,725
)
 
$
61,049

 
$
(1,821
)
Municipal securities
 
61,974

 
(4,211
)
 

 

 
61,974

 
(4,211
)
Agency mortgage-backed securities
 
18,798

 
(317
)
 
13,516

 
(3,410
)
 
32,314

 
(3,727
)
Private label mortgage-backed securities
 
10,201

 
(122
)
 
2,639

 
(30
)
 
12,840

 
(152
)
Asset-backed securities
 

 

 
4,713

 
(287
)
 
4,713

 
(287
)
Corporate securities
 
9,274

 
(286
)
 
20,076

 
(1,924
)
 
29,350

 
(2,210
)
Total
 
$
103,521

 
$
(5,032
)
 
$
98,719

 
$
(7,376
)
 
$
202,240

 
$
(12,408
)
 
 
March 31, 2020
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities held-to-maturity
 
 

 
 

 
 

 
 

 
 

 
 

Corporate securities
 
$
2,814

 
$
(186
)
 
$

 
$

 
$
2,814

 
$
(186
)
Total
 
$
2,814

 
$
(186
)
 
$

 
$

 
$
2,814

 
$
(186
)

 
 
 
December 31, 2019
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities available-for-sale
 
 

 
 

 
 

 
 

 
 

 
 

U.S. Government-sponsored agencies
 
$
4,820

 
$
(61
)
 
$
62,182

 
$
(1,881
)
 
$
67,002

 
$
(1,942
)
Municipal securities
 
1,279

 
(1,501
)
 

 

 
1,279

 
(1,501
)
Agency mortgage-backed securities
 
91,159

 
(829
)
 
83,212

 
(3,177
)
 
174,371

 
(4,006
)
Private label mortgage-backed securities
 
30,077

 
(180
)
 
2,884

 
(8
)
 
32,961

 
(188
)
Asset-backed securities
 

 

 
4,955

 
(45
)
 
4,955

 
(45
)
Corporate securities
 

 

 
22,985

 
(1,532
)
 
22,985

 
(1,532
)
Total
 
$
127,335

 
$
(2,571
)
 
$
176,218

 
$
(6,643
)
 
$
303,553

 
$
(9,214
)
Held to Maturity, Continuous Unrealized Loss Position, Fair Value
 
 
December 31, 2019
 
 
Less Than 12 Months
 
12 Months or Longer
 
Total
(in thousands)
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Securities held-to-maturity
 
 

 
 

 
 

 
 

 
 

 
 

Corporate securities
 
13,977

 
(132
)
 

 

 
13,977

 
(132
)
Total
 
$
13,977

 
$
(132
)
 
$

 
$

 
$
13,977

 
$
(132
)
Schedule of Accumulated Other Comprehensive Income (Loss)
Amounts reclassified from accumulated other comprehensive loss and the affected line items in the condensed consolidated statements of income during the three months ended March 31, 2020 were as follows:

(in thousands)



Details About Accumulated Other Comprehensive Loss Components
 
 
 
Affected Line Item in the
Statements of Income
 
Three Months Ended March 31, 2020
 
Realized gains on securities available-for-sale
 
 

 
 
Gain realized in earnings
 
$
41

 
Gain on sale of securities
Total reclassified amount before tax
 
41

 
Income Before Income Taxes
Tax expense
 
11

 
Income Tax Provision
Total reclassifications out of accumulated other comprehensive loss
 
$
30

 
Net Income

The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below.
(in thousands)
 
Available-For-Sale Securities
 
Cash Flow Hedges
 
Total
Balance, January 1, 2020
 
$
(4,388
)
 
$
(9,803
)
 
$
(14,191
)
Net change in unrealized gain (loss)
 
6,299

 
(13,458
)
 
(7,159
)
Reclassification of gain realized and included in earnings
 
(41
)
 

 
(41
)
Accumulated other comprehensive income (loss) before income tax
 
1,870

 
(23,261
)
 
(21,391
)
Income tax provision (benefit)
 
2,109

 
(3,634
)
 
(1,525
)
Balance, March 31, 2020
 
$
(239
)
 
$
(19,627
)
 
$
(19,866
)
 
 
 
 
 
 
 
Balance, January 1, 2019
 
$
(13,360
)
 
$
(3,181
)
 
$
(16,541
)
Net change in unrealized gain (loss)
 
6,910

 
(3,572
)
 
3,338

Accumulated other comprehensive loss before income tax
 
(6,450
)
 
(6,753
)
 
(13,203
)
Income tax provision (benefit)
 
1,930

 
(965
)
 
965

Balance, March 31, 2019
 
$
(8,380
)
 
$
(5,788
)
 
$
(14,168
)
v3.20.1
Accumulated Other Comprehensive income
3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
Accumulated Other Comprehensive income
Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below.
(in thousands)
 
Available-For-Sale Securities
 
Cash Flow Hedges
 
Total
Balance, January 1, 2020
 
$
(4,388
)
 
$
(9,803
)
 
$
(14,191
)
Net change in unrealized gain (loss)
 
6,299

 
(13,458
)
 
(7,159
)
Reclassification of gain realized and included in earnings
 
(41
)
 

 
(41
)
Accumulated other comprehensive income (loss) before income tax
 
1,870

 
(23,261
)
 
(21,391
)
Income tax provision (benefit)
 
2,109

 
(3,634
)
 
(1,525
)
Balance, March 31, 2020
 
$
(239
)
 
$
(19,627
)
 
$
(19,866
)
 
 
 
 
 
 
 
Balance, January 1, 2019
 
$
(13,360
)
 
$
(3,181
)
 
$
(16,541
)
Net change in unrealized gain (loss)
 
6,910

 
(3,572
)
 
3,338

Accumulated other comprehensive loss before income tax
 
(6,450
)
 
(6,753
)
 
(13,203
)
Income tax provision (benefit)
 
1,930

 
(965
)
 
965

Balance, March 31, 2019
 
$
(8,380
)
 
$
(5,788
)
 
$
(14,168
)
v3.20.1
Fair Value of Financial Instruments - Quantative Information About Unobservable Inputs (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Impaired loans $ 4,883 $ 4,887
Impaired loans 2,065 2,065
Servicing asset 2,415 2,481
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Servicing asset 0 0
Significant Other Observable Inputs (Level 2)    
Servicing asset 0 0
Significant Unobservable Inputs (Level 3)    
Servicing asset 2,415 2,481
Other Real Estate Owned | Significant Unobservable Inputs (Level 3)    
Impaired loans   $ 3,019
Other securities Valuation Technique   Fair value of collateral
Other securities Unobservable Inputs   Discount for type of property and current market conditions
IRLCs | Significant Unobservable Inputs (Level 3)    
IRLCs Fair Value $ 2,064 $ 910
Other securities Valuation Technique Discounted cash flow Discounted cash flow
Other securities Unobservable Inputs Loan closing rates Loan closing rates
Servicing asset | Significant Unobservable Inputs (Level 3)    
Other securities Valuation Technique Discounted cash flow Discounted cash flow
Other securities Unobservable Inputs Prepayment speeds Prepayment speeds
Servicing asset $ 2,415 $ 2,481
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3)    
Other real estate owned, discount rate   10.00%
Discount for type of property and current market conditions | Fair value of collateral | Impaired Loans | Significant Unobservable Inputs (Level 3) | Weighted-Average Range    
Other real estate owned, discount rate   10.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Minimum    
IRLC - Loan closing rates 36.00% 50.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Maximum    
IRLC - Loan closing rates 100.00% 100.00%
Loan closing rates | Discounted cash flow | IRLCs | Significant Unobservable Inputs (Level 3) | Weighted-Average Range    
IRLC - Loan closing rates 56.00% 84.00%
Prepayment speeds | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Minimum    
Servicing asset, discount rate 0.00% 0.00%
Prepayment speeds | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Maximum    
Servicing asset, discount rate 25.00% 25.00%
Prepayment speeds | Discounted cash flow | Servicing asset | Significant Unobservable Inputs (Level 3) | Weighted-Average Range    
Servicing asset, discount rate 14.00% 14.00%
Expected weighted-average loan life | Significant Unobservable Inputs (Level 3) | Minimum    
Loan life term 3 years 3 months 18 days 3 years 2 months 12 days
Expected weighted-average loan life | Significant Unobservable Inputs (Level 3) | Maximum    
Loan life term 5 years 3 months 18 days 5 years 8 months 12 days
Expected weighted-average loan life | Significant Unobservable Inputs (Level 3) | Weighted-Average Range    
Loan life term 4 years 8 months 12 days 5 years
v3.20.1
Benefit Plans (Details Textual) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Allocated share-based compensation expense $ 555 $ 478  
Compensation cost not yet recognized $ 3,600    
Period for recognition 2 years 1 month    
Percentage of annual retainer received in either common stock or deferred stock rights 100.00%    
Plan 2013      
Number of shares authorized (in shares)     750,000
Director      
Common stock shares reserved for future grants (in shares) 180,000    
Voting and Nonvoting Common Stock | Voting and Nonvoting Common Stock      
Allocated share-based compensation expense $ 555 $ 478  
v3.20.1
Subordinated Debt (Details Textual) - Subordinated Debt - USD ($)
1 Months Ended 3 Months Ended
Jun. 30, 2019
Mar. 31, 2020
Oct. 20, 2015
2025 Note      
Debt Instrument [Line Items]      
Subordinated debenture, principal amount     $ 10,000,000.0
Fixed annual interest rate (as a percent)     6.4375%
2026 Notes      
Debt Instrument [Line Items]      
Subordinated debenture, principal amount   $ 25,000,000.0  
Fixed annual interest rate (as a percent)   6.00%  
2029 Notes      
Debt Instrument [Line Items]      
Subordinated debenture, principal amount   $ 37,000,000.0  
Fixed annual interest rate (as a percent)   6.00%  
LIBOR | 2026 Notes      
Debt Instrument [Line Items]      
Basis spread on variable rate   485.00%  
LIBOR | 2029 Notes      
Debt Instrument [Line Items]      
Basis spread on variable rate 411.00%    
v3.20.1
Securities - Gross Unrealized Losses and Fair Value (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Less Than 12 Months, Fair Value $ 103,521 $ 127,335
Less Than 12 Months, Unrealized Losses (5,032) (2,571)
12 Months or Longer, Fair Value 98,719 176,218
12 Months or Longer, Unrealized Losses (7,376) (6,643)
Total, Fair Value 202,240 303,553
Total, Unrealized Losses (12,408) (9,214)
Held-to-maturity securities, Less Than 12 Months, Fair Value 2,814 13,977
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses (186) (132)
Held-to-maturity securities, 12 Months or Longer, Fair Value 0 0
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses 0 0
Held-to-maturity securities, Total, Fair Value 2,814 13,977
Held-to-maturity securities, Total, Unrealized Losses (186) (132)
U.S. Government-sponsored agencies    
Less Than 12 Months, Fair Value 3,274 4,820
Less Than 12 Months, Unrealized Losses (96) (61)
12 Months or Longer, Fair Value 57,775 62,182
12 Months or Longer, Unrealized Losses (1,725) (1,881)
Total, Fair Value 61,049 67,002
Total, Unrealized Losses (1,821) (1,942)
Municipal securities    
Less Than 12 Months, Fair Value 61,974 1,279
Less Than 12 Months, Unrealized Losses (4,211) (1,501)
12 Months or Longer, Fair Value 0 0
12 Months or Longer, Unrealized Losses 0 0
Total, Fair Value 61,974 1,279
Total, Unrealized Losses (4,211) (1,501)
Agency mortgage-backed securities    
Less Than 12 Months, Fair Value 18,798 91,159
Less Than 12 Months, Unrealized Losses (317) (829)
12 Months or Longer, Fair Value 13,516 83,212
12 Months or Longer, Unrealized Losses (3,410) (3,177)
Total, Fair Value 32,314 174,371
Total, Unrealized Losses (3,727) (4,006)
Private label mortgage-backed securities    
Less Than 12 Months, Fair Value 10,201 30,077
Less Than 12 Months, Unrealized Losses (122) (180)
12 Months or Longer, Fair Value 2,639 2,884
12 Months or Longer, Unrealized Losses (30) (8)
Total, Fair Value 12,840 32,961
Total, Unrealized Losses (152) (188)
Asset-backed securities    
Less Than 12 Months, Fair Value 0 0
Less Than 12 Months, Unrealized Losses 0 0
12 Months or Longer, Fair Value 4,713 4,955
12 Months or Longer, Unrealized Losses (287) (45)
Total, Fair Value 4,713 4,955
Total, Unrealized Losses (287) (45)
Corporate securities    
Less Than 12 Months, Fair Value 9,274 0
Less Than 12 Months, Unrealized Losses (286) 0
12 Months or Longer, Fair Value 20,076 22,985
12 Months or Longer, Unrealized Losses (1,924) (1,532)
Total, Fair Value 29,350 22,985
Total, Unrealized Losses (2,210) (1,532)
Held-to-maturity securities, Less Than 12 Months, Fair Value 2,814 13,977
Held-to-maturity securities, Less Than 12 Months, Unrealized Losses (186) (132)
Held-to-maturity securities, 12 Months or Longer, Fair Value 0 0
Held-to-maturity securities, 12 Months or Longer, Unrealized Losses 0 0
Held-to-maturity securities, Total, Fair Value 2,814 13,977
Held-to-maturity securities, Total, Unrealized Losses $ (186) $ (132)
v3.20.1
Loans - Change in the Balances of the ALLL (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Allowance for loan losses:    
Balance, beginning of period $ 21,840 $ 17,896
Provision (credit) charged to expense 1,461 1,285
Losses charged off (498) (429)
Recoveries 54 89
Balance, end of period 22,857 18,841
Commercial and industrial    
Allowance for loan losses:    
Balance, beginning of period 1,521 1,384
Provision (credit) charged to expense 346 79
Losses charged off (197) (112)
Recoveries 0 0
Balance, end of period 1,670 1,351
Owner-occupied commercial real estate    
Allowance for loan losses:    
Balance, beginning of period 561 783
Provision (credit) charged to expense 84 (38)
Losses charged off 0 0
Recoveries 0 0
Balance, end of period 645 745
Investor commercial real estate    
Allowance for loan losses:    
Balance, beginning of period 109 61
Provision (credit) charged to expense 19 42
Losses charged off 0 0
Recoveries 0 0
Balance, end of period 128 103
Construction    
Allowance for loan losses:    
Balance, beginning of period 380 251
Provision (credit) charged to expense 80 16
Losses charged off 0 0
Recoveries 0 0
Balance, end of period 460 267
Single tenant lease financing    
Allowance for loan losses:    
Balance, beginning of period 11,175 8,827
Provision (credit) charged to expense (420) 541
Losses charged off 0 0
Recoveries 0 0
Balance, end of period 10,755 9,368
Public finance    
Allowance for loan losses:    
Balance, beginning of period 1,580 1,670
Provision (credit) charged to expense (97) (20)
Losses charged off 0 0
Recoveries 0 0
Balance, end of period 1,483 1,650
Healthcare finance    
Allowance for loan losses:    
Balance, beginning of period 3,247 1,264
Provision (credit) charged to expense 1,071 467
Losses charged off 0 0
Recoveries 0 0
Balance, end of period 4,318 1,731
Small business lending    
Allowance for loan losses:    
Balance, beginning of period 54 203
Provision (credit) charged to expense 203 (8)
Losses charged off 0 0
Recoveries 8 0
Balance, end of period 265 195
Residential mortgage    
Allowance for loan losses:    
Balance, beginning of period 657 1,079
Provision (credit) charged to expense (143) (36)
Losses charged off (15) 0
Recoveries 1 1
Balance, end of period 500 1,044
Home equity    
Allowance for loan losses:    
Balance, beginning of period 46 53
Provision (credit) charged to expense 5 (6)
Losses charged off 0 0
Recoveries 2 2
Balance, end of period 53 49
Other consumer    
Allowance for loan losses:    
Balance, beginning of period 2,510 2,321
Provision (credit) charged to expense 313 248
Losses charged off (286) (317)
Recoveries 43 86
Balance, end of period $ 2,580 $ 2,338
v3.20.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Weighted Average Number of Shares
The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three months ended March 31, 2020 and 2019
(dollars in thousands, except per share data)
 
Three Months Ended March 31,
 
 
2020
 
2019
Basic earnings per share
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Weighted-average common shares
 
9,721,485

 
10,217,637

Basic earnings per common share
 
$
0.62

 
$
0.56

Diluted earnings per share
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Weighted-average common shares
 
9,721,485

 
10,217,637

Dilutive effect of equity compensation
 
29,043

 
12,894

     Weighted-average common and incremental shares
 
9,750,528

 
10,230,531

Diluted earnings per common share (1)
 
$
0.62

 
$
0.56


(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 8,575 and 45,565 for the three months ended March 31, 2020 and 2019, respectively
v3.20.1
Mortgage Banking Activities
3 Months Ended
Mar. 31, 2020
Mortgage Banking [Abstract]  
Mortgage Banking Activities
Mortgage Banking Activities

The Company’s residential real estate lending business originates mortgage loans for customers and typically sells a majority of the originated loans into the secondary market. For most of the mortgages it sells in the secondary market, the Company hedges its mortgage banking pipeline by entering into forward contracts for the future delivery of mortgage loans to third party investors and entering into IRLCs with potential borrowers to fund specific mortgage loans that will be sold into the secondary market. To facilitate the hedging of the loans, the Company has elected the fair value option for loans originated and intended for sale in the secondary market under mandatory pricing agreements. Changes in the fair value of loans held-for-sale, IRLCs and forward contracts are recorded in the mortgage banking activities line item within noninterest income.  Refer to Note 14 for further information on derivative financial instruments. 

During the three months ended March 31, 2020 and 2019, the Company originated mortgage loans held-for-sale of $215.4 million and $75.2 million, respectively, and sold $225.5 million and $81.0 million of mortgage loans, respectively, into the secondary market. Additionally, the Company sold $90.8 million of portfolio residential mortgage loans during the three months ended March 31, 2020 and sold $5.2 million of portfolio residential mortgage loans during the three months ended March 31, 2019.

The following table presents the components of income from mortgage banking activities for the three months ended March 31, 2020 and 2019.
 
Three Months Ended March 31,
(in thousands)
2020
 
2019
Gain on loans sold
$
4,343

 
$
1,473

Gain (loss) resulting from the change in fair value of loans held-for-sale
316

 
(182
)
(Loss) gain resulting from the change in fair value of derivatives
(991
)
 
326

Net revenue from mortgage banking activities
$
3,668

 
$
1,617



Fluctuations in interest rates and changes in IRLC and loan volume within the mortgage banking pipeline may cause volatility in the fair value of loans held-for-sale and the fair value of derivatives used to hedge the mortgage banking pipeline.
v3.20.1
Benefit Plans - Deferred Stock Rights (Details)
3 Months Ended
Mar. 31, 2020
shares
Deferred Stock Rights  
Outstanding, beginning of period 84,505
Granted 214
Exercised 0
Outstanding, end of period 84,719
v3.20.1
Servicing Asset - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Servicing Assets at Fair Value [Line Items]    
Changes in fair value $ (179,000) $ 0
Loan servicing    
Servicing Assets at Fair Value [Line Items]    
Loan servicing revenue 251,000 $ 0
Changes in fair value $ (200,000)  
v3.20.1
Fair Value of Financial Instruments - Fair Value Roll Forward (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Interest Rate Lock Commitments    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 910 $ 389
Additions 0  
Included in net income 1,154 392
Ending balance 2,064 781
Servicing asset    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance 2,481 0
Additions 113  
Included in net income (179) 0
Ending balance $ 2,415 $ 0
v3.20.1
Securities (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Investments, Debt and Equity Securities [Abstract]        
Available-for-sale securities, gross realized gain (loss) $ 41 $ 0    
Continuous unrealized loss position, fair value $ 205,100     $ 317,500
Continuous unrealized loss position, fair value (as a percent) 30.00%   53.00%  
v3.20.1
Loans - Recorded Investments in Loans (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Loans:        
Ending balance: collectively evaluated for impairment $ 2,815,742 $ 2,905,560    
Ending balance: individually evaluated for impairment 10,908 14,421    
Total Loans Receivable 2,826,650 2,919,981    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 21,088 20,071    
Ending balance: individually evaluated for impairment 1,769 1,769    
Ending balance 22,857 21,840 $ 18,841 $ 17,896
Commercial and industrial        
Loans:        
Ending balance: collectively evaluated for impairment 94,329 93,520    
Ending balance: individually evaluated for impairment 898 2,900    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 1,561 1,412    
Ending balance: individually evaluated for impairment 109 109    
Ending balance 1,670 1,521 1,351 1,384
Owner-occupied commercial real estate        
Loans:        
Ending balance: collectively evaluated for impairment 74,142 71,067    
Ending balance: individually evaluated for impairment 595 2,325    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 645 561    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 645 561 745 783
Investor commercial real estate        
Loans:        
Ending balance: collectively evaluated for impairment 13,421 12,567    
Ending balance: individually evaluated for impairment 0 0    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 128 109    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 128 109 103 61
Construction        
Loans:        
Ending balance: collectively evaluated for impairment 64,581 60,274    
Ending balance: individually evaluated for impairment 0 0    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 460 380    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 460 380 267 251
Single tenant lease financing        
Loans:        
Ending balance: collectively evaluated for impairment 967,595 991,199    
Ending balance: individually evaluated for impairment 4,680 4,680    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 9,095 9,515    
Ending balance: individually evaluated for impairment 1,660 1,660    
Ending balance 10,755 11,175 9,368 8,827
Public finance        
Loans:        
Ending balance: collectively evaluated for impairment 627,678 687,094    
Ending balance: individually evaluated for impairment 0 0    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 1,483 1,580    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 1,483 1,580 1,650 1,670
Healthcare finance        
Loans:        
Ending balance: collectively evaluated for impairment 372,266 300,612    
Ending balance: individually evaluated for impairment 0 0    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 4,318 3,247    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 4,318 3,247 1,731 1,264
Small business lending        
Loans:        
Ending balance: collectively evaluated for impairment 63,948 56,941    
Ending balance: individually evaluated for impairment 3,327 3,338    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 265 54    
Ending balance 265 54 195 203
Residential mortgage        
Loans:        
Ending balance: collectively evaluated for impairment 217,370 312,714    
Ending balance: individually evaluated for impairment 1,360 1,135    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 500 657    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 500 657 1,044 1,079
Home equity        
Loans:        
Ending balance: collectively evaluated for impairment 23,855 24,306    
Ending balance: individually evaluated for impairment 0 0    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 53 46    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 53 46 49 53
Other consumer        
Loans:        
Ending balance: collectively evaluated for impairment 296,557 295,266    
Ending balance: individually evaluated for impairment 48 43    
Allowance for loan losses:        
Ending balance: collectively evaluated for impairment 2,580 2,510    
Ending balance: individually evaluated for impairment 0 0    
Ending balance 2,580 2,510 $ 2,338 $ 2,321
Commercial Portfolio Segment        
Loans:        
Total Loans Receivable 2,287,460 2,286,517    
Commercial Portfolio Segment | Commercial and industrial        
Loans:        
Total Loans Receivable 95,227 96,420    
Commercial Portfolio Segment | Owner-occupied commercial real estate        
Loans:        
Total Loans Receivable 74,737 73,392    
Commercial Portfolio Segment | Investor commercial real estate        
Loans:        
Total Loans Receivable 13,421 12,567    
Commercial Portfolio Segment | Construction        
Loans:        
Total Loans Receivable 64,581 60,274    
Commercial Portfolio Segment | Single tenant lease financing        
Loans:        
Total Loans Receivable 972,275 995,879    
Commercial Portfolio Segment | Public finance        
Loans:        
Total Loans Receivable 627,678 687,094    
Commercial Portfolio Segment | Healthcare finance        
Loans:        
Total Loans Receivable 372,266 300,612    
Commercial Portfolio Segment | Small business lending        
Loans:        
Total Loans Receivable $ 67,275 $ 60,279    
v3.20.1
Derivative Financial Instruments - Carrying Amount and Adjustment (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Amortized cost, at fair value $ 608,567 $ 546,640
Derivatives designated as hedging instruments    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Amortized cost, at fair value 88,200  
Loans | Derivatives designated as hedging instruments    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Carrying amount of the hedged assets 494,019 474,957
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets 44,586 21,440
Securities available-for-sale | Derivatives designated as hedging instruments    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Carrying amount of the hedged assets 152,551 151,538
Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets $ 6,790 $ 2,802
v3.20.1
Derivative Financial Instruments - Gain (Loss) Recognized (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Asset Derivatives | Interest Rate Lock Commitments    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net $ 1,154 $ 392
Forward contracts | Liability Derivatives    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net $ (2,145) $ (67)
v3.20.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Amortized cost, at fair value $ 608,567 $ 546,640
Held-to-maturity, at fair value 69,468 62,560
Loans held-for-sale, at fair value 52,394 56,097
Unamortized discounts and debt issuance costs $ 2,395 $ 2,472
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, shares authorized (in shares) 4,913,779 4,913,779
Preferred stock, shares issued (in shares) 0 0
Preferred stock, share outstanding (in shares) 0 0
Voting Common Stock    
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 45,000,000 45,000,000
Common stock, shares issued (in shares) 9,741,800 10,170,778
Common stock, shares outstanding (in shares) 9,741,800 10,170,778
Nonvoting Common Stock    
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 86,221 86,221
Common stock, shares issued (in shares) 0 0
Common stock, shares outstanding (in shares) 0 0
v3.20.1
Leases - Maturity (Details)
$ in Thousands
Mar. 31, 2020
USD ($)
Leases [Abstract]  
2021 $ 824
2022 315
2023 230
2024 58
2025 0
Thereafter 0
Total lease payments 1,427
Less: imputed interest (39)
Operating lease liabilities $ 1,388
v3.20.1
- Summary (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]    
Less: accumulated depreciation $ (9,616) $ (9,165)
Premises and equipment, net 18,883 14,630
Land    
Property, Plant and Equipment [Line Items]    
Premises and equipment, gross 2,500 2,500
Right of use leased asset    
Property, Plant and Equipment [Line Items]    
Premises and equipment, gross 1,450 1,602
Building and improvements    
Property, Plant and Equipment [Line Items]    
Premises and equipment, gross 14,291 10,004
Furniture and equipment    
Property, Plant and Equipment [Line Items]    
Premises and equipment, gross $ 10,258 $ 9,689
v3.20.1
Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Stockholders' Equity [Abstract]    
Dividends declared (in dollars per share) $ 0.06 $ 0.06
v3.20.1
Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
Nonvested Restricted Stock Shares Activity
The following table summarizes the status of the 2013 Plan awards as of March 31, 2020, and activity for the three months ended March 31, 2020.
 
Restricted Stock Units
 
Weighted-Average Grant Date Fair Value Per Share
 
Restricted Stock Awards
 
Weighted-Average Grant Date Fair Value Per Share
 
Deferred Stock Units
 
Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2019
107,244

 
$
29.03

 

 
$

 

 
$

   Granted
66,756

 
27.56

 
13,164

 
27.56

 
3

 
23.48

   Vested
(48,499
)
 
30.34

 
(3,336
)
 
27.56

 
(3
)
 
23.48

   Forfeited

 

 
(1,638
)
 
27.56

 

 

Nonvested at March 31, 2020
125,501

 
$
27.74

 
8,190

 
$
27.56

 

 
$

Schedule Of Deferred Stock Option Plan
The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the three months ended March 31, 2020.
 
 
Deferred Stock Rights
Outstanding, beginning of period
 
84,505

Granted
 
214

Exercised
 

Outstanding, end of period
 
84,719

v3.20.1
Accumulated Other Comprehensive Loss (Tables)
3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
Amounts reclassified from accumulated other comprehensive loss and the affected line items in the condensed consolidated statements of income during the three months ended March 31, 2020 were as follows:

(in thousands)



Details About Accumulated Other Comprehensive Loss Components
 
 
 
Affected Line Item in the
Statements of Income
 
Three Months Ended March 31, 2020
 
Realized gains on securities available-for-sale
 
 

 
 
Gain realized in earnings
 
$
41

 
Gain on sale of securities
Total reclassified amount before tax
 
41

 
Income Before Income Taxes
Tax expense
 
11

 
Income Tax Provision
Total reclassifications out of accumulated other comprehensive loss
 
$
30

 
Net Income

The components of accumulated other comprehensive loss, included in stockholders' equity, are presented in the table below.
(in thousands)
 
Available-For-Sale Securities
 
Cash Flow Hedges
 
Total
Balance, January 1, 2020
 
$
(4,388
)
 
$
(9,803
)
 
$
(14,191
)
Net change in unrealized gain (loss)
 
6,299

 
(13,458
)
 
(7,159
)
Reclassification of gain realized and included in earnings
 
(41
)
 

 
(41
)
Accumulated other comprehensive income (loss) before income tax
 
1,870

 
(23,261
)
 
(21,391
)
Income tax provision (benefit)
 
2,109

 
(3,634
)
 
(1,525
)
Balance, March 31, 2020
 
$
(239
)
 
$
(19,627
)
 
$
(19,866
)
 
 
 
 
 
 
 
Balance, January 1, 2019
 
$
(13,360
)
 
$
(3,181
)
 
$
(16,541
)
Net change in unrealized gain (loss)
 
6,910

 
(3,572
)
 
3,338

Accumulated other comprehensive loss before income tax
 
(6,450
)
 
(6,753
)
 
(13,203
)
Income tax provision (benefit)
 
1,930

 
(965
)
 
965

Balance, March 31, 2019
 
$
(8,380
)
 
$
(5,788
)
 
$
(14,168
)
v3.20.1
Leases
3 Months Ended
Mar. 31, 2020
Leases [Abstract]  
Leases
Leases

A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property or equipment for a period of time in exchange for consideration. On January 1, 2019, the Company adopted ASU 2016-02 - Leases (Topic 842) and elected the optional transition method, which allows the Company to not separate non-lease components from the associated lease component if certain conditions are met. In addition, the Company elected not to adjust prior comparative periods.

The Company has two operating leases that are used for general office operations with remaining lease terms of two to four years. With the adoption of ASU 2016-02, operating lease agreements are required to be recognized on the condensed consolidated balance sheets as a right-of-use asset and a corresponding lease liability.

The following table shows the components of lease expense.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Operating lease cost
 
$
215

 
$
187



The following table shows supplemental cash flow information related to leases.

(in thousands)
 
Three Months Ended
 
 
March 31, 2020
 
March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
 
 
 
 
     Operating cash flows from operating leases
 
$
231

 
$
200



The following table shows the operating leases’ impact on the condensed consolidated balance sheets. The Company elected not to include short-term leases (leases with original terms of 12 months or less) or equipment leases, as those amounts are insignificant. The Company’s leases do not provide an implicit rate. The discount rate utilized to determine the present value of lease payments is the Company’s incremental borrowing rate based on the information available at the lease inception date. The incremental borrowing rate is the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment.
(dollars in thousands)
 
 
 
 
March 31, 2020
 
December 31, 2019
Operating lease right-of-use assets
 
$
(1,485
)
 
$
1,602

Operating lease liabilities
 
(1,485
)
 
1,602

 
 
 
 
 
Weighted-average remaining lease term (years)
 
 
 
 
     Operating leases
 
2.2

 
2.4

 
 
 
 
 
Weighted-average discount rate
 
 
 
 
     Operating leases
 
2.0
%
 
2.0
%


The following table shows the future minimum payments of operating leases with initial or remaining terms of one year or more as of March 31, 2020.

(in thousands)
 
 
Twelve months ended March 31,
 
 
2021
 
$
824

2022
 
315

2023
 
230

2024
 
58

2025
 

Thereafter
 

Total lease payments
 
1,427

     Less: imputed interest
 
(39
)
Total
 
$
1,388

v3.20.1
Earnings Per Share
3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
 
Earnings per share of common stock are based on the weighted-average number of basic shares and dilutive shares outstanding during the period.
 
The following is a reconciliation of the weighted-average common shares for the basic and diluted earnings per share computations for the three months ended March 31, 2020 and 2019
(dollars in thousands, except per share data)
 
Three Months Ended March 31,
 
 
2020
 
2019
Basic earnings per share
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Weighted-average common shares
 
9,721,485

 
10,217,637

Basic earnings per common share
 
$
0.62

 
$
0.56

Diluted earnings per share
 
 

 
 

Net income
 
$
6,019

 
$
5,696

Weighted-average common shares
 
9,721,485

 
10,217,637

Dilutive effect of equity compensation
 
29,043

 
12,894

     Weighted-average common and incremental shares
 
9,750,528

 
10,230,531

Diluted earnings per common share (1)
 
$
0.62

 
$
0.56


(1) Potential dilutive common shares are excluded from the computation of diluted EPS in the periods where the effect would be antidilutive. Excluded from the computation of diluted EPS were weighted-average antidilutive shares totaling 8,575 and 45,565 for the three months ended March 31, 2020 and 2019, respectively.
v3.20.1
Benefit Plans
3 Months Ended
Mar. 31, 2020
Retirement Benefits [Abstract]  
Benefit Plans
Benefit Plans
 
Employment Agreement
 
The Company is party to an employment agreement with its Chief Executive Officer that provides for an annual base salary and an annual bonus, if any, as determined from time to time by the Compensation Committee of our Board of Directors. The annual bonus is to be determined with reference to the achievement of annual performance objectives established by the Compensation Committee for the Chief Executive Officer and other senior officers. The agreement also provides that the Chief Executive Officer may be awarded additional compensation, benefits, or consideration as the Compensation Committee may determine.

The agreement provides for the continuation of salary and certain other benefits for a specified period of time upon termination of his employment under certain circumstances, including his resignation for “good reason” or termination by the Company without “cause” at any time or any termination of his employment for any reason within twelve months following a “change in control,” along with other specific conditions.
 
2013 Equity Incentive Plan
 
The 2013 Equity Incentive Plan (the “2013 Plan”) authorizes the issuance of 750,000 shares of the Company’s common stock in the form of equity-based awards to employees, directors, and other eligible persons.  Under the terms of the 2013 Plan, the pool of shares available for issuance may be used for available types of equity awards under the 2013 Plan, which includes stock options, stock appreciation rights, restricted stock awards, stock unit awards, and other share-based awards.  All employees, consultants, and advisors of the Company or any subsidiary, as well as all non-employee directors of the Company, are eligible to receive awards under the 2013 Plan.

The Company recorded $0.6 million of share-based compensation expense for the three months ended March 31, 2020, related to awards made under the 2013 Plan. The company recorded $0.5 million of share-based compensation expense for the three months ended March 31, 2019, related to awards made under the 2013 plan.

The following table summarizes the status of the 2013 Plan awards as of March 31, 2020, and activity for the three months ended March 31, 2020.
 
Restricted Stock Units
 
Weighted-Average Grant Date Fair Value Per Share
 
Restricted Stock Awards
 
Weighted-Average Grant Date Fair Value Per Share
 
Deferred Stock Units
 
Weighted-Average Grant Date Fair Value Per Share
Nonvested at December 31, 2019
107,244

 
$
29.03

 

 
$

 

 
$

   Granted
66,756

 
27.56

 
13,164

 
27.56

 
3

 
23.48

   Vested
(48,499
)
 
30.34

 
(3,336
)
 
27.56

 
(3
)
 
23.48

   Forfeited

 

 
(1,638
)
 
27.56

 

 

Nonvested at March 31, 2020
125,501

 
$
27.74

 
8,190

 
$
27.56

 

 
$



At March 31, 2020, the total unrecognized compensation cost related to nonvested awards was $3.6 million with a weighted-average expense recognition period of 2.1 years.

Directors Deferred Stock Plan
 
Until January 1, 2014, the Company had a practice of granting awards under a stock compensation plan for members of the Board of Directors (“Directors Deferred Stock Plan”). The Company reserved 180,000 shares of common stock that could have been issued pursuant to the Directors Deferred Stock Plan. The Directors Deferred Stock Plan provided directors the option to elect to receive up to 100% of their annual retainer in either common stock or deferred stock rights. Deferred stock rights were to be settled in common stock following the end of the deferral period payable on the basis of one share of common stock for each deferred stock right.
 
The following table summarizes the status of deferred stock rights related to the Directors Deferred Stock Plan for the three months ended March 31, 2020.
 
 
Deferred Stock Rights
Outstanding, beginning of period
 
84,505

Granted
 
214

Exercised
 

Outstanding, end of period
 
84,719



All deferred stock rights granted during the 2020 period were additional rights issued in lieu of cash dividends payable on outstanding deferred stock rights.